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ABSTRACT
Two high molecular weight complexes of alkaline
phosphatase in serum have been studied with a view to
discovering their nature and evaluating their respective
roles in clinical diagnosis. One of these ('slow band
alkaline phosphatase') was shown by inhibition and
immunochemical studies to consist of liver or bone
alkaline phosphatase attached to immunoglobulin G. It
appears only rarely in serum and is not useful in clinical
diagnosis. The other complex ('high molecular weight
alkaline phosphatase') was more intensively investigated.
Following purification from serum and bile, kinetic
studies showed that it resembled the normal liver iso¬
enzyme in serum and the low molecular weight isoenzymes in
bile. Other enzymes which derive from the liver cell
membrane were found to have similar high molecular weight
complexes which had similar electrophoretic and chromato¬
graphic properties. All the complexes were destroyed by
butanol extraction and converted to lower molecular
weight forms by detergents. Immunochemical experiments
showed that all the complexes shared antigenic determin¬
ants with lipoprotein X, although in many sera large
amounts of high molecular weight alkaline phosphatase were
present in the absence of detectable lipoprotein X. Using
the results of these experiments and other research in a
variety of fields, it is suggested that high molecular
weight alkaline phosphatase may consist of a family of
membrane fragments of two main interconvertible forms:
one equivalent to biliary lipoprotein, the other
equivalent to lipoprotein X. Only the former is present
in bile, but either of the two may be present in serum
depending on various conditions. Clinical evaluation
showed that measurement of the activity of high molecular
weight alkaline phosphatase in serum was a sensitive test
for obstructive liver disease and was particularly useful
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Alkaline phosphatase (E.C.3.1.3.1.), first
described by Robison (1923), is a dimeric zinc-containing
glycoprotein which catalyses the hydrolysis of a wide
range of phosphomonoesters at alkaline pH. The amino
acid sequence of the enzyme has not yet been established
but the active site probably contains a serine residue
to which the phosphate group of the substrate binds
during catalysis to form a phosphoryl-enzyme intermediate
(Engstrom, 1961). Magnesium ions are necessary for this
function .
Most human tissues contain alkaline phosphatase
(ALP), intestine, liver, kidney, bone and spleen being
particularly rich sources. The enzymes derived from
these tissues share the same broad catalytic properties
but differ in their detailed kinetic and physical
characteristics. Historically, the term 'isozyme' or
'isoenzyme' has been used to denote the different
molecular forms in which proteins may exist with
similar enzymatic specificity (Markert and Miller, 1959)
and this term has been applied to the ALPs derived from
different tissues in a single species e.g. liver iso¬
enzyme, bone isoenzyme etc. However, recent recommenda-
-2-
tions (the International Union of Pure and Applied
Chemistry and the International Union of Biochemistry
Commission on Biochemical Nomenclature, 1976) reserve
the term 'isoenzyme' for those multiple forms of enzymes
arising from genetically determined differences in
primary structure and not those derived by modification
of the same primary sequence. Such information is not
yet available for ALP. Moreover, the Commission
discourages the application of labels on the basis of
tissue distribution since confusion may arise on account
of species variation. Instead, they recommend labelling
on the basis of electrophoretic mobility. Nevertheless,
the terms liver isoenzyme, bone isoenzyme etc. will be
employed for the ALP forms deriving from these tissues
for the following reasonsj
1) only the human species is considered in this thesis
2) the relative mobilities of the ALP molecular forms
vary according to the electrophoretic medium employed
3) it seems desirable to maintain continuity with the
literature and established practice.
In this context, the term 'liver isoenzyme' denotes the
ALP of relatively low molecular weight (mol wt), namely
approximately 200 000, which derives from the liver.
-3-
1.1. THE ISOENZYMES OF ALKALINE PHOSPHATASE
1.1.1. Function of isoenzymes in tissues
The function of the various ALP isoenzymes is
largely uncertain. The bone isoenzyme appears to play a
role in the calcification and resorption of bone by a
combination of local supersaturation of phosphate
following hydrolysis of organic phosphate esters, and
removal of the inhibitor pyrophosphate (Russell et al,
1969). The intestinal isoenzyme is probably involved
in calcium and fat absorption (Warnock, 1968; Norman et
al, 1970) . The localisation of the enzyme on the small
intestinal mucosa, the proximal convoluted tubule of the
kidney, the syncytiotrophoblast of the placenta and the
sinusoidal and bile canalicular membranes of the hepato-
cyte all suggests a transport function. Pekarthy et al
(1972) have proposed that liver ALP is involved in the
transhepatic transport of choline by hydrolysis of
phosphorylcholine.
1.1.2. Serum isoenzymes
There are three ALP isoenzymes which appear in the
serum of healthy individuals: liver, bone and intestinal.
The placental isoenzyme appears in the serum of women in
the last trimester of pregnancy. These isoenzymes have
similar mol wts, of the order of 200 000, but they can be
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distinguished using a number of criteria:
1) Electrophoretic mobility. The liver, bone and
intestinal isoenzymes migrate with different mobilities
towards the anode during electrophoresis (see section
1.3.1.). If the serum is pre-incubated with neuramini¬
dase, the mobility of the liver and bone isoenzymes is
greatly decreased, indicating loss of sialic acid
residues . The intestinal isoenzyme, on the other hand,
does not alter its mobility, indicating either that it
has no sialic acid residues or that they are inaccessible
(Robinson and pierce, 1964).
2) Inhibition. The intestinal and placental isoenzymes
are strongly inhibited by L-phenylalanine whereas the
liver and bone isoenzymes are little affected (Fishman
et al, 1963). On the other hand, the liver and bone
isoenzymes are strongly inhibited by L-homoarginine
whereas the intestinal and placental isoenzymes are little
affected (Lin and Fishman, 1972). Both these inhibitions
are of the uncommon uncompetitive type in which the
inhibitor combines only with the enzyme-substrate
intermediate.
3) Inactivation by urea and heat. Liver ALP can be
distinguished from bone ALP and from the intestinal and
placental isoenzymes by their differential stability to
-5-
urea and heat. The isoenzymes are inactivated by urea,
which ruptures hydrogen bonds, in the following order of
lability: bone liver intestinal > placental (Bahr
and Wilkinson, 1967). In fact, the liver isoenzyme is
slightly activated at low urea concentrations, unlike
the other isoenzymes. Heating at 56°C inactivates the
isoenzymes in the following order of lability: boneJ>
liver >intestinal > placental (Petit Clerc, 1976) . At
65°C, all the isoenzymes except the placental are rapidly
inactivated.
4) Immunological properties. Different results have
been obtained depending upon the purity of the isoenzymes
used to raise antisera. Liver and bone ALP may belong
either to a single immunological class (Boyer, 1963) or
to two separate classes (Sussman et al, 1968), while the
intestinal and placental isoenzymes form two further
distinct classes (Boyer, 1963; Sussman et al, 1968).
1.2. THEORIES FOR SERUM ALKALINE PHOSPHATASE ELEVATIONS
IN DISEASE
Total serum ALP activities are increased in a
number of diseases affecting bone (e.g. Paget's disease,
osteomalacia) and liver (e.g. extrahepatic obstruction,
metastatic liver disease). Historically, there have been
a number of theories to account for this increase:
1) The retention theory, proposed by Gutman (1959), which
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postulated that all the ALP in serum derived from bone,
and that the principal method of removal of the enzyme
from the circulation was by excretion via the liver into
bile. The increase seen in osteoblastic bone disease was
a consequence of an increased rate of release of this ALP
into the circulation whereas the increase seen in liver
disease, particularly of a cholestatic type, was held to
be a consequence of failure of the liver to excrete this
bone enzyme into bile.
2) The hepatogenic theory (Hill and Sammons, 1967) which
suggested that the increase in ALP in liver disease arose,
not from failure to excrete a bone enzyme, but from
release of an enzyme deriving from the liver into the
circulation, possibly because it could not pass down the
biliary tract and was therefore regurgitated into serum
via canicular-sinusoidal connections. It was suggested
that both the bone enzyme and the liver enzyme were
removed from the circulation by catabolism rather than by
excretion, in a similar way to other plasma proteins.
3) The induction theory, first proposed by polin et al
(1962), which was a refinement of the hepatogenic theory.
This suggested that the mechanism of the increased rate
of release of liver ALP into plasma during cholestasis
was by induction of synthesis rather than either release
-7-
of pre-existing liver ALP into the circulation or
activation of the enzyme in the liver and circulation.
The retention theory has now been abandoned for
a number of reasons:
a) The demonstration of different isoenzymes in serum,
the properties of which closely resembled those of
isoenzymes extracted from liver, bone and intestine
(Hodson et al, 1962), made it clear that not all ALP
derives from bone. In bone disease the bone isoenzyme
in serum may be elevated whereas in liver disease the
liver isoenzyme may be raised.
b) Injection of plasma from dogs with a ligated common
bile duct into normal recipient dogs resulted in
continued high activities in the recipient dogs for
48 hours with very little of the infused ALP being
excreted in bile (Cantarow and Miller, 1948).
Similarly injection of purified human placental ALP
(measured by its heat stability) into humans demons¬
trated that in both normal subjects and patients with
biliary obstruction with raised endogenous ALP serum
levels, the placental isoenzyme followed a decay curve
in serum similar to that observed for other plasma
proteins (Clubb et al, 1965).
c) Little ALP activity is present in normal hepatic bile,
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insufficient to identify bile as a major route of
excretion. Furthermore, the isoenzyme pattern of
bile differs from that of normal serum.
The accumulated evidence therefore led to the adoption of
the hepatogenic theory.
Evidence for the induction theory stems from bile
duct ligation experiments in animals. Polin et al (1962)
first demonstrated that ligation of one hepatic duct in
dogs caused a) an increase in ALP in bile collected from
the other duct, b) a 10-fold increase in liver ALP, c) an
increase in serum ALP in the absence of hyperbilirubin-
aemia. They suggested that induction rather than decreased
excretion caused these elevations. Similar conclusions
were drawn following experimental biliary occlusion in
isolated perfused cat livers (Sebesta et al, 1964).
Further experiments involving bile duct ligation in rats
demonstrated that the increase in serum ALP lagged behind
the increase in liver ALP and both increases could be
prevented in vivo using inhibitors of protein synthesis
such as ethionine, cycloheximide and actinomycin D
(Bornig et al, 1967; Kaplan and Righetti, 1969; Kryszewski
et al, 1973). The induction theory is therefore now
widely accepted. It is presumed that the inducer is some
chemical substance, normally excreted in bile, which rises
-9-
?
in concentration during biliary obstruction. The
identity of this substance has not been proved although
Pekarthy et al (1972) suggest phosphorylcholine as a
possibility.
1.3. ISOENZYME PATTERNS IN HEALTH AND DISEASE
1.3.1. Electrophoretic techniques
Electrophoretic media which have been employed to
separate ALP isoenzymes can be divided into two classes:
a) those which do so principally on the basis of charge
differences and b) those which do so on the basis of a
combination of charge differences and molecular sieving
effects. Into the first category fall paper (Hill and
Sammons, 1967), agar, agarose (in the concentrations
generally employed, Demetriou and Beattie, 1971) and
cellulose acetate (Fritsche and Adams-park, 1972) . Starch
gel (Chiandussi et al, 1962; Hodson et al, 1962), poly-
acrylamide gel (Smith et al, 1968) and thin-layer
Sephadex G200 (Inglis et al, 1968) fall into the second
group.
In Health. In normal healthy individuals, only a limited
number of isoenzyme bands can be visualised in any of
these media. In general, the liver isoenzyme has the
fastest mobility. It may or may not be resolved from the
bone isoenzyme (only polyacrylamide gel can completely
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resolve them) which tends to be a broader more diffuse
band running immediately behind the liver isoenzyme. In
some individuals, particularly in those of 0 or B blood
groups who are also secretors, the intestinal isoenzyme
is also present, running with lower mobility than either
the liver or bone isoenzymes. In starch gel alone, a
further band may be seen in healthy individuals, migrating
in the ^lipoprotein position. This band may be intensified
in either liver or bone disease (Chiandussi et al, 1962;
Hodson et al, 1962; du Buisson and Pepler, 1966; Hill and
Sammons, 1967) .
In disease, various characteristic isoenzyme patt¬
erns may be seen.
Cancer-specific isoenzymes. Carcinoma of a wide variety
of primary sites may give rise to a new band corresponding
to the Regan isoenzyme. This is a cancer-specific enzyme
which has properties identical to those of the placental
isoenzyme, including inhibition by L-phenylalanine,
stability to heat and immunological properties (Fishman,
Inglis, Stolbach and Krant, 1968).
An isoenzyme similar to the Regan isoenzyme has
been described in patients with carcinoma of the liver or
gastrointestinal tract only. This is the Regan variant
or Kasahara isoenzyme (Higashino et al, 1972; Crofton
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and Smith, 1978). It is much rarer than the Regan iso¬
enzyme and differs from it in its lower heat stability
and higher electrophoretic mobility.
Bone disease. Bone disease of an osteoblastic type may
be accompanied by an increase in the bone isoenzyme band
in all the electrophoretic media.
Liver disease. The liver isoenzyme may be increased,
particularly in liver disease of an obstructive type. In
addition, a new band may appear on electrophoresis in
various media (Table 1.1). Any evidence for the identity
or non-identity of these bands has been very limited and
purely circumstantial e.g. Fritsche and Adams-Park (1972)
found that the same sera which possessed an isoenzyme
with pre-liver mobility on cellulose acetate also had an
origin band in polyacrylamide gel. No systematic studies
have been attempted.
Bile. Bile has been less investigated than serum.
Electrophoresis in paper gives an origin band only (Hill
and Sammons, 1967). In cellulose acetate, bile has two
isoenzyme bands, one in the bone isoenzyme position and
one with a pre-liver isoenzyme mobility (Fritsche and Adams-
Park, 1972). In starch gel, various combinations of bands
have been observed, frequently but not invariably similar
to the patterns seen in serum from patients with liver
•12-
TABLE 1.1.
position of extra electrophoretic bands which may appear
















































disease (Chiandussi et al, 1962; Pope and Cooperband,
1966; Hill and Sammons, 1967) .
1.3.2. Gel filtration chromatography
Estborn (1964) first applied gel filtration
chromatography to normal serum ALP: two peaks were
obtained on Sephadex G200, the major peak eluting with
proteins of approximately 200 000 mol wt and a minor
peak with proteins of mol wt greater than 800 000 (i.e.
with the and 3^ microglobulins, and the a and 3
lipoproteins) in the void volume. Akedo et al (1967)
showed that the void volume peak showed an increase
relative to the lower mol wt peak in liver disease but
gave no quantitative analysis of the results. Later,
Fennelly et al (1969) measured the void volume peak and
found that it comprised 2% of the total activity in
controls, 1% in non-metastatic bone disease, 6% in meta¬
static bone disease, 16% in non-metastatic liver disease
and 36% in metastatic liver disease. This was therefore
a high mol wt ALP which seemed to be virtually specific
for liver disease. In bile, nearly all the ALP activity
was in the void volume peak (price and Sammons, 1974).
Although the appearance in liver disease of the
new electrophoretic bands summarised in Table 1.1 and the
Sephadex G200 high mol wt peak provided circumstantial
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evidence that they might be related, no studies have been
performed to relate electrophoretic to gel filtration
findings except one which showed that the excluded
fraction on Sephadex G200 remained at the origin on poly-
acrylamide gel electrophoresis (price and Sammons, 1974).
Similar void volume peaks on Sepharose 4B chromato¬
graphy have been described for membrane marker enzymes
adenosinetriphosphatase, leucine aminopeptidase and
51 nucleotidase by Shinkai and Akedo (1972) . These
workers suggest that high mol wt ALP consists of a multi-
enzyme complex which represents a fragment of plasma
membrane released from the liver in liver disease. This
hypothesis is tested and explored in this thesis.
1.4. A RARE HIGH MOLECULAR WEIGHT FORM OF ALKALINE
PHOSPHATASE
Using starch gel electrophoresis, an atypical
slowly migrating zone of ALP activity (slow band) was
first reported by Streifler et al (1972) in a patient
with ulcerative colitis. This was followed by a paper by
Qirbi and Moss (1975) which described the occurrence of a
similar slow band on polyacrylamide gel electrophoresis
in a further 3 out of a total of 54 patients with ulcera¬
tive colitis or Crohn's disease. In each case the slow
band formed between 50 and 100% of the total ALP activity.
Isolated reports of similar slow bands have also appeared
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(Nagamine and Ohkuma, 1975; Lee, 197 6) . Dingjan et al
(1975) found a slow band in 7 out of 2500 sera submitted
for routine ALP analysis.
Preliminary investigations in a series of patients
with the slow band revealed that it had a mol wt inter¬
mediate between that of the liver isoenzyme and the high
mol wt ALP considered elsewhere in this thesis. It has
therefore been included in the thesis as a separate
chapter (Chapter 6). To avoid confusion with the high mol
wt ALP which forms the principal object of study of the
thesis, it has been termed 'slow band ALP'. The aims of
the investigations into this slow band ALP were:
1) to assess its clinical significance
2) to compare its properties with those of the liver, bone
and intestinal isoenzymes in order to shed light on its
nature
3) to discover whether it was a simple aggregate of lower
mol wt forms or whether it was a complex of ALP with
some other protein, carbohydrate or lipid.
1.5. OTHER SERUM ENZYMES SHOWING INCREASED ACTIVITY
IN CHOLESTATIC LIVER DISEASE
Besides ALP, other enzymes may show increased
activity in the serum of patients with intra- or extra-
hepatic obstruction. Those which have been most commonly
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measured for diagnostic purposes include y glutamyltrans-
ferase (YGT), leucine aminopeptidase (LAP) and 5'nucleo¬
tidase (5'NT)- All three are membrane-marker enzymes.
1.5.1. y Glutamyltransferase (E.C.2.3.2.2.)
YGT is present in a large number of tissues, but
chiefly in the kidney, pancreas, liver and prostate.
Within the liver, it is principally located on the bile
canalicular membrane of the hepatocyte, but some may also
be found within the periportal hepatocytes (Rosalki, 1975).
yGT is also to be found in bile. The reaction which it
catalyses is:
( X-L-glutamyl) - peptide + ^ peptide + X-L-glutamyl -
amino acid ^ amino acid
It is thought that it may play a role in the transport of
amino acids and also in facilitating the transfer of amino
acids from t-RNA to ribosomal protein.
^GT is a sensitive enzyme for the detection of
liver disease but it is not helpful for distinguishing
between different types of liver disease. It is particul¬
arly useful in detecting cholestasis and cirrhosis,
especially when the latter is of the alcoholic type. There
is a good deal of evidence to suggest that alcohol induces
synthesis of the enzyme, although this is not yet proven.
Phenobarbitone also appears to induce JfGT synthesis
together with synthesis of other microsomal enzymes
-17-
(Rosalki, 1975) . However, bile duct ligation experiments
in rats have shown that the rise in serum 2fGT precedes the
rise in liver YGT which occurs considerably later than the
rise in liver ALP. The effect of inhibitors of protein
synthesis on this late rise in liver tfGT could not be
assessed since the rats could not be maintained for long
enough on these toxic compounds (Kryszewski et al, 1973).
Isoenzyme analysis of XGT has frequently been
undertaken in a number of electrophoretic media in an
attempt to make the assay more specific for different
types of liver disease. Depending on the medium used, a
number of bands may be observed in normal sera while in
liver diseases of various types a complex variety of
additional bands may appear (Rutenberg et al, 1967; Patel
and 0'Gorman, 1973; Rosalki, 1975) . No comparisons with
the ALP isoenzyme bands have been undertaken, but 3fGT
activity has been observed at the origin during starch gel
and polyacrylamide electrophoresis (c.f. Table 1.1), in
addition to many other bands of activity (Orlewski and
Szczeklik, 1967; Azzopardi and Jayle, 1973) . In general,
isoenzyme analysis of Ygt has not been found to be useful
in clinical diagnosis.
Sephadex G200 gel filtration of serum generally shows
3 peaks of JfGT activity, the first coinciding with the
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void volume (Jacyszyn and Laursen, 1968). This high mol
wt peak may give bands either at the origin or in the
/3lipoprotein position on starch gel electrophoresis, and
is increased in obstructive jaundice (Orlewski and
Szczeklik, 1967; Rosalki, 1975).
1.5.2. Leucine aminopeptidase (E ,C . 3 .4 .11.1 and 3.4.11.2)
The recommended name for this enzyme is aminopep¬
tidase only (Enzyme Commission recommendations, 1972) but
since leucine derivatives are some of the commoner subs¬
trates used and leucine aminopeptidase is the name generally
employed in the literature it will be retained here for
clarity.
LAP is widely distributed in human tissues, but
chiefly in the small intestine, kidney and liver. Within
the liver, LAP is mostly located on the plasma membrane
(E.C.3 .4 .11.2) (Emmelot et al, 1968) but also probably in
the cytosol (E.C.3.4 .11.1) . It catalyses the reaction:
RNH.leucine + H„0 ^ leucine + R.NH^2 s 2
where R may be a variety of groups e.g. a peptide or
amino acid. Leucine may be replaced at the N-terminal by
a number of other aminoacids although the enzyme is less
effective in hydrolysing these.
Like XGT, serum LAP activities may be increased
in liver disease, particularly in intra- or extra-hepatic
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hepatic obstruction (Kowlessar et al, 1961) , but the
enzyme is less sensitive than JfGT in detecting liver
disease (Rosalki, 1975).
Few investigations into the isoenzyme distribution
of LAP in health and disease have been undertaken. Normal
serum contains a single isoenzyme on starch gel electro¬
phoresis (Lawrence et al, 1960; Kowlessar, Haeffner and
Riley, 1961) . A further band in the origin region may
appear in liver disease of all types. This band corres¬
ponds to an ALP band of similar mobility which is also
present (Table 1.1) in these diseases. Bile did not
possess this band in the region of the origin. Shinkai
and Akedo (1972) also found LAP activity in the void
volume fraction on Sepharose 4B chromatography of serum
from patients with hepatic cancer.
1.5.3. 5'nucleotidase (E,C.3.1.3.5.)
5'NT differs from ALP in that its activity is con¬
fined to hydrolysis of nucleotide pentose-5'-phosphate
groups only. A typical substrate is adenosine-5'-
phosphate (AMP):
AMP + H^O v Adenosine + inorganic phosphate
5'NT is present in a number of human tissues, including
liver, thyroid, aorta and bone. In the liver, it can be
demonstrated histologically principally on the bile
-20-
canalicular membrane (Birns et al, 1962).
Like XGT and LAP, serum levels may be increased in
liver disease, particularly obstructive jaundice. However,
although the activities of 5'NT show an overall correla¬
tion with LAP (Kowlessar, Haeffner, Riley and Sleisenger,
1961) they have been reported to be less sensitive in
detecting liver disease (Rosalki, 1975). Bile duct
ligation experiments in rats show that, like XGT but
unlike ALP, a rise in serum activity precedes a late rise
in liver activity. It was not possible to show whether
this late rise was due to de novo protein synthesis
(Kryszewski et al, 1973). It has been suggested that the
late rise in tfGT and 5'NT may be due to the proliferation
of biliary epithelium which begins two days after bile
duct obstruction.
Little information is available concerning
isoenzyme patterns of 5'NT. In liver disease, all of it
appeared to be in the origin region on starch gel electro¬
phoresis (Kowlessar, Haeffner and Riley, 1961), and in the
void volume peak on Sepharose 4B chromatography (Shinkai
and Akedo, 1972) .
1.6. LIPOPROTEIN X
In obstructive jaundice it has been known for some
time that there are derangements of lipid metabolism:
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there is a decrease in high density lipoprotein and
esterified cholesterol in plasma, coupled with an
increase in free cholesterol, phospholipid and low density
lipoprotein (Frederickson et al, 1967). The low density
lipoprotein is of abnormal composition and is hetero¬
geneous . Whereas some of it contains the apo-B protein
of normal low density lipoprotein, some is immunologically
distinct and has a separate and distinctive composition.
This abnormal lipoprotein has been called lipoprotein X
(LPX) (Seidel et al, 1969) . LPX has less than 2% protein,
partly albumin and partly of the apo-C type, virtually no
triglyceride, no esterified cholesterol, considerable
amounts of unesterified cholesterol and large quantities
of phospholipid comprising 60% of the complex (Seidel et
al, 1969; picard and Veissiere, 1970; Seidel et al, 1973) .
LPX is not present in the serum of normal
individuals. It has been claimed that it appears in the
serum of virtually all patients with histologically
demonstrable biliary stasis, whether intra- or extra-
hepatic, and that conversely it is absent in virtually
all patients without histologically demonstrable biliary
stasis, making it more specific for cholestasis than any
other test currently available (Seidel et al, 1970). It
cannot, however, distinguish between intra- and extra-
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hepatic obstruction.
1.7. AIMS OF THE STUDY
The study was principally concerned with the
nature of high mol wt ALP and its clinical evaluation.
Other enzymes and LPX were only studied insofar as they
contributed to this assessment.
High mol wt ALP might comprise ALP associated with
a) protein b) lipid c) carbohydrate or d) membrane
fragments containing protein, lipid and carbohydrate.
Some of its properties appear to favour the latter
hypothesis e.g. a mol wt similar to that of other high
mol wt enzymes in serum, known to be principally located
on the plasma membrane within the liver (Shinkai and
Akedo, 1972). However, this is purely circumstantial
evidence. Electrophoretic, catalytic, chromatographic,
physical, chemical and immunological investigations were
designed to test and develop these alternative hypotheses
with special reference to the last hypothesis. The
investigations were also designed to test whether high
mol wt ALP in serum was heterogeneous, whether and in
what respects it resembled the high mol wt ALP in bile,
and its similarity or otherwise to the normal liver
isoenzyme found in serum. The role of high mol wt ALP in
diagnosis was also assessed and combined with the
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biochemical studies and with research in a variety of
fields to derive a unified theory of the nature of high
mol wt ALP and the pathological processes governing its
release into serum in liver disease (Chapter 7).
Comparisons with similar work carried out by other
investigators are discussed where appropriate in the
text.
The detailed aims of the study were as follows:
1) To establish whether or not the high mol wt ALP
obtained by gel chromatography is identical to any of
the bands seen in various media following electro¬
phoresis of serum from patients with liver disease,
and to discover which bands in one medium correspond
to bands in another medium. In this way, it was hoped
that the hitherto confused picture could be clarified.
A secondary aim was to identify the simplest, most
reproducible, accurate and sensitive method of
demonstrating the presence or absence of the high mol
wt component and, possibly, of measurement (Chapter 2).
2) To compare the catalytic properties of the high mol wt
ALP from serum with those of the liver isoenzyme and
also the high and low mol wt isoenzymes in bile. The
bone isoenzyme was also studied as a control. Such
comparisons, it was hoped, might give some pointer as
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to the possible origins of the high mol wt ALP in
serum and whether it was closely related to the liver
or bile isoenzymes (Chapter 3)-
3) To establish the existence or otherwise of high mol wt
components of JfGT, LAP and 5'NT in serum and bile
(for which there is some a priori evidence) since they
like ALP, are membrane-marker enzymes which are
released into serum in liver disease. Experiments
were designed to test the membrane fragment hypothesis
and were conducted on the high mol wt components of all
four membrane-marker enzymes in serum and bile in order
to test whether or not they formed a single complex.
Since LPX has a high mol wt and is also released into
the circulation in liver disease, investigations were
also directed towards discovering whether any associa¬
tion exists between it and the membrane marker enzymes
(Chapter 4) .
4) To establish the place of measurements of serum high
mol wt ALP in the diagnosis of liver disease. Such an
investigation could only be a pilot study, given the
limitations of time, but it was hoped that high mol wt
ALP could be compared with a broad range of other liver
function tests for each of the common categories of
liver disease. This might then point the way towards
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the most rewarding direction for further research. As
a secondary objective it was hoped that the behaviour
of high mol wt ALP vis a vis the other liver function
tests in disease might shed light on the patho¬





This chapter concerns the development and validation
of the general methods used throughout this thesis for
measuring total and high mol wt ALP, X GT, LAP, and 5' NT
and for demonstrating the presence or absence of the high
mol wt enzymes and LPX. An attempt was made also to
identify the different electrophoretic bands seen in
various media and relate the bands to those described in
the literature (section 1.3.1) . Methods used only for
particular experiments are described where appropriate
in the text.
2.1. MATERIALS
The materials and equipment used are listed below,
subdivided for convenience of reference into categories
roughly equivalent to the separate chapters of the thesis.
2.1.1. Measurement of total activities of enzymes.
Alkaline phosphatase. 4-Nitrophenyl disodium orthophosphate;
2-amino-2-methyl-propan-l-ol; diethanoJamine; Tris (hydraxy-
methyl) methylamine (AnalaR grade) all from British Drug
Houses Chemicals Ltd., Poole, Dorset (BDH).
X Glutamyl transferase. V-Glutamyl-p-nitroanilide;
glycylglycine from Sigma Chemical Co., Poole, Dorset (Sigma) .
Leucine aminopeptidase. L-Leucine-p-nitroanilide from Sigma.
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5'nucleotidase. Sodium-0-glycerophosphate from BDH.
Sodium adenosine 51 monophosphate (from yeast); calf
intestinal adenosine deaminase from Sigma.
2.1.2. Isoenzymes
Electrophoretic media. Acrylamide; N:N'-methylene-bis-
acrylamide; agarose (for electrophoresis) all from BDH;
Cellulose acetate strips from Shandon.
4-26% Polyacrylamide gradient gels from Universal
Scientific Ltd., London.
Electrophoresis substrates and dyes. a-Naphthyl acid
phosphate (potassium salt) ; ^-glutamyl-/3-napthylamide;
L-leucyl-0-naphthylamide HCl; 4-aminodiphenylamine
diazonium sulphate; Fast Blue BB salt; Fast Violet B salt
all from Sigma. Fast Garnet GBC salt from George Gurr
Ltd., London. Dimethyl sulphoxide from BDH.
Chromatography. Sepharose 6B from Pharmacia Fine Chemicals,
Uppsala, Sweden (Pharmacia). Diethyl amino ethyl cellulose,
medium mesh from Sigma. Hibitane (chlorhexidine gluconate
20% w/v) from Imperial Chemical Industries, Ltd.,
Macclesfield, Cheshire.
2.1.3. Purification and Kinetics
Protamine sulphate from salmon (Grade II) ;
Coomassie Brilliant Blue G; L-leucine; L-phenylalanine all
from Sigma. L-(+)-homoarginine-HCl (99+%) fromAMrich
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Chemical Co. Ltd., Gillingham, Dorset.
2.1.4. Physical and Biochemical properties
Urease (from jack-beans); catalase (from bovine
liver) both from Sigma. Neuraminidase (from vibrio comma
(cholerae)) from Hoechst Pharmaceuticals, Hounslow
(Hoechst). Urea (AnalaR); Butan-l-ol (AnalaR); di-iso-
propyl ether; sodium dodecyl sulphate all from BDH.
Triton X-100 (cctylphenoxypolyethoxyethanol) from Sigma.
Bacto-agar from Difco Laboratories, Detroit, Michigan,
U.S.A. Nigrosin from George Gurr Ltd., London. Amido
black 10B stain from Coming ACI, Palo Alto, California.
Antisera against human lipoprotein X, B lipoprotein, IgG,
IgA and IgM from Hoechst.
2.1.5. Slow band alkaline phosphatase
Human Xglobulin from Sigma. Human albumin; anti-
sera against human IgG, IgA and IgM from Hoechst.
2.1.6. Equipment
LKB 8600 reaction rate analyser; SP1800 ultraviolet
recording spectrophotometer (from Pye Unicam); Sequential
Multiple Analyzer plus Computer (Technicon).
Electrophoresis tank for vertical slab gels (Shandon);
electrophoresis tank for horizontal gels (Shandon);
Shandon power supply (up to 400 volts); electrophoresis
tank for polyacrylamide gradient gels and power pack
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(Universal Scientific Ltd.); Vitatron densitometer.
Chromatography columns (Pharmacia); LKB 8300 Uvicord II
spectrophotometer; LKB biocal recorder; LKB 7000 ultrorac
fraction collector; LKB 2115 multiperpex pump; LKB
Conductolyzer Type 5300B; disposable plastic syringes;
gauze Inco tissues (Robinsons, Chesterfield).
2.2. MEASUREMENT OF TOTAL ENZYME ACTIVITIES
2.2.1. Alkaline phosphatase
In serum, ALP activity was measured on the
Technicon Sequential Multiple Analyzer plus Computer
(SMAC) using as substrate 10 miroyi p-nitrophenyl phosphate
in 0.6 mo]/l 2-amino-2-methyl-l-propanol buffer pH 10.2
containing 0.5 mmoyi magnesium chloride (Bowers and
McComb, 1966). The between batch coefficient of
variation was 2.5%.
In column effluents, to obtain greater sensitivity,
a continuous monitoring (kinetic) method was used to
measure ALP activity (McComb and Bowers, 1972) . After
mixing the column effluent with an equal volume of 1.8 mdyi
diethanolamine buffer pH 10.2 containing 1 miro]/l magnesium
chloride, p-nitrophenyl phosphate was added to give a
final concentration of 14 mmoyi. The reaction was monit-
o
ored at 410 nm at 37 C in an LKB reaction rate analyser.
A molar extinction coefficient of 18 800 for p-nitrophenol
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was used in the calculation.
2.2.2. yGlutamyl transferase
A modification of the method of Rosalki and
Tarlow (1974) was used for the measurement of YGT
activity in serum and in column effluents.
50 j-il serum was mixed with 1.0 ml Tris-glycyl-
glycine buffer pH 8.5. The reaction was started with
o.l ml Y-glutamyl-p-nitroanilide as substrate, dissolved
in 0.5mol/l HCl. The concentrations of the reagents were





The reaction was monitored at 410 nm at 37°C in an LKB
8600 reaction rate analyzer. A molar extinction coeffic¬
ient of 9900 for p-nitroaniline was used in the
calculations .
A similar method was used for the measurement of
YGT in column effluents except that 0.5 ml column
effluent was mixed with 0.5 ml Tris-glycylglycine buffer
the composition of which had been adjusted to give the
same final reaction conditions.
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2.2.3. Leucine aminopeptidase
A modification of the method of Szasz (1967) was
used for the measurement of LAP activity in serum and in
column effluents.
50 /jI serum was mixed with 1.0 ml 0.1 mol/1 Tris-
HCl buffer pH 7.7. The reaction was started with 50 jul
L-leucine-p-nitroanilide dissolved in 0.25 mol/1 HCl.
The concentrations of the reagents were such as to give
the following final reaction conditions:
0.8 mmol/1 L-leucine-p-nitroanilide
0.1 mol/1 Tris-HCl buffer pH 7.5
The reaction was monitored at 410 nm at 37°C in an LKB
8600 reaction rate analyser. A molar extinction coeffic¬
ient of 9900 for p-nitroaniline was used in the calculations.
A similar method was used for the measurement of
LAP in column effluents except that 0.5 ml column
effluent was mixed with 0.5 ml buffer the composition of
which had been adjusted to give the same final reaction
conditions.
2.2.4. 5'nucleotidase
5'NT activity in serum and in column effluents was
measured according to the method of Belfield and Goldberg
(1969). Using 5'adenosine monophosphate (5'AMP) as
substrate and adenosine deaminase (ADA) as coupling enzyme.
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the principle of the reaction was as follows:
5' NT
5'AMP + H^O ——^ Adenosine + inorganic phosphate
ADA v
Adenosine + H^O 7 Inosine + NH^
^Glycerophosphate was used to inhibit the non-specific
phosphatase activity. The reaction was started by the
addition of 5'AMP and the decrease in absorbance at 265 nm
due to the conversion of adenosine to inosine was monit¬
ored continuously at 37°C against a reagent blank on an
SP1800 spectrophotometer. The final reaction concentra¬
tions were as follows:
0.1 mol/1 Tris-HCl buffer pH 7.9
10 mmol/1 MgCl^
15 mmol/1 sodium ^glycerophosphate
2 mg/1 adenosine deaminase
0.1 mmol/1 5'AMP
For the calculations, an extinction coefficient of 8.0 x
6 2 — 1
10 cm mole was assumed for the difference between the
absorbance of 5'AMP and inosine at 265 nm under the
conditions of the reaction.
2.3. ELECTROPHORESIS AND LOCALISATION OF ISOENZYMES
2.3.1. Alkaline phosphatase
Polyacrylamide gel. Electrophoresis of sera in uniform
vertical polyacrylamide gel slabs was performed according
to a modification (Warwick et al, 1972) of the method of
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Kaplan and Rogers (1969). The buffer used throughout was
0.37 mol/1 Tris-borate pH 9.5 containing 0.5 mmol/1 MgCl^
and electrophoresis was at a constant voltage of 300 volts.
For the weaker gels, a retaining strip of 7% polyacrylamide
gel was used at the lower edge of each gel slab since
otherwise these gels did not have enough structural
strength to remain in place between the glass plates.
For similar reasons, after staining, instead of being
stored in the wet state in polythene wrappings, the weak
gels were stored by drying them between a glass plate and
filter paper backing.
Electrophoresis of sera in 4-26% polyacrylamide
gradient gels, pre-equilibrated with the same buffer, was
at lOOv for 24 hours at 4°C.
Qualitative localisation of the isoenzyme bands
was achieved by immersion in 0.75 mmol/1 a-naphthyl acid
phosphate in buffer for 20 min followed by immersion in
0.75 mmol/1 a-naphthyl acid phosphate/0.5 g/1 4-aminodi-
phenylamine diazonium sulphate in buffer overnight at 4°C
in the dark. Semi-quantitative localisation used the
second substrate-dye solution only for 5 hours at room
temperature in the dark. The gels were cleared using 7%
acetic acid.
Agarose gel. Various concentrations of agarose gel in
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0.2 mol/1 Tris-borate buffer pH 10.0 were prepared by-
melting the agarose in buffer in a bath of boiling water.
10 ml of the solution was poured onto a horizontal 10 x
7.5 cm plate and allowed to set at room temperature.
Three 1 x 10 mm slots in each gel were cut, sera were
applied to the slots and subjected to electrophoresis in
the same buffer at a constant voltage of 300v for 3-4
hours at 4°C. The staining procedure was the same as
that described for polyacrylamide gel.
Cellulose acetate. Cellulose acetate strips (7.5cm x
14.5 cm) were pre-soaked in 50 mmol/1 Tris-barbital
buffer pH 8.8. Sera were applied using a 1 applicator
and subjected to electrophoresis in the same buffer at a
constant voltage of 200v for 1h hours.
Two alternative methods were used for staining
cellulose acetate strips. The first method used essen¬
tially the one-step staining method described for poly¬
acrylamide and agarose gels, except that, instead of
being immersed in the staining solution, the strip was
imprinted for 2 hours at room temperature face down on a
glass plate covered with a thin film of the staining
solution. An alternative technique, based on the method
of Burlina and Galzigna (1976) was also investigated
because of the problems of diffusion in cellulose acetate.
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During electrophoresis, a solution of 2% agarose in
0.37 mol/1 Tris-borate buffer pH 9.5 containing 0.5 mmol/1
magnesium chloride was prepared by melting the agarose
in the buffer in a bath of boiling water, and cooled to
37°C. An equal volume of a solution containing 4 g/1
a-naphthyl acid phosphate and 4 g/1 4-aminodiphenylamine
diazonium sulphate was prepared in the same buffer and
warmed to 37°C. Immediately before use, the two
solutions were combined, mixed thoroughly and poured onto
a tray to set at room temperature. The cellulose acetate
strip was imprinted on the gel face down and incubated in
the dark at room temperature for 1% hours.
2.3.2. ^Glutamyl transferase
The electrophoretic medium which provided the
greatest sensitivity in the detection and localisation of
tfGT isoenzymes was found to be polyacrylamide gel.
Uniform 2.5% and 7% gels and 4-26% gradient gels were
used for the electrophoretic separation of the isoenzymes.
A gel buffer of 0.72 mol/1 Tris-HCl buffer pH 8.9 and a
tank buffer of 0.05 mol/1 Tris-glycine buffer pH 8.3 were
employed (Azzopardi and Jayle, 1973) . Electrophoresis
was for 2-3 hours at a constant voltage of 300v for the
uniform gels and overnight at lOOv for gradient gels.
A substrate solution was prepared by dissolving
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25 mg Y-glutamyl-3-naphthylamide in 0.25 ml dimethyl
sulphoxide and 0.25 ml 1 mol/1 NaOH and mixing this
solution with 50 ml 50 mmol/1 Tris/25 mmol/1 glycyl-
glycine buffer pH 8.9 (Rosalki, personal communication).
The gel was immersed in this solution for 2 hours at
room temperature. It was then transferred to a staining
solution of 2 g/1 Fast Garnet GBC in 0.25 mol/1 Tris-
maleate buffer pH 6.2 for 2 hours at room temperature.
Fast Garnet GBC was found to give greater sensitivity
than the other dyes tested (Fast Blue BB, Fast Violet B
and 4-aminodiphenylamine diazonium sulphate). The gels
were cleared using 1% acetic acid.
2.3.3. Leucine aminopeptidase
Electrophoresis in polyacrylamide gel was carried
out exactly as described for "&GT.
The substrate solution was prepared by dissolving
20 mg L-leucyl-3-naphthylamide in 2 ml 0.01 mol/1 HCl and
mixing this solution with 50 ml 0.02 mol/1 phosphate buffer
pH 7.0 (Goldbarg and Rutenburg, 1958). The gel was
immersed in this solution for 2 hours at room temperature
and then transferred to a staining solution of 2 g/1 Fast
Garnet GBC in 0.25 mol/1 Tris-maleate buffer pH 6.2 for 2




Immunoelectrophoresis was carried out by a modifi¬
cation (Seidel et al, 1970) of the Scheidegger technique
(1955) . 1% unpurified agar in 0.05 mol/1 barbital buffer
pH 8.6 was used on 10 x 8 cm horizontal plates. 4 ^il
sample was applied to 2 mm diameter wells and subjected
to electrophoresis at a constant voltage of 200v for 2
hours. 1 mm wide troughs were cut equidistant between the
wells and filled with LPX antiserum which was allowed to
diffuse at room temperature overnight. After the formation
of any precipitin arcs, the gels were washed for 2 days in
saline, stained for protein using nigrosin which was found
to be the most sensitive stain for this purpose, and
cleared in methanol:acetic acid:water (9:2:9). The gels
were also stained for enzyme activity using the methods
outlined in section 2.3.
A precipitin spur on the cathodal side of the wells
indicated that LPX was present. The LPX antiserum used
was raised against Apo-C but is known to cross-react with
other plasma proteins including some lipoproteins.
However, all these cross-reacting proteins and lipoproteins
migrate towards the anode under the conditions of the
assay and only LPX migrates towards the cathode. In
practice, therefore, the method is specific.
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An attempt was also made to detect LPX by the
Seidel (1971) technique which, following electrophoresis,
involves _in situ precipitation of LPX by a drop of anti¬
serum placed on the cathodal side of the wells. However,
this method was found to be less reliable than the
Scheidegger technique because the precipitate sometimes
redissolved.
Quantitation of LPX by Laurell rocket electro-
immunoassay (Laurell, 1966) proved to be unsatisfactory.
Irregularly shaped rockets, often with ill-defined peaks,
were obtained. Moreover the height of the rocket did not
appear to correlate with the presence, amount or complete
absence of LPX using the Scheidegger technique. When the
experiment was repeated using ^lipoprotein antiserum
instead of LPX antiserum in the gel, the appearance,
following prolonged electrophoresis, of similar rockets
migrating towards the cathode suggested that under these
conditions some Slipoprotein might have migrated towards
the cathode. This would then have cross-reacted with the
LPX antiserum in the original gel. Such a hypothesis
would explain the appearance of apparent "LPX" rockets in
sera from normal subjects possessing no serum LPX
according to the Scheidegger technique.
In summary, the evidence indicated that the
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Scheidegger technique was the most suitable method for
detecting LPX in serum and this method was accordingly
chosen.
2.5. MOBILITY OF ALKALINE PHOSPHATASE ISOENZYMES DURING
ELECTROPHORESIS IN VARIOUS MEDIA
Sera containing liver, bone, intestinal and high mol
wt ALP in varying proportions were subjected to electro¬
phoresis in the following media according to the methods
outlined in paragraph 2.3.1.
1) cellulose acetate
2) 1%, 2% and 2.2% agarose gels
3) 2%, 2.5%, 3% and 7% polyacrylamide gels
4) 4-26% polyacrylamide gradient gel
The gels and cellulose acetate strips were stained
for ALP by the methods described in paragraph 2.3.1.
Examples of the isoenzyme patterns obtained in the various
media are shown in Fig. 2.1. The positions of the iso¬
enzyme bands in these media are shown schematically in
Fig. 2.2.
Cellulose acetate. Cellulose acetate separates proteins
purely on the basis of charge. In this medium high mol wt
ALP migrated ahead of the liver isoenzyme (Fig. 2.2 (a)).
High mol wt ALP would therefore appear to be more highly
charged than any of the isoenzymes commonly found in serum.
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Figure 2.1. Positions of ALP isoenzyme bands after electro¬
phoresis of sera in various electrophoretic
media. 0, origin; I, intestinal isoenzyme;
B, bone isoenzyme; L, liver isoenzyme; H, high
mol wt ALP. Electrophoresis was towards the























Figure—2.2. Schematic representation of positions of ALP
isoenzyme bands after electrophoresis of sera
in various electrophoretic media.




















Agarose gel. It is generally assumed that agarose gel
also separates proteins purely on the basis of charge.
However, in 1% agarose, the concentration commonly
employed, the high mol wt ALP migrated closely behind the
liver isoenzyme, suggesting that some retardation was
taking place owing to the large molecular size of the
component. This hypothesis gains support from the evidence
that increasing concentrations of agarose progressively
retarded high mol wt ALP (Fig 2.2. (b)). A 2.2% agarose
concentration was found to be optimal since at this
concentration high mol wt ALP was separated from all the
other alkaline phosphatase isoenzymes.
polyacrylamide gel. polyacrylamide gels separate
proteins partly on the basis of charge and partly on the
basis of molecular size. This is illustrated by the
observation that high mol wt ALP was found to be excluded
from the 7% gel matrix and remained at the origin, but it
penetrated progressively further into 3%, 2.5% and 2% gels
respectively (Fig 2.2.(c)). In a 4-26% polyacrylamide
gradient gel, proteins are separated purely on the basis
of molecular size since electrophoresis is to equilibrium.
In this gel, high mol wt ALP migrated only a short
distance into the gel matrix. A 2.5% polyacrylamide gel
was found to be optimal since this gel allowed full
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penetration of high mol wt ALP into the gel matrix and
good separation from the other isoenzymes, while
retaining sufficient structural strength.
2.6. QUANTITATION OF ALKALINE PHOSPHATASE
ISOENZYMES BY ELECTROPHORESIS
Cellulose acetate was found to be an unsuitable
medium for quantitation of ALP isoenzymes because of
problems related to diffusion. When the strips were
stained by imprinting on glass plates overlaid with a
film of staining solution, diffusion took place laterally
within the strip and outwards into the staining solution.
The technique of imprinting on agarose gel appeared to
diminish the first of these effects but had little effect
on the second. Indeed, it aggravated the problem because
the lower mol wt isoenzymes appeared to diffuse much more
readily into the agarose gel than did the high mol wt
component, thereby giving rise to larger inaccuracies in
measurement.
For this reason only agarose and polyacrylamide
gels were investigated with regard to their suitability
for measurement of the high mol wt component. In each
case quantitation was achieved by scanning the stained
gels using a Vitatron densitometer followed by measure¬
ment of the areas under the peaks. In both types of gel,
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non-specific dye uptake gave a faint yellow band in the
region of the gel between the high mol wt band and the
liver isoenzyme band. This did not coincide with any
isoenzyme band and did not interfere with measurement.
2.6.1. Staining time
In order to select the optimum length of time for
the one-step staining procedure (section 2.3.1.), linearity
of colour development with time was assessed. After
electrophoresis of several identical aliquots of a serum
containing liver and high mol wt ALP, the gel was
immersed at room temperature in substrate-dye solution for
various lengths of time. At the end of each time period
a slice of gel corresponding to one aliquot of serum was
immersed in 7% acetic acid to stop the reaction and clear
the colour background. After clearing, the isoenzyme
bands were measured by scanning.
For 2.5% polyacrylamide gel, the increase in colour
developed (expressed as area under the peak) with time was
linear up to 6 hours (Fig 2.3.) . The amount of high mol
wt ALP present, expressed as the calculated percentage of
the total ALP activity, was found to be constant for a
staining time between 3 and 6 hours. 4 hours was chosen
as the optimal staining time. For 2.2% agarose, similar
considerations led to the adoption of 4 hours as the
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Figure 2.3. Development of colour (measured by scanning
densitometry) with time following electro¬
phoresis on 2.5% polyacrylamide gel.
Time of staining (hours)
Time of staining (hours)
-48-
optimal staining time.
2.6.2. Dilutional linearity of staining reaction
A serum containing liver and high mol wt ALP was
diluted serially in 0.15 mol/1 saline. These dilutions
were subjected to electrophoresis in 2.5% polyacrylamide
gel and 2.2% agarose gel. The gels were stained for 4
hours, cleared in 7% acetic acid and scanned. The
activities of the liver and high mol wt components of
ALP were calculated for each dilution using the formula:
Activity of _ area under isoenzyme peak x activity of dilution
isoenzyme total area under both peaks
Fig. 2.4. demonstrates that in both types of gel there is
a linear relationship between the activities of both liver
and high mol wt ALP and dilution. However, there is
slightly more scatter of the individual data points in the
case of 2.2% agarose gel. In both gels, there is some
evidence that there may be some degree of non-linearity at
low activities since the regression lines do not pass
through the origin.
2.6.3. Precision
The within-run coefficients of variation for the
percentage of high mol wt ALP in serum were 3.7% (N=10,
Mean:28.8%) for 2.5% polyacrylamide gel and 4.6% (N=9,
Mean?31.9%) for 2.2% agarose gel.










The between-run coefficients of variation for the
percentage of high mol wt ALP in serum, based on analysis
of duplicates, were 14.6% (N=9, Mean:9.7%, Range: 2.4-17.7%)
for 2.5% polyacrylamide gel and 27.5% (N=14, Mean:16.4%,
Range: 2.7-40.5%) for 2.2% agarose gel.
2.6.4. Comparisons between high molecular weight alkaline
phosphatase estimates obtained by electrophoresis in
different media
Electrophoresis of 6 sera was carried out in
various media and the high mol wt ALP estimated by
scanning densitometry according to the methods described
in section 2.3.1. The sera contained liver, bone,
intestinal and high mol wt ALP in varying proportions.
The results are shown in Table 2.1. With the exception of
the agar imprinting technique used with cellulose acetate
strips, roughly comparable results for the different
methods were obtained. The overlay technique gave results
which were about twice as high as those with other methods.
This was attributed to the slower rate of diffusion of the
high mol wt ALP into the agarose, leaving more of this
enzyme on the strip which was subsequently scanned for
quantitation of the isoenzymes: the overlay, on the other
hand, showed denser staining in the region of the lower
mol wt ALP. In general, the lack of close agreement
TABLE2.1.
PercentageofhighmolwtALPisixera,estimatedbycanningd nsi ometry,foll wing electrophoresisandstain ngithreem ia HighmolwtALP(%total) TotalALP2.2%.5Cellulosecetat Serumactivity(iu/1)agarosepolyacrylamide gelelThin-filmAgartemp ate stainingstaining 144260228 2304230256 35441721339 421647550 56834145 6520814
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between the results obtained in the various media reflects
the poor precision, and suggests that the electrophoretic
techniques are best regarded as semi-quantitative.
2.7. QUANTITATION OF HIGH MOLECULAR WEIGHT ALKALINE
PHOSPHATASE BY SEPHAROSE 6B CHROMATOGRAPHY
2.7.1. Assay procedure
2ml serum was applied to a 95 x 2.5cm column
containing Sepharose 6B equilibrated with 0.1 mol/1 Tris-
HCl buffer pH 7.7 containing 50 mmol/1 NaCl. The serum
was eluted overnight at 4°C using the same buffer at a
flow rate of 28 ml per hour, and 5 ml fractions were
collected. The protein content of the eluate was
measured by continuous monitoring at 280 nm. The ALP
activity in each fraction was measured by the method
outlined in paragraph 2.2.1. A typical sample elution
profile is shown in Fig 2.5. The peak corresponding to
high mol wt ALP eluted in the void volume. The low mol
wt peak contained the liver, bone and intestinal isoenzymes.
The activities of all the fractions in each peak
were summed and the activity of the high mol wt component
was calculated using the formula:
Activity of high mol wt A . . , _ . . /n.-1, , . .rt = x activity of serum (iu/1)
component (iu/1) A + B
where A = sum of activities of fractions in high mol wt
peak
B = sum of activities of fractions in low mol wt
peak.
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Figure 2.5. Elution profile of a serum containing liver
and high mol wt ALP, obtained by Sepharose 6B
chromatography. The bone and intestinal




2.7.2. Validation of method
The mean recovery of ALP activity from the column
was 97.4% (N=7, Range 78-115%). Since the method was
time-consuming and tedious to perform, it was not
practicable to calculate the precision for a large number
of samples. However, duplicate analyses of the 4 samples
shown in Table 2.2 suggested that the reproducibility was
acceptable. The between-batch coefficient of variation
for measurement of ALP activities in the fractions was
Reproducibility of estimates of high mol wt ALP (expressed
as a percentage of total ALP activity in serum) obtained
1.3% (N=46) .
TABLE 2.2.
by Sepharose 6B chromatography
Serum High mol wt ALP (%)
First analysis Second analysis
1 21.4 19.7
2 21.3 19.6
3 30.3 32 .5
4 12 .6 13 .0
-56-
2.8 COMPARISON BETWEEN ESTIMATES OF HIGH MOLECULAR
WEIGHT ALKALINE PHOSPHATASE BASED ON a) SEPHAROSE 6B
CHROMATOGRAPHY AND b) 2.5% POLYACRYLAMIDE GEL
ELECTROPHORESIS
Two sera, A and B (Table 2.3.), containing liver and
high mol wt ALP only were analysed by Sepharose 6B chromato¬
graphy and by electrophoresis in 2.5% polyacrylamide gel.
The electrophoretic method gave much lower estimates of high
mol wt ALP, a discrepancy of approximately four-fold.
Comparison between estimates of high mol wt ALP, expressed
as a percentage of total ALP activity in serum, obtained
by Sepharose 6B chromatography using a) p-nitrophenyl
phosphate (pNPP) and b) g-naphthyl acid phosphate (ctNP)
as substrates, and by electrophoresis on 2.5% polyacrylam¬
ide gel using g-naphthyl acid phosphate as substrate
Method Substrate % high mol wt ALP
TABLE 2.3.
Serum A Serum B Serum C Serum D
Sepharose 6B pNPP
aNP
21.4 19.5 8 .0
1.533.3
Electrophoresis aNP 5.6 4.5 28.5
Since the gel chromatography method used p-nitrophenyl
phosphate as substrate whereas the electrophoretic method
used anaphthyl phosphate as substrate it was thought that
-57-
this discrepancy might be due to different substrate
specificities of liver and high mol wt ALP. A quantitative
assay was therefore set up, using anaphthyl phosphate as
substrate, to measure the activities of the Sepharose 6B
column eluate. This assay reproduced as closely as possible
the reaction conditions of the substrate solution used in
polyacrylamide gel staining. Thus, the final reaction
conditions of this assay were as follows:
0.75 mmol/1 a-naphthyl acid phosphate
0.37 mol/1 Tris-borate buffer pH 9.5
0.5 mmol/1 MgCl^
The increase in absorbance was monitored at 340 nm at 37°C.
The between-batch coefficient of variation for this method
was 6.4% (N=30) .
When serum C(Table 2.3.) was analysed by Sepharose 6B
chromatography and by polyacrylamide gel electrophoresis,
using anaphthyl phosphate as substrate on both occasions,
results in much closer agreement with each other were found.
These observations suggest that liver and high mol
wt ALP differ in their specificities for p-nitrophenyl
phosphate and a-naphthyl phosphate under the conditions of
assay. In order to confirm this, serum D(Table 2.3.) was
applied to the Sepharose 6B column and the activity in each
fraction was measured using a) p-nitrophenyl phosphate as
substrate and b) a-naphthyl phosphate as substrate. Much
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lower results were obtained for high mol wt ALP using
a-naphthyl phosphate (again a four-fold discrepancy).
The ratio of these activities for each fraction was then
calculated. Fig 2.6. presents this ratio in graphical
form. For the low mol wt ALP, the mean ratio was 69
(S.D. 7, N=15) whereas for high mol wt ALP, the mean
ratio was 181 (S .D. 4, N=2), a discrepancy of nearly
three-fold. This confirms that high mol wt ALP differed
from liver ALP in its relative affinities for p-nitrophenyl
phosphate and a-naphthyl phosphate and that this difference
largely accounted for the observed discrepancies between
the estimates of high mol wt ALP based on Sepharose 6B
chromatography and polyacrylamide gel electrophoresis.
Further investigations into this phenomenon are presented
in section 3.2.4.
The results of the electrophoretic assay in this
experiment are considerably lower than those obtained in
Table 2.1. This difference can only be accounted for by
small alterations in staining procedure which occurred
during the intervening time,e.g. time allowed for colour
development, temperature, activity of samples etc. The
electrophoretic assay was sensitive to such small deviations
from the standard method, a factor which led to distrust
of its reliability as a quantitative assay.
-59-
Fiqure 2.6. Ratio of ALP activity using p-nitrophenyl
phosphate as substrate to activity using
a-naphthyl acid phosphate as substrate (both
activities expressed in instrumental units) .
The ratio is plotted against the fractions
obtained during Sepharose 6B chromatography














































2.9. QUANTITATION OF HIGH MOLECULAR WEIGHT ALKALINE
PHOSPHATASE BY ION-EXCHANGE CHROMATOGRAPHY
Because it was tedious and time-consuming to use
Sepharose 6B chromatography for the measurement of high mol
wt ALP in large numbers of samples, an alternative method
was developed based on ion-exchange chromatography. The
method was suitable for the analysis of small batches of
samples.
2.9.1. Ion-exchange method
Apparatus. Small columns were employed using 20 ml
disposable plastic syringe barrels (internal diameter 2 cm).
The gel matrix was supported by small circles of gauze.
The upper seal of each column was formed by the original
rubber syringe plunger end, through which was passed a
small-diameter Teflon tube connected to a peristaltic pump.
Reagents. 1. DEAE-cellulose pre-cycled and equilibrated
with buffer A.
2. Buffer A: 0.1 mol/1 NaCl in 0.01 mol/1
Tris-HCl buffer pH 7.5.
3. Buffer B: 0.3 mol/1 NaCl in 0.01 mol/1
Tris-HCl buffer pH 7.5.
Assay protocol. 20 ml DEAE-cellulose was poured into each
column and washed through with Buffer A for two hours at a
flow rate of 78 ml/hour in order to achieve complete
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equilibration. The final bed volume was approximately
10 ml.
After equilibration the supernatant was removed and
replaced with 1 ml serum which had been dialysed overnight
against Buffer A. The serum was allowed to soak into the
resin and was replaced with approximately 4 ml Buffer A.
Buffer A (30 ml) was then pumped through the column, and a
single 30 ml fraction collected, designated Fraction I.
Pumping was stopped, the supernatant removed and
replaced with approximately 4 ml Buffer B. A second
elution using Buffer B was carried out, a single 30 ml
fraction again being collected, designated Fraction II
(this fraction contained high mol wt ALP).
The ALP activities of the undialysed serum, Fraction
I and Fraction II were measured. The activity of high mol
wt ALP was calculated from the formula:
High mol wt ALP activity =
(activity Fraction II) x (activity of serum) iu/1
(activity Fraction I + activity Fraction II)
It was possible to analyse up to 8 sera in each batch. The
whole assay, including measurement of activities and
calculation of results, takes about 2 hours to perform for
each batch.
2.9.2. Validation of Conditions
Effect of ionic strength. 5 ml serum containing liver and
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high mol wt ALP was applied to a 16 x 2.5 cm DEAE-cellulose
column and eluted with a gradient of increasing ionic
strength, using NaCl in 0.01 mol/1 Tris-HCl pH 7.5. The
elution profile showed two main peaks of activity (Fig 2.7.) .
The fractions corresponding to each of these peaks were
pooled, concentrated and applied to a Sepharose 6B column.
They were also subjected to electrophoresis on 1% poly-
acrylamide gel together with a serum marker containing
liver and high mol wt ALP. By these means, it was shown
that the second ion-exchange peak corresponded to the high
mol wt ALP. The ionic-strength corresponding to the
trough between the two peaks was 0.1 mol/1 (the ionic
strength of Buffer A).
Volume of fractions. The two-step ion-exchange method was
carried out on a serum containing liver and high mol wt
ALP except that, instead of collecting a single 30 ml
fraction at each ionic strength, 20 x 2.5 ml fractions were
collected at each ionic strength. ALP activity was
measured in each of these fractions and the elution profile
shown in Fig 2.8. was obtained. It can be seen that
elution of the activity corresponding to each ionic
strength was complete when 30 ml had been collected. This
volume was therefore chosen for Fractions I and II.












Figure 2.8. Elation pattern of a serum containing liver
and high mol wt ALP obtained by the two step












Identification of Fractions I and II; assessment of
cross-contamination. A serum containing liver and high
mol wt ALP only was analysed by the two-step ion exchange
method. Fractions I and II were each concentrated and
subjected to electrophoresis on 2.5% polyacrylamide gel.
The undialysed serum was also subjected to electrophoresis
as a marker. Fig 2.9. shows that Fraction I corresponded
to the liver isoenzyme and Fraction II to high mol wt ALP.
There was no detectable cross-contamination or carry-over.
Investigation of interference by other ALP isoenzymes.
When the two-step ion-exchange method was carried out on
51 sera shown by electrophoresis to contain only liver and
high mol wt ALP in varying proportions, the percentage
activity found in Fraction II ranged from 4 to 35% (6 to
318 iu/1). In 24 sera, shown by electrophoresis to contain
undetectable levels of high mol wt ALP but varying propor¬
tions of liver, bone, intestinal and placental isoenzymes,
the percentage activity found in Fraction II ranged from
1 to 4% (1 to 9 iu/1) .
One serum contained the rare slow band ALP (see
Chapter 6) and gave 4% activity (7 iu/1) in Fraction II.
Another serum contained the Regan variant (Crofton and
Smith, 1978) , a rare cancer-associated isoenzyme, in
addition to the liver isoenzyme; this serum gave 9%
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Figure 2.9. ALP electrophoresis patterns on 2.5% poly-
acrylamide gel. From left to right: a) serum
containing liver and high mol wt ALP; b) Fraction
I (concentrated) from this serum; c) Fraction II
(concentrated) from this serum. 0, origin;
L, liver isoenzyme; H, high mol wt ALP.




(16 iu/1) activity in Fraction II. Fractions I and II from
the serum were each concentrated and subjected to electro¬
phoresis on 2.5% polyacrylamide gel. Fraction II contained
only the Regan variant and no high mol wt component was
present.
Comparison with Sepharose 6B chromatography. Six sera with
varying proportions of high mol wt ALP were analysed by the
two-step ion-exchange method and by Sepharose 6B chromato¬
graphy. ALP activities were measured in the fractions
corresponding to the liver and high mol wt ALP peaks
respectively. Correspondence between the two methods was
good (Fig 2.10). Although the ion-exchange method appeared
to give a slightly higher estimate of high mol wt ALP this
was probably within the limits of analytical error for the
two methods.
Precision and yield. Yields from the ion-exchange columns
ranged from 85% to 105% with a mean of 95% (N=ll).
The between-batch coefficient of variation
(including the dialysis step) for high mol wt ALP measured
by the two-step ion-exchange method was 3.4% (N=30, mean
activity 102 iu/1, range 6 to 350 iu/1).
2.10. CHOICE OF METHODS FOR THE DETECTION AND MEASUREMENT
OF HIGH MOLECULAR WEIGHT ALKALINE PHOSPHATASE
The major characteristics by which high mol wt ALP
-68-
Figure 2.10. Comparison between high mol wt ALP activities
measured by Sepharose 6B chromatography
(X-axis) and ion-exchange chromatography
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differs from most of the other forms of ALP are its high
mol wt (by definition) and its charge. Measurement by
Sepharose 6B chromatography is based on the first of these
characteristics, ion-exchange chromatography on the second
and electrophoresis on both, depending on the medium used.
Molecular sieving column chromatography has been
used most commonly in the past (Fennelly et al, 1969) in
the detection and measurement of high mol wt ALP. However,
a cautionary note should be struck in the comparison of
Sephadex G200 chromatography with Sepharose 6B, 4B and 2B
chromatography as methods of measuring high mol wt ALP.
Sephadex G200 has a smaller mesh size than the Sepharose
range of gels and its void volume peak therefore contains
proteins of lower mol wt e.g. macroglobulin, IgM and
most of the a and 3 lipoproteins. This is reflected in the
protein elution pattern which shows a detectable void
volume peak in Sephadex but not in Sepharose. Therefore
the two types of gel may not be measuring the same thing.
For instance, Jennings et al (1970) found that the void
volume peak from a Sephadex G200 column contained two ALP
components, one of which remained at the origin during
starch gel electrophoresis and one of which migrated in the
3 lipoprotein position. If only the higher mol wt of these
two ALP components, namely that which remains at the origin,
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is regarded as the true 'high mol wt ALP' specific for
liver disease, then Sephadex G200 chromatography over¬
estimates it. Only Sepharose gels which do not exclude
such proteins as 0 lipoprotein and have little or no
detectable protein in their void volumes will provide an
accurate estimate of the high mol wt ALP which is specific
for liver disease and with which this thesis is concerned.
Sepharose gel chromatography must therefore be regarded as
the reference method, although it is slow and tedious.
The technique of quantitation by densitometry of
cellulose acetate strips following electrophoresis and
staining by gel overlay was first described by Rhone et al
(1973). I have found this method to be very imprecise,
presumably owing to diffusion and variable background
staining. In addition, the agar overlay technique was
inaccurate since it overestimated the amount of high mol
wt ALP in serum. Fixative techniques have been advocated
to prevent diffusion before staining (Siede and Seiffert,
1977), thereby improving precision, but these are tedious.
Moreover, since the fixative bath contains ethanol and lead
acetate, the enzyme may be adversely affected.
Of the electrophoretic media investigated, 2.5%
polyacrylamide gel appeared to give the most reproducible
results and showed an acceptable linearity between colour
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intensity and activity. No other isoenzyme interfered with
the measurement. There was poor correlation between
results obtained using 2.5% polyacrylamide gel and those
using alternative media, but this could be explained by the
poor precision which was generally found. The major
disadvantages of this apparently simple method of measuring
high mol wt ALP were its lack of long-term reliability and
the lack of concordance between the results obtained by
electrophoresis and those obtained by Sepharose 6B chromato¬
graphy. This phenomenon was largely attributable to an
apparent difference in substrate specificities between high
mol wt ALP and the liver isoenzyme at the substrate
concentrations employed (see section 3.2.4.). It may also
have been partly attributable to the use of a diazo dye
which inhibits the enzyme reaction to some extent, making
linear development of colour difficult to achieve (Rhone
and Mizuno, 1972; Fritsche and Adams-Park, 1972). For this
reason electrophoresis on 2.5% polyacrylamide gel was
abandoned as a quantitative technique but retained as a
qualitative tool to demonstrate the presence or absence of
high mol wt ALP.
Another electrophoretic method for measuring high
mol wt ALP, based on elution from sequential strips of
polyacrylamide gel followed by measurement of activities
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in each eluate, has been described by Price and Saramons
(1974). This is a time-consuming procedure. Furthermore,
recovery of enzyme activity from macerated gel may vary
from isoenzyme to isoenzyme, from serum to serum and from
gel to gel. In particular, it seems likely that large
molecules will be more difficult to recover from the gel
than small molecules and that the proportion may be
critically dependent on the characteristics of the gel,
such as its strength and degree of cross-polymerisation,
as well as the conditions of elution.
The ion-exchange method was found to be relatively
rapid, reliable and precise. The common isoenzymes of ALP,
namely those of liver, bone, intestinal and placental
origin, and the slow band ALP (see Chapter 6) which is
occasionally encountered, did not appear to interfere.
Only the Regan variant (Crofton and Smith, 1978), as might
be expected from its high electrophoretic mobility and
presumably greater charge, eluted in Fraction II. This is
a rare cancer-associated isoenzyme, much less commonly
encountered than the better-known Regan isoenzyme, and the
proportion of cases in which its presence would interfere
with the ion-exchange method is likely to be very small.
There was fairly good correlation between estimates
of high mol wt ALP obtained by the ion-exchange method
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and by Sepharose 6B chromatography, taking into account
the fact that the two methods are based on different
properties of high mol wt ALP. Although the slightly
higher results obtained by the ion-exchange method could be
due to a small amount of carry-over, the evidence fails to
support this. It is probable that the slight discrepancy
between the two methods was within the limits of their
analytical error.
In summary, Sepharose 6B was chosen as the
reference method for measuring high mol wt ALP in serum,
but for routine measurements the two-step ion-exchange
method was used. 2.5% polyacrylamide gel electrophoresis





3.1. PURIFICATION OF ALKALINE PHOSPHATASE ISOENZYMES FROM
SERUM AND BILE
All isoenzymes were purified from serum or bile
rather than from tissue sources because high mol wt ALP in
serum or bile may not necessarily occur in the same form
in the tissues. Also, tissue extraction generally requires
solubilisation with butanol (Morton, 1954) which destroys
high mol wt ALP (section 4.7.1.). Since the activity of
ALP in serum and bile is small relative to activities of
liver or intestinal homogenates, and since large quantities
of serum were not available it was not possible to achieve
high degrees of purity in the preparations, nor was this
attempted. The aim instead was a degree of purification
sufficient to separate the isoenzymes from one another and
from most of the contaminating plasma proteins. This
would enable valid comparisons to be made between the
isoenzymes but must be viewed against a purity recently
attained for the liver isoenzyme of 1450 units/mg specific
activity (Latner and Hodson, 1976).
3.1.1. Preparation of serum and bile
Serum containing either liver and high mol wt ALP
or bone ALP was dialysed overnight at 4°C against 0.01 mol/1
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Tris-HCl buffer pH 7.5. The serum was then centrifuged
to remove any precipitate and the supernatant was
designated Fraction I.
Normal hepatic bile was collected via a T-tube
from patients following gallbladder removal. The bile
was mixed with an equal volume of 10 g/1 protamine
sulphate in water in order to precipitate lipid and
pigment (Price et al, 1972) . After centrifugation, the
supernatant, which was a clear pale yellow colour, was
concentrated 10-fold by negative pressure ultra-filtration
and dialysed overnight at 4°C against 0.01 mol/1 Tris-HCl
buffer pH 7.5. The dialysed bile was also designated
Fraction I.
3.1.2. Ion-exchange chromatography
5 ml Fraction I was applied to a DEAE cellulose
column (approximately 16 x 2.5 cm) pre-equilibrated with
0.01 mol/1 Tris-HCl buffer pH 7.5. The column was washed
with one bed volume of this starting buffer. A salt
gradient was then set up with 500 ml starting buffer in
the mixing chamber and 500 ml 1 mol/1 NaCl in 0.01 mol/1
Tris-HCl buffer pH 7.5 in the reservoir. The flow rate
was 120 ml/hour. The protein content of the eluate was
monitored at 280 nm and 5 ml fractions were collected.
ALP activities and the ionic strengths in the fractions
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were measured- The overall yield of ALP from the column
was approximately 90%.
Up to two peaks of ALP activity were eluted from
serum and bile (Fig 3.1). In serum, there were three
protein peaks whereas bile contained only one broad
protein peak. The fractions corresponding to the peaks
of ALP activity were pooled and concentrated approximately
10-fold by negative pressure ultrafiltration. The
concentrates were designated Fractions IIA (for the first
peak of activity eluting at an ionic strength of 80 mmol/1)
and IIB (for the second peak of activity eluting at an
ionic strength of 130 mmol/1) respectively.
The peaks eluted from the ion-exchange column were
identified by their position during subsequent elution from
the Sepharose 6B column (Fig 3.2, section 3.1.3.) . They
were also identified by electrophoresis on 2.5% polyacryl-
amide gel.
The mean ionic strengths at which various isoenzymes
eluted were as follows:
liver isoenzyme: 80 mmol/1 (range 72-86 mmol/1)
bone isoenzyme: 81 mmol/1 (range 77-85 mmol/1)
low mol wt biliary component: 75 mmol/1
high mol wt serum component: 135 mmol/1 (range 130-140
mmol/1)
high mol wt biliary component: 120 mmol/1
The liver and bone isoenzymes in serum and the low mol wt
component(s) in bile therefore eluted in similar positions
Figure3.1.
PurificationStage2.Elut onpa ternsoALPinser mandbil , obtainedbyDEAE-cellulosechromatographyona16x2.5cmlumn —•—iALPactivity;proteinelutionprofile;—-±—-ionic strengthgradi t.









































































































Figure3.1.(continued). (c)hepaticbileon aininglowandhighmoltALP LowM.W.Component
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(Fraction IIA). The high mol wt components in serum and
bile also eluted in similar positions (Fraction IIB).
3.1.3. Sepharose 6B chromatography
2 ml of Fractions IIA and IIB were separately
applied to a 90 x 2.5 cm Sepharose 6B column pre-
equilibrated with 0.1 mol/1 Tris-HCl buffer pH 7.7
containing 0.05 mol/1 NaCl. Elution was carried out
overnight at a flow rate of 28 ml/hour. The protein
content of the eluate was monitored at 280 nm and 5 ml
fractions were collected. The ALP activities in these
fractions were measured.
Fraction IIA contained only liver or bone ALP from
serum, or the low mol wt component(s) from bile, with no
high mol wt ALP present (Fig 3.2.(a)) . Two protein peaks
were present in Fraction IIA derived from serum, but
protein was undetectable in Fraction IIA derived from bile.
The fractions corresponding to the ALP peak were pooled
and concentrated 15 to 20-fold by negative pressure ultra¬
filtration. The concentrate was designated Fraction IIIA
and represented partial purifications of liver or bone ALP
from serum or low mol wt ALP from bile.
Two protein peaks were also present in Fraction IIB
derived from serum but again protein was undetectable in
Fraction IIB derived from bile (Figs 3.2. (b) and 3.2. (c) ) .
Figure3.2.PurificationStageEl tiop tternsofALPinPurif cationFr tiII fromserumandbile,obtainedySepharose6Bc romatographyo90x2.5c column.—•—ALPactivityfrserum;Ac—ALPactivityfrobile proteinelutionprof le(Frac iIIAf mserumnly). (a)PurificationFra tiIIA(seetext)f omserumndbil Elutionvolume(ml.)






























Fraction IIB contained a mixture of high and low mol wt ALP
owing to incomplete resolution of the peaks on ion-exchange
chromatography. However, only the fractions corresponding
to the high mol wt peak were pooled and concentrated to
give Fraction IIIB. This represented a partial purifica¬
tion of the high mol wt components from serum and bile.
All partially purified preparations were stored at -20°C.
It was found that for high mol wt ALP from serum
and bile higher yields with similar degrees of purifica¬
tion could be attained by omission of the ion-exchange
stage in purification. This stage was therefore left out
in routine purification of the high mol wt components from
serum and bile.
The ALP activities of Fractions I to III were
measured and their protein content estimated by the Lowry
method (Lowry et al, 1951) .
Typical purification schedules for liver, bone and
high mol wt ALP from serum are shown in Table 3.1. For
the liver isoenzyme, the degree of purification ranged
from 27- to 48-fold. For the high mol wt component the
degree of purification ranged from 189- to 236-fold for
the three-stage purification scheme, but actually improved
to 326-fold (with a 60% yield) for the two-stage scheme.





































































*TheactivityofhighmolwtALPintoriginalserumascalculatedfrot e proportionsfliverandhighm lwtALPobservedon-exchangechr matography oftheserum.
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pattern, the high mol wt component peak coincided with the
main albumin peak.
Similar activities and yields were obtained for the
partially purified preparations of low and high mol wt ALP
from bile, but purification schedules cannot be given.
This is because the protein concentration in Fraction I of
bile could not be measured either by the Lowry method or
by the Coomassie Brilliant Blue method (Bradford, 1976)
owing to interference by some component in bile.
3.2. ENZYMIC PROPERTIES
Because high mol wt ALP rises in serum only in
patients with liver disease, it was thought that it might
be related to the liver isoenzyme as regards its structure
and properties. To test this hypothesis, the enzymic
properties of high mol wt ALP were compared principally
with those of the liver isoenzyme. Since bile also
contains a high mol wt ALP which may be related to the
serum high mol wt ALP (similar mol wts and charges), this
was included in many of the kinetic studies. The bone
isoenzyme from serum and low mol wt ALP from bile were
also investigated for comparison.
All studies on the enzymic properties were done on
the partially purified preparations of ALP described in
section 3.1.
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3.2.1. Statistical analysis of experimental data
In the analysis of enzyme kinetics, the fitted lines
in the Lineweaver Burk plots were based on estimates of
K and V obtained by a least-squares non-linear fitting
m max
procedure of the direct velocity versus substrate concen¬
tration data points (Wilkinson, 1961). This procedure
assumes equal variance of each of the measured data points.
The fitted lines in the velocity ^ versus inhibitor
concentration plots were obtained by a weighted regression
procedure which assumed equal variance for each velocity
and weighted the variance of each velocity ^ data point
accordingly. The calculations and graphical output were
programmed on a Hewlett-Packard 9821 Desk Calculator
equipped with Printer/Plotter.
One way analysis of variance on the 5 estimates of
Kj. for each isoenzyme was carried out according to the
fixed effects model in which was regarded as a fixed
but unknown quantity to be determined (Snedecor and
Cochran , 1967). This analysis assumes that the data are
normally distributed (although the analysis is insensitive
to minor departures from normality) and that the variances
in all classes are equal. The latter assumption was
tested (Snedecor and Cochran, 1967) and found to be true.
The Scheffe method (Snedecor and Cochran, 1967) was used
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to test for differences between the mean K^s for each
isoenzyme since this method is appropriate when the
difference has not been anticipated by the experimenter.
3.2.2. Buffer type, concentration and pH optima
The activities of liver and high mol wt ALP were
measured in various concentrations of three transphos-
phorylating buffers, namely:
1. Diethanclamine (DEA) buffer pH 10.2
2. 2-amino-2-methylpropan-l-ol (AMP) buffer pH 10.2
3. Tris-borate buffer pH 9.5.
All buffers contained 0.5 mmol/1 MgCl^ and the concentra¬
tion of the substrate, p-nitrophenyl phosphate, was 14
mmol/1 in each case.
DEA buffer was the most sensitive buffer for both
isoenzymes and Tris-borate the least sensitive (Fig 3.3.).
Both isoenzymes exhibited optimal activities at similar
buffer concentrations, namely:
1. DEA buffer pH 10.2 : 1.5 mol/1
2. AMP buffer pH 10.2 : 0.5 mol/1
3. Tris-borate buffer pH 9.5 : 0.5 mol/1
The pH optima of liver and high mol wt ALP in the
three buffers at these optimal buffer concentrations are
shown in Fig 3.4. Again both isoenzymes showed similar
pH optima, namely:
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Figure 3.3. Effect of buffer type and concentration on
ALP activities in partially purified ALP
preparations. A DEA -HCl pH 10.2;




Figure 3.4 Effect of buffer type and pH on ALP activities in
partially purified ALP preparations. —▲— 1.5 mol/1
DEA-HCl; —•— 0.5 mol/1 AMP-HCl; —•— 0.5 mol/1
Tris-borate.


























































1. 1.5 mol/1 DEA buffer : pH 10.2
2. 0.5 mol/1 AMP buffer : pH 10.7
3. 0.5 mol/1 Tris-borate buffer ; pH 10.6
The buffer conditions found to be optimum for the assay of
liver and high mol wt ALP agree well with those found
previously for the liver isoenzyme (McComb and Bowers,
1972; Bretaudiere et al, 1977).
Because DEA was the most sensitive transphosphory-
lating buffer and because its pH optimum with respect to
ALP was better defined, it was used in subsequent experi¬
ments at a concentration of 1.5 mol/1 and pH 10.2.
3.2.3. Linearity of velocity versus enzyme concentration
The activities of various dilutions of liver and
high mol wt ALP were measured in 1.5 mol/1 DEA-HCl buffer
pH 10.2 containing 0.5 mmol/1 MgCl^ (Fig 3.5.) . The
substrate was 14 mmol/1 p-nitrophenyl phosphate.
The graph of velocity versus enzyme concentration
was linear for both isoenzymes.
3.2.4.
g-Naphthyl phosphate as substrate. In order to compare
substrate specificities, the activities of the following
ALP preparations were measured at various concentrations
of the substrate a-naphthyl acid phosphate in 1.5 mol/1
DEA-HCl buffer pH 10.2 containing 0.5 mmol/1 MgCl^
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Figure 3.5. Relationship of reaction velocity to enzyme
concentration using partially purified ALP
preparations.
Ill enzyme preparation in 1 ml reaction solution
111 enzyme preparation in 1 ml reaction solution
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a) liver ALP b) bone ALP c) high mol wt serum ALP
d) high mol wt biliary ALP e) low mol wt biliary ALP.
Fig 3.6. shows the velocity ^ versus [a-naphthyl
phosphate ] ^ Lineweaver-Burk plots for each isoenzyme
investigated. The K^s of the isoenzymes (Table 3.2.)
were similar, though not identical, for all the ALP
isoenzymes tested except high mol wt serum ALP which had
a approximately twice that of the other isoenzymes, a
significant difference.
TABLE 3.2.




High mol wt serum
ALP
High mol wt biliary
ALP

















p-Nitrophenyl phosphate as substrate. Similarly, the
activities of the ALP isoenzyme preparations were measured
at varying concentrations of p-r.itrophenyl phosphate in
the same buffer. The K^s of the isoenzymes (Table 3.3.)
Figure3.6.Lineweaver-Burkplotsof1/versu[anaphthylcidphosphate]f ac ALPpreparation.Vism asurednte msofabsorb ncechangp i340. (a)Liverlkalinephosphatase [anaphthylphosphate](mmol/l)-l
Figure3.6.(continued).
[Ofnaphthylphosphate]
I 2.046.8.01 .0 *(mmol/l)~*
Figure3.6.(continued). (c)HighM.W.serumalkalinephosphatase
Conaphthylphosphate]"1(mmol/1)"*
















were similar, though not identical, for all isoenzymes
except high mol wt serum ALP. Again the Km of the latter
was approximately twice that of the other isoenzymes.
TABLE 3.3.




High mol wt serum
ALP
High mol wt biliary
ALP


















High mol wt serum ALP therefore has a lower affinity
for both a-naphthyl phosphate and p-nitrophenyl phosphate
than any of the other ALP isoenzymes, including high mol wt
biliary ALP. This explains the discrepancy between
estimates of high mol wt ALP in serum using the two subs¬
trates (section 2.8.) . Routine assays used the optimised
concentration of 14 mmol/1 p-nitrophenyl phosphate which is
on the plateau of the activity versus substrate concentration
curve for all isoenzymes, including high mol wt serum ALP.
The difference in affinities was therefore masked. On the
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other hand, a-naphthyl phosphate was used at the sub-
optimal concentration of 0.75 mmol/1 which led to the
difference in affinities becoming apparent. The difference
in K^s between high mol wt ALP and the other isoenzymes
in serum therefore had an effect when a-naphthyl phosphate
was employed as substrate but not when p-nitrophenyl
phosphate was employed.
The difference in K s between liver and high mol
m
wt ALP with respect to p-nitrophenyl phosphate as substrate
is in conflict with the findings of Akedo et al (1967) but
the purity of their preparations was considerably lower.
3.2.5. Inhibition by L-homoarginine
L-phenylalanine is the best known inhibitor of ALP
(Ghosh and Fishman, 1966). It inhibits the intestinal and
placental isoenzymes to a much greater extent than those
from liver and bone. In the present study it was found to
inhibit the liver isoenzyme by 10% and high mol wt ALP by
only 4% at a concentration of 4 mmol/1. More recently
inhibition of liver and bone ALP by L-homoarginine has been
described (Lin and Fishman, 1972) . This inhibitor was
therefore studied in more detail.
The activities of the ALP isoenzymes were measured
in the presence of selected concentrations of p-nitro-
phenyl phosphate as substrate and L-homoarginine as
-101-
inhibitor.
Fig 3.7. shows the velocity ^ versus [p-nitrophenyl
phosphate] ^ Lineweaver-Burk plots for each of these iso¬
enzymes at the selected concentrations of L-homoarginine .
L -homoarginine appeared to affect both Km and Vmax, giving
parallel lines for all five ALP isoenzymes. The slopes
(= ) for each isoenzyme individually (Table 3.4.)
show no significant differences. This suggests that the
inhibition was of the uncompetitive type for all the
isoenzymes.
In uncompetitive inhibition, the enzyme-inhibitor
complex is not formed. Instead the inhibitor can only
combine with the enzyme-substrate intermediate, resulting
in a complex which does not break down. This may be
summarised by the following equilibria:
E + S 51 ES (1)
ES + I -—* EIS (2 )
ES > E + P (3)
If e is the enzyme (E) concentration, s the substrate (S)
concentration, i the inhibitor (I) concentration, p the
enzyme-substrate intermediate (ES) concentration, q the
enzyme-substrate-inhibitor complex (EIS) concentration,
Km the dissociation constant of ES, the dissociation
constant of EIS, v the velocity of the reaction in equation


















Slopes of Lineweaver-Burk plots at various concentrations
of L-homoarginine
[L-homoarg- Slope(K /V )
m maxALP isoenzyme inine] S .E.(slope)
(mmol/1) (xlo"3) (xlo"3)
Liver ALP 0 3 .5 0.3
2 4.3 0.3
4 5.1 0 .6
6 5.3 1.0









High mol wt 0 18 2
biliary ALP 2 17 4
4 18 1
6 23 2
Low mol wt 0 5.1 0.5
biliary ALP 2 4.6 1.4
4 6.7 1.4
6 6.0 1.1
* Calculated from the formula:
(S .E . slope) 2 = (S . E - K ) 2 + (S.E.Vmax)
-108-
(3) and k the velocity constant for equation (3), the
following equations can be set up by the Law of Mass Action:
(e-p-q)s=Kp (4)
m
pi = K±q (5)
v = kp (6)




Now ke = V since under these circumstances all the
max
enzyme would be involved in the ES complex.
V
max
Therefore, v = :—
Vs + (1 + i?
1 Km 1 1 + /Ki
Rearranging, — = . — +^ ^
v V s V
max max
Therefore the usual Lineweaver-Burk plots of ^"/v versus
/s will result in a series of parallel lines at all
inhibitor concentrations with a slope of m/V
max
1 1 K , , 1
Rearranging again, — = (1 + m/ ) + —— . l
v V s K. v
max l max
Therefore a plot of "*"/v against i will also result in a
series of parallel lines at all substrate concentrations
with a slope of ~/K.V , from which K. can be calculated.
i max l
Therefore, in order to confirm the uncompetitive
nature of the inhibitors and calculate K^, velocity was
Figure3.8.


























Slopes of velocity versus [ L-homoarginine] plots at
various concentrations of p-nitrophenyl phosphate
ALP isoenzyme
[p-nitrophenyl
phosphate] Slope S.E. (s
(mmol/1) (xlO~3) (xlO~





Bone ALP 0.25 16.1 1.2
0.5 17 .0 0.1
1.0 15.4 0.4
1.5 15 .0 0.4
2 .5 15.7 0.3
High mol wt 0.25 15.0 2 .0
serum ALP
0.5 13 .3 0.5
1.0 14.1 0.8
1.5 13 .5 0 .2
2.5 13 .2 0.4
High mol wt 0.25 25 .4 2.4
biliary ALP 0.5 24.1 2 .0
1 .0 26.6 0.7
1.5 2 6.0 0.4
2.5 23 .8 1.1
Low mol wt 0.25 5.8 0.4





plotted against L-homoarginine concentration for each
concentration of p-nitrophenyl phosphate (Fig 3.8.) .
Table 3.5. shows the slopes with their standard errors,
confirming that the lines were parallel.
TABLE 3.6.
Estimates of derived from velocity 1 versus
[L-homoarginine] plots
ALP Isoenzyme mean (n = 5~) S.D.
(mmol/1) (mmol/1)
Liver ALP 1.1 0.13
Bone ALP 1.1 0.05
High mol wt serum ALP 1.2 0.06
High mol wt biliary ALP 1.2 0.06
Low mol wt biliary ALP 1.6 0.09
Table 3.6. shows the mean and S.D. of the estimates of K.
l
derived from these slopes for each isoenzyme. One way
analysis of variance showed that there was at least one isoenzyme
which differed significantly from the others (p <0.001).
The K. of the low mol wt biliary isoenzyme was found to
be significantly different from the other K^s (p <0.001).
The K.s of the high mol wt ALPs from serum and bile were
x
slightly but significantly higher than the K_^s of the
liver and bone isoenzymes (p < 0.05). However, this
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slight difference could be explained by the higher degree
of purity attained for the high mol wt ALPs and is in any
case too small to indicate a basic difference between the
isoenzymes.
In conclusion, with respect to inhibition by L-
homoarginine the high mol wt ALPs from serum and bile
resemble each other and also the liver and bone isoenzymes.
3.2.6. Activation by magnesium ions
Although it is generally recognised that ALP is
2+
activated by magnesium ions (Mg ) no detailed mechanism
has been worked out. It is thought that the binding of
2 +
substrate and of Mg to the enzyme are two independent
2 +
events and that Mg must therefore play a part in substrate
decomposition (Ahlers, 1974). This may be summarised by
the following equilibria, using the same notation as in
section 3.2.5.
2 K 2+
E + Mg + A s EMg + (1)
K
E + S ^ ES (2)
\
2+ Km v 2 +
EMg + S N EMg S (3)
2+ A 2+ ,
ES + Mg v EMg S (4)
2+ v 2+
EMg S ——> EMg + products (5)
2 +
If a is the concentration of Mg , p the concentration of
-117-
2 +
ES, q the concentration of EMg S, r the concentration of
2+ 2 +
EMg and K the dissociation constant of EMg , then the
following equations may be set up by the Law of Mass Action:
(e - p - q - r) a II J*> n (6)
(e - p - q - r) s - Kmp (7)
rs - V (8)
pa - V (9)
V - kq (10)
Solving these for p, q and r, we obtain:
/ITS
V
(1 + KJ (1 + K ) ( }m A
which is symmetrical for substrate and activator.
Now, let V =
a 1 + K
V
Then from (11), v = .
+ V
a
• 1 1 KA 1
Rearranging, — = — + — . —^ ^
v V V a
a a
and a 1/v versus a 1/a plot will give a negative intercept on
the 1/a axis of 1/K . This intercept is independent of
A
variations in substrate concentration. Since equation (11)
is symmetrical for substrate and activator, a 1/v versus
1/S plot will also give a negative intercept on the 1/S
axis of 1/K^. This intercept is also independent of
-118-
variations in magnesium concentration.
The activities of liver and high mol wt serum ALP
were measured in 1.5 mol/1 DEA-HCl buffer pH 10.2 at
various concentrations of p-nitrophenyl phosphate and at
various concentrations of added magnesium chloride.
Fig 3.9. shows the double reciprocal plots of
reaction velocity versus p-nitrophenyl phosphate concen-
2+
tration at selected Mg concentrations. The K did not
m
2+
seem to be significantly affected by Mg concentration
2+
but there was an increase in V as Mg concentration
max
increased (Table 3.7.). This is in agreement with the
mechanism for activation presented above.
It is interesting to note that in this experiment
the K 's of liver and high mol wt ALP appeared to be
m
2+
similar at most Mg concentrations, contrary to the
findings in section 3.2.4. The explanation may be that
the differences only manifested themselves at much higher
2 +
Mg concentrations i.e. 500 yumol/1 rather than the
maximum of 50 ^mol/1 in this experiment.
2 +
The endogenous Mg content of the buffered enzyme
preparations was measured by atomic absorption spectro¬
photometry and found to be 13 ^umol/1 for the liver iso¬
enzyme and 8 ^umol/1 for high mol wt ALP. A further
6 ^imol/1 was contributed by a 10 mmol/1 solution of
-119-
Figure 3.9. Lineweaver-Burk plots of 1/v versus
[p-nitrophenyl phosphate]-1 at selected
concentrations of magnesium ions. V is
measured as yumoles p-nitrophenol produced
per min per litre, —a— 0; —5; —o— 10;












1.17(0.1 ) 1.13(0.08) 1.10(0. 7) 1.19(0.10) 1.07(0. 8)
1.13(0.04) 1.28(0.13) 1.17(0. 0) 1.17(0.20) 1.63(0.31)
2211(96) 2831(58) 3023(93) 3275(85) 3193(68)
268(3) 323(10) 338(9) 362(19) 421(27)
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p-nitrophenyl phosphate. Correcting the concentration of
2+ 2+
added Mg , the velocity versus Mg concentration plots
shown in Fig 3.10. were obtained.
It is apparent from Fig 3.10 that the fit would be
2 +
improved if the origin were adjusted along the [Mg ] axis.
This procedure could be rationalised by the hypothesis
2+
that not all the endogenous Mg ions were available to
the enzyme: some might be inaccessibly bound to contamin¬
ating protein in the partially purified preparations.
On an empirical basis it was found that minimum
residual variance of the experimental points from the
fitted curve was obtained by assuming an available endo-
2 +
genous Mg ion concentration of 2 /imol/1 in the buffered
liver isoenzyme preparation and 4 ^imol/1 in the buffered
high mol wt ALP preparation (Fig 3.11.) . The double
2+
reciprocal plots of reaction velocity versus Mg concen¬
tration using these modified data are shown in Fig 3.12.
The apparent K , defined as the reciprocal of the
n
2+ -1
intercept on the [Mg ] axis, is shown in Table 3.8. for
various concentrations of substrate. If liver and high
mol wt ALP are considered separately, there appears to be
little significant variation in the value of the apparent
K with variations in substrate concentration. Again this
A 73
is in agreement with the mechanism for activation presented



























Figure3.12.1/vversus[Mg]plotsase ec edconc ntrationsfp-nitr phenyl phosphate,w ere[Mg+̂]istak nh"be tfit"magn siumconcentration (seetext).Vim asureda/amol sp-nitroph nolroducedi litre.—O—0.5;o1.—A—2 —•—3 ▲0.0mmol/1p-nitro¬ phenylhosphate.





























































above. For the liver isoenzyme the mean apparent K was
l.l^pmol/1 and for high mol wt ALP 1.9 _pmol/l. No
definite conclusions can be drawn concerning the signifi¬
cance of this apparent difference, owing to the assumptions
underlying the data used in the calculation.
Some support for the hypothesis that a proportion
2 +
of the endogenous Mg may have been sequestered by protein
2+
came from observations on the effect of added Mg on the
activities of the fractions obtained by Sepharose 6B
chromatography. Fig 3.13 shows the ALP elution profiles
when the fractions were analysed in the presence and
absence of 0.5 mmol/1 added magnesium chloride. The ratios
2+
of the activities in the presence of added Mg to the
2+
activities in the absence of added Mg were calculated
and plotted as an elution profile (Fig 3.14.), omitting
those fractions in which activities were negligible. This
elution profile varied in parallel with the protein elution
2+
profile. The endogenous Mg concentration in each
fraction, measured by atomic absorption spectrophotometry,
varied randomly between 2.0 and 4.0 p.mol/1 throughout the
elution profile. The findings illustrated by Fig 3.14 are
therefore best explained by the supposition that some of
2+
the endogenous Mg was sequestered by protein. This would
result in an apparent increase in the activation by added
-131-
Figure 3.13. Elution profile of a serum containing liver
and high mol wt ALP, following Sepharose 6B
chromatography. ALP activity in eluate
measured in the presence ( A, ) and absence





Figure 3.14. Elution profiles of the serum in Fig 3.13
following Sepharose 6B chromatography,
showing relationship of activation by
magnesium ions to protein elution profile
(- - -) - see text for details. —±—
endogenous magnesium concentration in
fractions; —•— ratio of ALP activity ^
measured in the presence of 0.5 mmol/1 Mg
to activity measured in the absence of
added Mg^+.
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Mg in parallel with the increase in protein concentration.
An attempt to demonstrate this effect by adding 2 g/1 human
albumin to the reaction buffer was unsuccessful since the
2 +
albumin preparation contained Mg , as measured by atomic
absorption spectrophotometry.
3.2.7. Effect of divalent metal ions other than magnesium
The activities of liver and high mol wt serum ALP
were measured in the absence and in the presence of 1 jumol/1
and 100yumol/l divalent metal ions. Calcium and nickel ions
were present in the form of their chloride salts, manganese
and zinc ions in the form of their sulphate salts.
TABLE 3.9.
Inhibition by divalent metal ions
% inhibition
Metal ion Concentration High mol wt
mol/1) Liver ALP ALP
Calcium 1 9 3
100 6 3
Manganese 1 7 4
100 13 11
Nickel 1 0 4
100 26 16
Zinc 1 6 8
100 71 65
Table 3.9. shows that 1^mol/1 of all 4 divalent metal ions
caused only slight inhibition of the activities of the two
-134-
isoenzyme preparations, and to a similar degree in both
cases. At 100 ^prnol/1 calcium and manganese ions still
only inhibited the isoenzymes slightly. Nickel ions
showed a slightly more marked inhibitory effect on both
isoenzymes at this concentration. Zinc ions at 100^umol/l
inhibited both isoenzymes markedly.
3.2.8. Summary




3) inhibition by L-homoarginine
4) inhibition by divalent metal ions
Both high mol wt and liver ALP were activated by
2 +
Mg but it was not possible to draw conclusions concerning
the similarity or otherwise of the apparent K 's owing to
probable ion-binding effects.
However, high mol wt ALP differed from the liver
isoenzyme, and also from the bone isoenzyme and high and low
mol wt biliary ALP, with regard to its affinities for the




PHYSICAL AND BIOCHEMICAL CHARACTERISTICS
The large molecular size of high mol wt ALP might
result from aggregation of liver isoenzyme molecules or
association of ALP with a) protein alone, b) lipid alone,
c) carbohydrate alone or d) a combination of these moieties
in the form of membrane fragments. Owing to the histolog¬
ical location of ALP on the sinusoidal and biliary
canalicular membranes of the hepatocyte and the observa¬
tions of Shinkai and Akedo (1972) that LAP and 5' N'T also
occurred in a high mol wt form, it was the latter
hypothesis which was principally tested by the experiments
presented in this chapter. Following preliminary studies
on molecular size, charge and stability to heat and urea,
the relationship of high mol wt ALP both in serum and bile
to the membrane marker enzymes, YGT, LAP and 5'NT, was
therefore investigated. Its relationship to LPX was also
studied since this, like high mol wt ALP, has a high mol wt
and appears in the serum of patients with cholestasis.
Finally, the effects of various agents, which have been
used to solubilise membranes, on the structural integrity
of high mol wt ALP were explored.
-136-
4.1. MOLECULAR WEIGHT
A 95 x 2.5 cm Sepharose 6B column (bed volume:
238 ml; void volume: 171 ml; flow-rate: 28 ml/hour) was
4
calibrated by proteins of mol wts ranging from 6.9 x 10
0
to 1.0 x 10 as shown in Table 4.1. The semi-logarithmic
calibration curve for the column (Fig 4.1.) is linear
5 6
between mol wts 2.5 x 10 and 1.0 x 10 but tails off in
5
the lower mol wt range below 2 x 10 .
TABLE 4.1.









Mol wt Method used for determination
0
1.0 x 10 Radial immunodiffusion
(Mancini et al, 1965)
5
8.2 x 10 Radial immunodiffusion
(Mancini et al, 1965)
4.8 x 105 Urea substrate: ammonium ion
estimated by Nessler's reagent
(Gentzkow, 1942)
5
2.4 x 10 Hydrogen peroxide substrate;
reaction rate at 240 nm
(Beers and Sizer, 1952)
1.6 x 105 Radial immunodiffusion
(Mancini et al, 1965)
Lactate 1.4 x 10"
dehydrogenase
Pyruvate/NADH substrates;
reaction rate at 340 nm (Scand.
Soc. Clin. Chem. Clin. Physiol,
recommended method, 1974)
Albumin 6.9 x 10 Absorption at 280 nm
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Figure 4.1. Semi-logarithmic plot of elution volume versus
mol wt in the calibration of a 95 x 2.5 cm
Sepharose 6B column.
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Liver and bone ALP were found to have similar mol
wts of 2.2 x 105. High mol wt ALPs from both serum and
bile were excluded from the gel matrix and appeared in the
void volume. It was concluded that their mol wts exceeded
g
1 x 10 . Since no reliable mol wt markers are available
above this mol wt, it was not considered worthwhile to
proceed to a larger mesh gel e.g. Sepharose 2B.
In order to check these findings, various isoenzymes
of ALP, in purified form and in the native serum or bile,
were subjected to electrophoresis to equilibrium in 4 to
26% polyacrylamide gradient gels. Serum proteins acted as
mol wt markers (Fig 4.2.) . This procedure confirmed the mol wts
found by gel filtration (Table 4.2.). The high mol wt
TABLE 4.2.
Mol wts of various ALP isoenzymes, determined by
electrophoresis to equilibrium in polyacrylamide gradient gel















Low mol wt , . , 2 .2 x 10I from bxle
High mol wt J >1 x 10




















components from both serum and bile migrated exactly the
same distance into the gel. In addition, the low mol wt
isoenzyme in bile was found to have a mol wt similar to
5
that of the liver isoenzyme (2.2 x 10 ).
The estimate of 2.2 x 105 for the mol wt of the
liver isoenzyme is in close agreement with previous
measurements made in the presence of NaCl but at variance
with measurements made in the absence of NaCl which
indicated a mol wt of 1.46 x 10^ (Trepanier et al, 1976).
This may be due to non-specific adsorption of the glyco¬
protein to the Sephadex, Sepharose or polyacrylamide gel
matrix in the absence of NaCl. On the other hand, in the
presence of NaCl there may be some unfolding of the poly¬
peptide chains leading to an alteration in the Stokes
2 +
radius (c.f. Ca -activated adenosine triphosphatase,
Farias et al, 1975) . The large size of the high mol wt
ALP is also in agreement with previous studies which have
shown it to be excluded not only by Sephadex G200 but by
Sepharose gels 6B, 4B and 2B in order of increasing mesh
size (Akedo et al, 1967; de Broe et al, 1975) .
4 .2 . CHARGE
The high mol wt ALPS from both serum and bile
migrated in the a., globulin position (ahead of the normal
liver isoenzyme and of all the other ALP isoenzymes which
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normally occur in serum) during electrophoresis in cellulose
acetate, which is the only electrophoretic medium to exert
no molecular sieving effect (section 2.5, Fig 2.2.) . Both
high mol wt ALPs also eluted from an ion-exchange column at
a higher ionic strength (135 mmol/1) than all other commonly
encountered isoenzymes of ALP (80 mmol/1)(section 3.1.2.,
Fig 3.1.) . These ionic strengths are in agreement with
those observed for biliary ALP by Price et al (1972). The
high mol wt ALPS from serum and bile must therefore carry
an identical net negative charge which is higher than any
other commonly occurring ALP isoenzyme at alkaline pH.
4.3. EFFECT OF NEURAMINIDASE
Sera and purified ALP isoenzymes were incubated for
2 hours at 37°C with 100 iu/1 neuraminidase in 0.05 mol/1
acetate buffer pH 5.5 containing 0.15 mol/1 NaCl and
9 mmol/1 CaC^- The incubation mixture contained 2 volumes
serum/enzyme preparation to 1 volume neuraminidase solution
(Fishman, Inglis and Ghosh, 1968).
Electrophoresis in 2.5% polyacrylamide gel demons¬
trated that the neuraminidase-treated liver and bone ALP
migrated more slowly than the corresponding untreated
specimens. On the other hand, the migration rates of the
neuraminidase-treated intestinal and high mol wt ALP were
not affected. Since it was possible that the molecular
-142-
sieving effect of the gel on the high mol wt ALF might be
masking a real alteration in charge, electrophoresis was
repeated in cellulose acetate. The results (Table 4.3.)
showed that the migration rates of both liver and high mol
wt ALP were retarded to similar extents by neuraminidase
treatment in this medium. An interesting observation was
TABLE 4.3.
Reduction in electrophoretic mobility of liver and high
mol wt ALP by the action of neuraminidase. The
electrophoretic medium was cellulose acetate
ALP Isoenzyme
Liver











that the retardation was much greater for both isoenzymes
in the purified state than it was in whole serum. This may
have been due to competition for the active site of
neuraminidase from other sialic acid-containing proteins
in serum, or because in serum the sialic acid residues were
somehow more protected. The effect of neuraminidase on the
high mol wt ALP in bile was not studied but it seems likely
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that the high negative charge of high mol wt ALP in both
serum and bile is largely caused by the presence of the
sialic acid residues.
4.4. INACTIVATION BY UREA
Urea is a highly polar molecule which acts by
disrupting hydrogen bonds. There are two types of
inhibition of ALP by urea: the first, at concentrations
below 3 mol/1, is reversible, instantaneous and non¬
competitive in nature; the second, at concentrations above
3 mol/1, is irreversible and time-dependent (Birkett et al,
1967). It was the second type of inhibition that was
investigated here.
At time zero, partially purified preparations of
liver and high mol wt ALP were mixed with equal volumes of
urea solution to a final concentration of 5 mol/1 urea.
The mixtures were incubated at room temperature. At timed
intervals, 50 p1 samples were withdrawn, mixed immediately
with 1 ml 0.9 mol/1 diethanoJamine buffer pH 10.3 containing
0.5 mmol/1 MgCl^ (to dilute out the urea and prevent
further inactivation), and the ALP activities measured.
The inactivation of both liver and high mol wt ALP
(from serum) followed mono-exponential decay curves up to
25 minutes (Fig 4.3.) with half-lives of 9.0 min and 7.0
min respectively, estimated graphically. After 25 minutes
-144-
Figure 4.3. Semi-logarithmic plot of ALP inactivation by
5 mol/1 urea versus time.
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the rate of decay of both isoenzymes diminished.
Electrophoresis of the urea-treated samples in 2.5%
polyacrylamide gel showed diminished staining intensity
but no qualitative alteration in the positions of the
isoenzyme bands. Urea, which interferes with hydrogen
bonding, therefore probably caused unfolding of the ALP
polypeptide chains to a similar extent in liver and high
mol wt ALP without disrupting the link between ALP and the
other moieties present in high mol wt ALP.
4.5. INACTIVATION BY HEAT AT 56°C
In a two component system in which both the
components show exponential decay when heated,
• •
, « ■, _ -kit _ -k2t
remaining activity = Ae x + Be ^
where t is the time of exposure to heat, A and B are the
percentage activities of each component and k^, k^ are
decay constants appropriate to each component. Using this
formula and a curve fitting program on a Hewlett-Packard
desk-top computer a bi-exponential decay curve could be
fitted to a series of experimental points assuming constant
variance for all points. The same program was used to
calculate the percentage and half-life of each component
in the system.
Partially purified preparations of ALP were heated
at 56°C (- 0.5°C) for varying lengths of time according to
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the method of Whitby and Moss (1975) . The inactivation
curves obtained were mono-exponential for the liver and
bone isoenzymes but bi-exponential for high mol wt ALP
from serum and bile (Fig 4.4.)/ the two components being
present in approximately equal amounts in each case
(Table 4.4.). One component in each case was heat labile
whereas the second component was much more heat-stable
(Table 4.4.) . Overall, high mol wt ALP from both serum
and bile was slightly more heat-labile than the liver
isoenzyme.
In whole serum, it is doubtful whether the slight
difference in heat lability between liver and high mol wt
ALP could be resolved into two separate components.
Therefore the contribution by high mol wt ALP to total
serum ALP in different proportions in liver disease may
partly explain the observed variation in apparent liver
isoenzyme half-life from serum to serum (Whitby and Moss,
1975) .
The two components present in high mol wt ALP could
not be resolved by Sepharose 6B or ion-exchange chromato¬
graphy. The apparent heterogeneity may have existed in the
original serum and bile; alternatively, it may have been
an artefact arising from the purification procedure.
Possible explanations for these findings are discussed
-147-
Figure 4.4. Semi-logarithmic plot of ALP inactivation by-
heat at 56°C versus time. liver isoenzyme;
—•— bone isoenzyme; -A—high mol wt ALP (from
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more fully in Chapter 7.
4.6. RELATIONSHIP OF HIGH MOLECULAR WEIGHT ALKALINE
PHOSPHATASE TO HIGH MOLECULAR WEIGHT COMPONENTS OF
VARIOUS MEMBRANE MARKER ENZYMES
Various enzymes are known to be located principally
on the plasma membrane of the hepatocyte. Besides ALP
itself, these include "JCGT, LAP and 5' NT. The relation¬
ship between these enzymes was explored in a number of
ways .
4.6.1. Electrophoresis
Purified preparations. Electrophoresis of purified high
mol wt ALP from serum and bile in 2.5% polyacrylamide gel
gave a single band of ALP activity near the origin. A
single band in exactly the same position was found when
the gel was stained for JfGT and LAP. Similarly, electro¬
phoresis to equilibrium in a 4 to 26% polyacrylamide
gradient gel gave a single band of activity near the
origin for all 3 enzymes (Fig 4.5.) . This showed that the
high mol wt components of all 3 enzymes had a similar mol
wt.
Sera. 9 sera which contained high mol wt ALP (demonstrated
by electrophoresis) invariably also contained high mol wt
^GT and LAP. Conversely, 9 sera which did not contain
high mol wt ALP did not have high mol wt tfGT or LAP. In
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Figure 4.5. Positions of ALP, 2fGT and LAP isoenzymes
following electrophoresis in a) 2.5% polyacryl-
amide gel and b) 4 to 26% polyacrylamide gel
(to equilibrium). Samples: 1, serum containing
liver and high mol wt ALP; 2, purified liver
ALP; 3, purified high mol wt ALP from serum;
4, purified high mol wt ALP from bile.
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other words, these high mol wt enzymes appeared to be
present or absent in unison.
4.6.2. Sepharose 6B chromatography
Serum. 7 sera containing varying amounts of liver and
high mol wt ALP were eluted from a 95 x 2.6 cm Sepharose
6B column. The original sera and the eluted fractions were
assayed for the membrane marker enzymes ALP (6 sera), YGT
(7 sera), LAP (7 sera) and 51 NT (5 sera) . The elution
profile of one of these sera is shown as an example in
Fig 4.6. In addition to various low mol wt isoenzymes,
all four enzymes possessed a high mol wt component which
always eluted in the void volume. By contrast, lactate
dehydrogenase (a cytoplasmic enzyme) did not have a high
mol wt component in serum.
The total activities of enzyme present in the high
and low mol wt peaks were calculated and the high mol wt
component in the original serum was expressed either as
iu/1 or as a percentage of total enzyme activity. The
total activities of the enzymes were significantly
correlated with one another (Fig 4.7., Table 4.5. (a)) .
Similar significant correlations were observed between the
high mol wt enzymes, expressed as iu/1 (Fig 4.8., Table
4.5.(b)) . Much lower correlations occurred between these
high mol wt enzymes when they were expressed merely as a
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Fiqure 4.6. Elution profiles of ALP, tfGT, LAP and 5'NT
activities on a Sepharose 6B column following



















Fiqure 4.7. Total activities of ALP, JTGT, LAP and 5' NT
plotted against one another in pairs (7 sera).
The arrow indicates serum from a patient with
alcoholism.
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Figure 4.8. High mol wt component activities of ALP, VGT,
LAP and 5'NT plotted against one another in
pairs (7 sera). The arrow indicates serum
from a patient with alcoholism.
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Two-tailed probabilities associated with the correlation
coefficients between pairs of enzymes
(a) Total enzyme activities (iu/1)
ALP YGT LAP 5'NT




(b) High mol wt forms (iu/1)
ALP Y GT LAP 5'NT




(c) High mol wt forms (percentage of total activity)
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percentage of the total activity (Table 4.5. (c)) . It
seems likely, therefore, that the high mol wt enzymes are
correlated with one another in their own right, and not
just because the total activities are correlated. Whether
they always vary in parallel, indicating a common control
mechanism, or whether certain factors may influence the
activity of one high mol wt enzyme to a greater extent
than the others could be discovered by studying further
patients. In Figs 4.7. and 4.8. the arrow indicates a
patient with chronic alcoholism, in whom YGT activity
may therefore have been induced, but this case had a
variable effect on the correlation coefficients.
Bile. A concentrated sample of normal hepatic bile, from
which most of the lipid and pigment had been removed
(section 3.1.1.), was also eluted from the Sepharose 6B
column. In addition to various low mol wt isoenzymes, ALP,
YGT and LAP all showed prominent high mol wt peaks in the
void volume (Fig 4.9.). This suggests that any qualitative
relationship between the high mol wt components of the
four enzymes in serum may also be true of their high mol
wt components in bile.
4.6.3. Ion-exchange chromatography
Serum containing liver and high mol wt ALP was
dialysed overnight against 0.01 mol/1 Tris-HCl buffer pH
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Figure 4.9. Elution profiles of ALP, GT and LAP activities
on a Sepharose 6B column following application
of concentrated normal hepatic bile from which
lipid and pigment have been removed.
Elution volume (ml)
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7.5. 5 ml of this dialysed serum was applied to a 16 x
2.5 cm column of DEAE-cellulose pre-equilibrated with the
same buffer, and subjected to salt (NaCl) gradient chroma¬
tography. The elution profiles of ALP, VGT and LAP each
showed two distinct peaks, although these did overlap using
this gradient (Fig 4.10). None of these peaks coincided
in the ionic strengths at which they eluted.
In order to identify the enzyme peaks, four pools,
A, B, C, and D were made as shown in Fig. 4.10. These were
concentrated approximately 10-fold and applied consecutively
to a Sepharose 6B column. ALP, GT and LAP activities were
measured in the eluate (Fig. 4.11.). Each pool was also
subjected in triplicate to electrophoresis to equilibrium
in 4 to 26% polyacrylamide gradient gel, followed by
staining for the three enzymes.
The results (summarised in Tables 4.6 and 4.7) show
that for each enzyme, the first peak to appear on ion-
exchange chromatography corresponded to the low mol wt
component(s) and the second peak to the high mol wt component.
Therefore the high mol wt enzyme peaks did not coincide
exactly in their elution positions but partially overlapped.
There are various possible explanations for the partially
overlapping peaks of the high mol wt enzymes. Firstly,
dissociation of a single complex containing all 3 enzymes
-159-
Figure 4.10. Elution profiles of ALP(-*-) , X GT (-A-) and
LAP (-■-*) from a DEAE-cellulose ion-exchange
column following application of a serum from






Figure 4.11. Elution profiles of a) ALP b) XGT and c) LAP
from a Sepharose 6B column following
application of pooled fractions A, B, C and D
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on the column must be considered. This is unlikely
because both before and after ion exchange chromatography
the high mol wt enzymes retained their properties, in
particular their behaviour on electrophoresis and Sepharose
6B chromatography. Secondly, there may be a series of
complexes, each containing only one enzyme. Thirdly, there
may be a heterogeneous collection of complexes, all
containing all three enzymes in different relative
proportions. This would result in the observed pattern
of partially overlapping peaks. This is discussed further
in Chapter 7.
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4.7. EFFECT OF ORGANIC SOLVENTS AND DETERGENTS
4.7.1. Extraction with butan-l-ol
Butan-l-ol (n-butanol) is a solvent which dissolves
fats and lipids. It has been extensively used in the
solubilisation of ALP from tissues prior to the purifica¬
tion of the enzyme (Morton, 1954). If high mol wt ALP
consisted of a complex of ALP with either lipid, lipoprotein
or membrane fragments, it might be susceptible to extraction
by butanol. If, on the other hand, it consisted of
aggregates of ALP or ALP complexed to protein or carbo¬
hydrate it would remain unaffected by butanol extraction.
Serum. 5 sera containing liver and high mol wt ALP were
mixed with butanol in the proportions of 5 volumes of
serum to 1 volume of butanol. Extraction proceeded at 4°C
for 30 min with frequent mixing. After centrifugation,
the upper fatty butanol layer (which had no detectable
enzyme activity) was discarded. Electrophoresis of
treated and untreated sera in 2.5% polyacrylamide gel
showed that butanol had completely abolished the band
corresponding to high mol wt ALP. This was accompanied by
a variable increase in the staining intensity of the liver
isoenzyme band (Table 4.8.). This is insufficient
evidence from which to conclude that butanol actually
converts high mol wt ALP into the liver isoenzyme. To
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TABLE 4.3.
Effect of butanol extraction on liver and high mol wt ALP
in 5 sera, visualised by electrophoresis in 2.5%
polyacrylamide gel and quantitated by scanning
Band staining (experimental units)
Serum High mol wt Liver
Untreated Treated Untreated Treated
1 Faint 0 112 137
2 Fa int 0 236 212
3 10 0 49 91
4 Faint 0 40 53
5 19 0 129 157
test this hypothesis, studies on separate preparations of
liver and high mol wt ALP were required.
Separate preparations of low and high mol wt ALP, ^GT and
LAP. A similar butanol extraction experiment was conducted
on high and low mol wt ALP separated by Sepharose 6B
chromatography. The high mol wt component contained ALP,
tfGT and LAP activity. The low mol wt component, because
it was relatively impure, also contained ALP, XGT and LAP
activity making it preferable to a purer preparation for
the purposes of this experiment.
Electrophoresis of the butanol-treated and
untreated preparations, before and after dialysis to
remove any remaining butanol, showed that qualitatively
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liver ALP was unaffected by treatment with butanol but the
band corresponding to the high mol wt component disappeared
entirely with no reappearance of activity elsewhere
(Fig 4.12.) . Removal of the remaining butanol by dialysis
did not result in any reappearance of the high mol wt
component.
Measurement of enzyme activities demonstrated that
high mol wt ALP almost completely and high mol wt YGT and
LAP completely disappeared from the aqueous layer after
treatment with butanol (Table 4.9.). Nor did the organic
layer of butanol show any activity. Dialysis of the aqueous
layers did not restore activity. Low mol wt liver ALP
showed a slight enhancement of activity when treated with
butanol, but the activity of low mol wt Y"GT was halved and
that of low mol wt LAP completely destroyed by treatment
with butanol, presumably owing to denaturation. No return
of activity was observed following dialysis to remove
butanol.
The results suggest that the increase in activity
of liver ALP in serum following treatment with butanol was
not a consequence of conversion of high mol wt ALP into
the liver isoenzyme by the solvent. It seems on the con¬
trary to have stemmed from an independent enhancing
effect of butanol on the liver isoenzyme itself. High
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Fiqure 4.12. ALP isoenzyme patterns in 2.5% polyacryla-
mide gel showing the effects of butanol
extraction 1) purified liver isoenzyme
2) liver isoenzyme + butanol 3) liver iso¬
enzyme + butanol after dialysis 4) purified
high mol wt ALP 5) high mol wt ALP + butanol
6) high mol wt ALP + butanol after dialysis.
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TABLE 4.9.
Quantitative effect of butanol extraction on partially
purified low and high mol wt ALP, yGT and LAP
Enzyme activities (iu/1)
ALP yGT LAP
Isoenzyme Butanol- Butanol- Butanol-
Control treated Control treated Control treated
Low mol wt 73 78 7.4 3.1 3.7 0
High mol wt 40 3 9.7 0 2.1 0
mol wt ALP may have been extracted into the organic layer
and there denatured. Similar conclusions apply to VGT, and
LAP, although these also suffered partial or complete
denaturation of their low mol wt isoenzymes by the harsh
treatment of this organic solvent.
The experiment was repeated using, instead of butanol
alone, a mixture of butanol and di-isopropyl ether
(40:60 v/v) which has been recommended as having less of
a denaturing effect on proteins and enzymes (Cham and
Knowles, 1976). In this experiment the high mol wt
component from bile was also included. However, although
the use of this gentler solvent mixture did preserve low
mol wt yGT and LAP from denaturation, the effect on the
high mol wt components of all three enzymes from both
serum and bile was the same i.e. they disappeared entirely
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with no reappearance elsewhere in the gel. Either they were
denatured in the aqueous layer (unlikely since under these
conditions none of the low mol wt components of the three
enzymes were denatured) or, more likely, they were extracted
into the organic layer, being lipid soluble, and there
denatured by the high concentration of solvent.
Various conflicting findings have been reported for
the effect of butanol on ALP in serum. Price et al (1972)
found an overall activation whereas Walker and Pollard
(1971) found that many sera showed a loss in activity
although some showed striking increases. As far as high
mol wt ALP itself is concerned, most reports agree that
its activity disappears (Jennings et al, 1970; Walker and
Pollard, 1971; Price et al, 1972 ; Epstein et al, 1978) .
Opinions vary as to whether or not it is converted to a
lower mol wt form. Jennings et al (1970), using Sephadex
G200 chromatography, concluded that it was, although
activity was frequently very low owing to denaturation.
Walker and Pollard (1971) sometimes observed conversion
of the origin activity on 5% polyacrylamide gel electro¬
phoresis into faster diffuse bands running behind (not
with) the liver isoenzyme, but more often no trace of
activity appeared elsewhere in the gel. Fritsche and
Adams-Park (1974) found that high mol wt ALP, running in
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the globulin position on cellulose acetate electro¬
phoresis, remained at the origin after butanol extraction,
possibly indicating some degree of denaturation. Price
et al (1972) observed conversion of high mol wt biliary
ALP into a lower mol wt form. Only one study has been
done on enzymes other than ALP, namely high mol wt YGT in
bile (Wenham et al, 1978). Here butanol caused considerable
loss of activity but appeared to result in some conversion
into a lower mol wt form.
In summary, the conflicting evidence suggests that
this powerful organic solvent has effects of varying
severity on enzyme structure under different extraction
conditions. Possibly the source and purity of the butanol
may also be a contributory factor. In the present study,
high mol wt ALP, GT and LAP from serum and bile were all
apparently denatured by butanol without conversion to a
lower mol wt form. It is probable that they were
extracted into the butanol layer together with the lipid.
This suggests that they consist of enzymes attached to
lipid, lipoprotein or membrane fragments. Since all three
enzymes are membrane-bound in the liver, the latter
possibility seems the most likely.
4.7.2. Treatment with Triton X-lQO
Triton X-100 (polyoxyethylene glycol (9-10)p-t-
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octyl-phenol) is a relatively mild non-ionic detergent
which has frequently been used to solubilise membrane
proteins (Sohn and Marinetti, 1974; Helenius and Simons,
1975). Since the working hypothesis being tested was
that high mol wt ALP, GT and LAP represented membrane
fragments, the solubilising effects of Triton X-100 on
these complexes were assessed.
The following samples were incubated with 0.2%
o
Triton X-100 in a 1:1 (v:v) ratio for 24 hours at 4 C:
1) serum containing liver and high mol wt ALP
2) partially purified liver ALP
3) partially purified high mol wt serum ALP
4) partially purified high mol wt biliary ALP.
Comparison of detergent-treated with control samples
following electrophoresis in 2.5% polyacrylamide gel showed
that Triton X-100 had altered the mobility of all three
high mol wt enzymes (i„e. ALP, VGT, LAP) from serum and
bile to a similar extent. They had penetrated further
into the gel, to a position intermediate between that of
the untreated high mol wt enzymes and that of the low mol
wt or liver isoenzymes (Fig 4.13.) . The purified high mol
wt enzymes formed a single band after detergent treatment
but the unpurified high mol wt enzymes in whole serum
appeared to be partially protected from the effects of the
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Figure 4.13. Detergent-altered isoenzyme patterns in 2.5%
polyacrylamide gel showing the effects of
Triton X-100. a) ALP b) GT c) LAP. 1) serum
containing low and high mol wt forms 2) puri¬
fied liver ALP 3) purified high mol wt form
from serum 4) purified high mol wt form from
bile. [N.B. in gel (b) the staining in the
upper part of the gel is orange, non-specific
background staining. The position of the pink





detergent so that some of the original high mol wt enzymes
remained. In the case of VGT and LAP one extra band was
formed in the detergent-treated serum, running just behind
the normal low mol wt isoenzyme band.
The mol wt of the new bands, estimated by 4 to 26%
polyacrylamide gradient gel electrophoresis, was inter¬
mediate between that of the original high mol wt enzymes
and that of the normal liver or low mol wt isoenzymes. An
exact value could not be determined because Triton X-100,
being a non-ionic detergent, could not be introduced into
the gradient gel even by prolonged electrophoresis for
several days. Some degree of reassociation may therefore
have taken place in the detergent-treated samples as they
passed through the gel, leading to a smear of activity
through a range of gel concentrations (Figs 4.14. and
4.15.) . The average mol wt was approximately 660 000 and
was certainly greater than that of liver ALP (240 000).
This is in agreement with recent observations of Epstein
et al (1978), using whole serum, that high mol wt ALP was
converted by Triton X-100 to lower mol wt forms whose
size was still greater than that of the liver isoenzyme.
In conclusion, Triton X-100 had no effect on the
low mol wt isoenzymes of ALP, ^GT and LAP but it converted
the purified high mol wt components of these three
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Figure 4.14. Effect of the detergents Triton X-100 and SDS
on ALP isoenzymes in purified preparations of
1) liver ALP 2) high mol wt ALP from serum
3) high mol wt ALP from bile. Electrophoresis
was to equilibrium in 4 to 25% polyacrylamide
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Fiqure 4.15. Effect of Triton X-100 on LAP isoenzymes in
1) serum from a patient with liver disease
2) purified liver ALP (no LAP present)
3) purified high mol wt component from serum
and 4) purified high mol wt component from bile.
Electrophoresis was to equilibrium in 4 to 26%
polyacrylamide gradient gels. The serum proteins
are shown for comparison.[The faint bands obser¬
ved in the gels stained for LAP are coloured
blue, not pink, and correspond to protein




enzymes from both serum and bile to lower mol wt forms of
apparently identical mol wt (approximately 66O 000). The
nature of these lower mol wt forms is discussed in
Chapter 7.
4.7.3. Treatment with sodium dodecyl sulphate (SDS) and
e
mercapto\thanol
SDS is an anionic detergent which, like Triton X-100,
has often been used to solubilise membrane proteins. The
more hydrophilic nature of its polar groups renders it a
more powerful solubilising agent than Triton X-100 but
because it frequently disrupts the quaternary structure of
the membrane protein, it is more likely to cause denatura-
tion (Sohn and Marinetti, 1974; Helenius and Simons, 1975).
Mercaptoethanol is generally included with SDS as a reducing
agent to prevent disulphide bridges being formed between
polypeptide chains and consequent reassociation.
The same samples as in the previous section were
incubated with a solution of 2% SDS:0.2% mercaptoethanol
in the ratio of 1:1 (v:v) at 37°C for 5 minutes, at room
temperature for 30 minutes and overnight at 4°C. This
protocol was used to maximise solubilisation and minimise
denaturation . Nevertheless SDS inactivated both "JfGT and
LAP completely, presumably by interfering with their
quaternary structure. Therefore no results are available
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for these enzymes.
Electrophoresis of detergent-treated and control
sera in 2.5% polyacrylamide gel showed that liver ALP was
unaffected by SDS but the high mol wt ALPS from serum and
bile were both converted to lower mol wt forms which
migrated with the mobility of the liver isoenzyme (Fig
4.16.). The mol wts of these new forms were estimated by
electrophoresis to equilibrium in 4 to 26% polyacrylamj.de
gradient gel pre-equilibrated with 0.1% SDS, and found to
be 410 000 for the solubilised complexes from both serum
and bile c.f. liver and low mol wt biliary ALP with mol
wts of 240 000 (Figs 4.14. and 4.17.) . By contrast, Akedo
et al (1967), using chloroform-methanol and SDS, converted
high mol wt into a form of only slightly lower mol wt,
which was still excluded from a Sephadex G200 gel.
In conclusion, like Triton X-100, SDS had no effect
on liver ALP but converted high mol wt ALP from both serum
and bile to smaller forms of identical mol wt (410 000).
This was still higher than the mol wt of the liver and low
mol wt biliary isoenzymes. The nature of this detergent-
solubilised enzyme is discussed in Chapter 7. Since both
Triton X-100 and SDS, which interfere with hydrophobic
bonding, disrupted the structure of the high mol wt
enzymes. it seems likely that hydrophobic bonding plays a
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Figure 4.16. Detergent-altered ALP isoenzyme patterns in 2.5%
polyacrylamide gel showing the effects of SDS.
1) serum containing low and high mol wt ALP
2) purified liver ALP 3) purified high mol wt
ALP from serum 4) purified high mol wt ALP from
bile .
4











large part in maintaining that structure. This is
consistent with the theory that they represent membrane
fragments.
4.8. RELATIONSHIP OF THE HIGH MOLECULAR WEIGHT ENZYMES
WITH LIPOPROTEIN X
Like high mol wt ALP, LPX is released into the
circulation in cholestatic liver disease. Recent experi¬
ments using electron microscopy have revealed that morpho¬
logically LPX resembles stacked membraneous vesicles
(Hauser et al, 1977). It was thought possible that LPX and
high mol wt ALP, tfGT and LAP might be related or even
identical. Experiments were therefore directed towards
establishing whether or not a relationship existed.
4.8.1. Qualitative evidence for association of lipoprotein
X with membrane marker enzymes
As a pilot experiment, LPX Immunoelectrophoresis was
performed in duplicate on a) serum from a patient with
obstructive jaundice and b) a control serum from a patient
with no evidence of liver disease. After washing in saline
for 2 days, any precipitin arcs formed were stained for
protein and ALP respectively. Only serum (a) gave a
positive LPX precipitin arc and this stained strongly for
ALP (Fig 4.18.) .
More detailed investigations were then carried out
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Figure 4.18. LPX precipitin arc stained for ALP in a serum
from a patient with obstructive jaundice .
No precipitin arc in the control serum (b).
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on four sera from patients with obstructive jaundice and
a control serum. These were subjected to Immunoelectro¬
phoresis in quadruplicate by the method of Scheidegger
(1955) against the antisera listed in Table 4.10. After
washing in saline for 2 days, any precipitin arcs formed
were stained for a) protein b) ALP c) XGT and d) LAP.
Only the LPX (Fig 4.19.) and /3lipoprotein (Fig
4.20) precipitin arcs stained for enzyme activity;
furthermore this staining was present only in the sera
from the patients with obstructive jaundice and not in the
control serum (Table 4.10.). For XGT and LAP, where Fast
Garnet GBC was used as a stain, the colour of the LPX
precipitin arcs was pink whereas the colour of the anodal
'tails' (Fig 4.19.) and that of the ^lipoprotein arcs
(Fig 4.20.) was orange,the colour of the unreacted dye.
In order to check whether any of the precipitin arcs
stained as a result of non-specific dye uptake, the
experiment was repeated omitting the enzyme substrates.
No non-specific dye uptake was observed.
The antiserum against LPX is known to cross-react
with other proteins and lipoproteins in serum. LPX is
therefore identified by its characteristic migration
towards the cathode under the conditions of the assay,
whereas the other proteins and lipoproteins, including
TABLE4.10.
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Figure 4.19. LPX Immunoelectrophoresis plate stained for
a) ALP b) yGT and c) LAP. The arcs on the
cathodal side of the origin correspond to LPX.
Samples 1 and 6 are control sera; samples 2 to
5 are sera from patients with obstructive
jaundice. [N.B. The staining on the anodal side
of the origin in gels (b) and (c) is orange
compared to the pink colour of the LPX precip¬
itin arcs].
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Figure 4.20. /3LP Immunoelectrophoresis plate stained for
a) ALP b) tfGT and c) LAP. Samples 1 and 6 are
control sera; samples 2 to 5 are sera from
patients with obstructive jaundice. [N.B. the
staining in gels (b) and (c) is orange].
(a)
+
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3lipoprotein, migrate towards the anode. However, to add
to the problem, LPX may migrate to the anode under certain
conditions e.g. after prolonged storage or in the presence
of high concentrations of bile salts (Manzato et al, 1976).
There are therefore at least three possible explanations
for the observations:
1) The enzymes are associated with LPX and not with
0lipoprotein but some LPX migrates anodally and cross-
reacts with 0lipoprotein antiserum.
2) Some association may exist between the enzymes and
^lipoprotein as well as between the enzymes and LPX.
The observations of Lawrence and Melnick (1961) support
this theory. They found that the ^lipoprotein precipitin
line stained not only for ALP and LAP (as shown here) but
also for many other enzymes originating both from membrane
and from cytoplasm. Isolation of ^lipoprotein by ultra-
centrifugation, followed by sonication resulted in activa¬
tion of these enzymes. The authors proposed that many
enzymes were non-specifically sequestered in serum
^lipoprotein. This explanation is in keeping with the ALP
band which migrates in the Blipoprotein position during
starch gel electrophoresis (Chiandussi et al, 1962;
Hodson et al, 1962). As explained in section 2.10, although
such a /3lipoprotein-associated ALP would appear in the void
-188-
volume during Sephadex G200 chromatography, it would not
be excluded by the larger mesh gels used in the Sepharose
range. It is therefore not included in the definition of
the high mol wt ALP which is specific for liver disease
and which forms the subject of this thesis.
3) The different colour of the staining of the anodal
precipitates may suggest that this staining was an artefact
and did not reflect enzyme activity. In keeping with this
theory, Seidel et al (1970) took the view that the anodal
'tails' represented non-specific precipitation such as
occurs with any serum in agar gel. A different approach
was required to resolve the question.
4.8.2. Qualitative evidence for association of
lipoprotein X with high molecular weight components of
membrane marker enzymes
From the sera of 72 patients with liver disease
(Chapter 5), 7 sera were selected which had strongly
positive LPX precipitin arcs. All of these 7 sera had high
mol wt ALP activities greater than 36 iu/1 (approximate
upper limit of reference range: 10 iu/1). This was
circumstantial evidence that the two might be related.
When partially purified preparations of liver and
high mol wt ALP from serum and bile were subjected to
Immunoelectrophoresis against LPX and ^lipoprotein
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antisera, no precipitin arcs were found although general
precipitation of protein staining for ALP activity around
the sample well was observed. No such precipitation
occurred for the liver isoenzyme. The absence of a
cathodal precipitin arc may have been because the antisera
used had a low titre and were insensitive to low concen¬
trations of antigen. Alternatively, the physical
characteristics of LPX or ^lipoprotein may have been
altered during the purification process so that they did
not migrate during electrophoresis. The problem therefore
had to be approached indirectly.
The following samples were incubated for 24 hours
o
at 4 c with a) LPX antiserum b) ^lipoprotein antiserum and
c) saline (as controls) in the ratio of 1 volume sample:
2 volumes antiserum:
1) serum containing liver and high mol wt ALP
2) partially purified liver ALP
3) partially purified high mol wt serum ALP
4) partially purified high mol wt biliary ALP.
Electrophoresis of the supernatants in 2.5% poly-
acrylamide gel (Fig 4.21.) and 4 to 26% polyacrylamide
gradient gel (Fig 4.22.), followed by staining for ALP, "JfGT
and LAP, showed that incubation with LPX and ^lipoprotein
antisera had no effect on the low mol wt isoenzymes of ALP,
Figure4.21.(a).ALPisoenzymepatte ns2.5%polyacrylamidelshowingtheff cts ofprecipitationbyant sera.1)urifiedliveALP+sal ne,2p r fi highmolwtALPfromserum+aline3)LPXantiserumlo4liv r LPXantiserum5)highmolwtALP+ntiserum6L Xa tis rlone 7)0LPantiserumlone8liv rA+ntiserum9highmolwtL 0LPantiserumlo)/3LPtiserulone.
Figure4.21.(b).LAPisoenzymepatterns2.5%polyacryla ideg lshowingtheffectsf precipitationbyantisera.1)LPXantiserumlone20LPantiserulon 3)purifiedhighmolwtcompon ntfr mserum+alin4)purifiedhigh molwtcomponentfrserum+LPXantiseru5)purifiedhighmolt componentfroserum+0LPantiserum6)purifiedhighmolwtcomp n t frombile+saline7)purifiedhighmolwtcompon ntfr leLPX antiserum8)purifiedhighmolwtcompon ntfrb l+0LPantiserum. 1234567
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Figure 4.22. ALP isoenzyme patterns in 4 to 26% polyacryl-
amide gradient gel showing the effects of
precipitation by antisera. 1) whole serum
containing liver and high mol wt ALP + saline
2) whole serum + LPX antiserum 3) whole serum +
0LP antiserum 4) purified liver ALP + saline
5) liver ALP + LPX antiserum 6) liver ALP +
6LP antiserum 7) purified high mol wt component
from serum + saline 8) high mol wt component
(serum) + LPX antiserum 9) high mol wt component
(serum)+ 0LP antiserum 10) purified high mol wt
component from bile + saline 11) high mol wt
component (bile) + LPX antiserum 12) high mol wt
component (bile) + 0LP antiserum.
Similar patterns were observed for XGT and LAP.
[N.B. The ALP precipitates formed in incubations
(2), (8) and (11) were more obviously excluded at
the origin in the original gel than in this photo¬
graph, in which the top of the gel has become
slightly displaced].
ORIGIN
12 11 10 98 76543 2 1
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VGT and LAP. However, incubation of the high mol wt
components from both serum and bile with LPX antiserum
resulted in the disappearance of the high mol wt components
of all three enzymes. Immunoelectrophoresis showed that
this was accompanied by the disappearance of the LPX
precipitin arc which had stained for all three enzymes.
It was also accompanied by the disappearance of the non¬
specific anodal precipitate (LPX immunoelectrophoresis) and
of the ^lipoprotein precipitin arc (^lipoprotein immuno¬
electrophores is) . By contrast, incubation of the high mol
wt components with /3lipoprotein antiserum had no effect on
the activity of the high mol wt enzymes. Immunoelectro¬
phoresis showed that both the non-specific anodal
precipitate (LPX Immunoelectrophoresis) and the ^lipoprotein
precipitin arc (/3lipoprotein immunoelectrophores is) had
largely disappeared. The LPX precipitin arc was unaffected.
These observations are summarised in Tables 4.11. and 4.12.
The immunoelectrophoretic evidence suggests that the
LPX antiserum employed did indeed cross-react with
^lipoprotein but that the ^lipoprotein antiserum employed
gave no cross-reaction with LPX. The balance of the
evidence strongly suggests that the high mol wt components
of all three enzymes from serum and bile are associated
with LPX in the form of a complex and not with ^lipoprotein
-194-
TABLE 4.11.
Effect of incubation with a) saline b) ^lipoprotein
antiserum and c) LPX antiserum on low and high mol
wtALP, *GT and LAP
Enzyme
component
Low mol wt (serum)
High mol wt (serum)
High mol wt (bile)














Effect of incubation with a) saline b) ^lipoprotein
antiserum and c) LPX antiserum on the protein and enzyme
staining associated with the LPX precipitin arc, non¬
specific anodal precipitation and the ^lipoprotein arc,
following immunoelectrophoresis
Presence(+) or absence (-) of precipitate









since they are precipitated by LPX antiserum but not by
j3lipoprotein antiserum. Therefore, although there may be
some non-specific association between the enzymes and
^lipoprotein, the high mol wt enzymes, as defined in this
thesis, are not involved in the association.
4.8.3. Semi-quantitative evidence; association of membrane
marker enzymes with lipoprotein X
From the sera of 72 patients with liver disease
(Chapter 5), 13 sera with positive LPX were selected.
Following immunoelectrophoresis, the LPX precipitin arcs
were stained for protein, ALP, XGT and LAP. The depth of
staining was rated on a scale from 1 to 3 (Table 4.13.).
TABLE 4.13.
Depth of protein and enzyme staining (scored on a scale from
1 to 3) associated with LPX precipitin arcs in 13 sera
Serum Protein ALP *GT LAP
1 2 1 2 3
2 2 1 1 1
3 2 1 2 1
4 3 2 3 3
5 2 1 1 1
6 3 2 3 3
7 3 2 1 2
8 2 1 2 2
9 3 2 2 1
10 3 2 2 3
11 3 2 2 3
12 3 1 2 2
13 3 O 0A. 2
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Correlation procedures were unsuitable because of the
large number of ties in a small sample. Instead a t-test
between each protein/enzyme pair was carried out. As an
example, protein staining was divided into two categories
(score 2 and score 3). The t-test was then performed on the
ALP scores of each of these two categories to see whether or
not the ALP scores were significantly higher in the score 3
protein category than in the score 2 protein category.
TABLE 4.14.
One-tailed associated probabilities in t-test to compare
depths of protein and enzyme staining associated with LPX
precipitin arcs in 13 sera. See text for details
Scores divided Scores associated with each group
into 2 groups Protein ALP LAP yGT




Table 4.14 shows the one-tailed probabilities
associated with the calculated t values. In each case, a
positive relationship between depth of staining of LPX-
associated protein and enzymes was found but this only
reached significance (p < 0.05) for the protein-ALP and
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VGT-LAP pairs. However, the associated probabilities were
sufficiently low to suggest that if the number of sera
studied had been increased to, say, 20 the t values for
all the pairs might have achieved significance in this
relatively crude test of association. It therefore seems
likely that sera with a high LPX (estimated by protein
content) are also likely to have large amounts of enzyme
associated with the LPX.
Approaching the problem rather differently, high
mol wt ALP was measured in the 13 sera, and also in an
additional 4 sera which scored 1 for protein staining of
the LPX precipitin arcs. The protein scores were divided
into three categories and one-way analysis of variance was
carried out on the high mol wt ALP activities (logarith¬
mically transformed to normalise the data) in each category
(Table 4.15.) . The results show that patients with large
amounts of LPX are also likely to have high activities of
high mol wt ALP (p 0.005) .
If a t-test is carried out between LPX-associated
ALP and high mol wt ALP (Fig 4.23.), the geometric means of
the classes scoring 1 and 2 for LPX-associated ALP are 21
and 71 iu/1 high mol wt ALP respectively (p < 0.05).
Therefore patients with large amounts of LPX-associated ALP
are also likely to have high activities of high mol wt ALP.
-198-
Figure 4.23. High mol wt ALP activities in sera showing




















High mol wt ALP activities measured in 17 sera containing LPX





10 iu/1 22 iu/1 73 iu/1
6-16 iu/1 7-57 iu/1 37-207 iu/1
Two-tailed probability






* The t-test was carried out for each pair of LPX categories
as shown.
However, the converse of these statements is not true.
Fig 4.24. shows that high mol wt ALP frequently rose to high
levels of activity in the absence of detectable LPX (and
therefore of detectable LPX-associated enzyme). Brocklehurst
et al (1978) have also found that the origin band on starch
gel electrophoresis may occur in the absence of detectable
LPX.
In summary, patients with large amounts of LPX were
likely to have large amounts of enzyme associated with LPX
-200-
Fiqure 4.24. High mol wt ALP activities in sera containing
various amounts of LPX as shown by depth of
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and large amounts of high mol wt ALP. On the other hand,
patients with large amounts of high mol wt ALP did not
necessarily have large amounts of LPX. The experiments
were not sufficiently quantitative to establish conclusively
whether or not LPX has a constant enzyme composition.
4.9. SUMMARY OF INVESTIGATIONS INTO THE NATURE OF
HIGH MOLECULAR WEIGHT ALKALINE PHOSPHATASE
1. High mol wt ALIS from serum and bile both have probably
identical mol wts of greater than 1 million and carry
an identical net positive charge which is greater than
any other isoenzyme tested at alkaline pH. Since the
electrophoretic mobility of high mol wt serum ALP was
greatly reduced by incubation with neuraminidase, it
seems likely that much of this charge was due to the
presence of sialic acid residues.
2. The inactivation curves of both liver and high mol wt
serum ALP during treatment with 5 mol/1 urea were
monoexponential with respect to time and exhibited
similar half-lives. No qualitative effect on the
structural integrity of the two isoenzymes was
observed.
The heat inactivation curves of high mol wt ALP from
serum and bile were both biphasic. Overall, high mol
wt ALP was slightly more heat-labile than the liver
-202-
isoenzyme.
Electrophoresis and Sepharose 6B column chromatography
suggested a qualitative and quantitative association
between the high mol wt components of ALP, tfGT, LAP and
5"NT (all membrane marker enzymes) both in serum and in
bile. However, ion-exchange chromatography indicated
that these high mol wt components probably did not have
a constant composition.
Treatment with organic solvents and detergents showed
that high mol wt ALP, YGT and LAP from both serum and
bile all behaved in a similar fashion. They were
inactivated by butan-l-ol, unlike the low mol wt
isoenzymes, possibly because they were extracted into
the organic layer. Treatment with detergents converted
them to smaller forms of identical mol wt but these
smaller forms were still larger than the low mol wt
isoenzymes usually present in serum and bile.
There was qualitative evidence for the association of
ALP, *GT and LAP activities with LPX. This association
was with the high mol wt components of these enzymes
rather than the low mol wt components. There was some
semi-quantitative and statistical evidence that sera
with large amounts of LPX also had large quantities of
enzyme associated with LPX and high activities of high
-203-
mol wt ALP. High activities of LPX-associated ALP
were also associated with high activities of high mol
wt ALP. On the other hand, some patients had high
activities of high mol wt ALP in their serum with no
detectable LPX.
6. These various lines of evidence taken together suggest
that the serum and biliary high mol wt forms of ALP,
XGT, LAP and 5'NT, and LPX are very similar entities
behaving in a similar fashion during physical and
chemical manipulation. There is some evidence for a
quantitative as well as a qualitative relationship.
Study of further LPX-positive sera might help to




CLINICAL EVALUATION OF HIGH MOLECULAR WEIGHT
ALKALINE PHOSPHATASE
5.1. AIMS OF STUDY
No assessments of the clinical value of quantitative
measurements of high mol wt ALP in relation to other
biochemical tests have yet been made. This pilot study
therefore had three aims:
1) to assess whether high mol wt ALP measurements alone
could yield useful diagnostic information not at
present provided by other commonly used tests of
liver function.
2) to elucidate its role as part of a group of biochemical
tests in the computer assisted diagnosis of liver
disease.
3) to gain some insight into the circumstances under
which high mol wt ALP is released into the circulation.
5.2. SELECTION OF PATIENTS
72 adult patients with liver disease and raised
serum ALP activities ( >100 iu/1) were studied. Also
included in the investigation as controls were 8 healthy
volunteers with normal serum ALP activities and 14 patients
who had raised serum ALP activities due to bone disease
(Table 5.1.) .
TABLE5.1.
































































AgeRange (years) 25-55 24-78 19-65 19-29 33-34 30-84 38-69 52-64 67-76 61-68 25-85 32-82
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Patients for study were selected by scrutiny of
the ALP measurements carried out by a routine clinical
chemistry laboratory, by examination of the patient's
notes and by discussion with the doctor looking after the
patient. Only patients with established diagnoses were
admitted to the study. Bone disease was diagnosed
radiologically. Diagnosis of serum hepatitis was made if
(a) serum levels of bilirubin or alanine aminotransferase
or both were raised and (b)hepatitis B surface antigen
was detected by radioimmunoassay. Similarly, a diagnosis
of infectious hepatitis was made if (a) serum levels of
bilirubin or alanine aminotransferase or both were raised
and (b) the patient's serum contained a specific IgM
antibody to hepatitis A antigen (detected by radioimmuno¬
assay) . Samples were taken during the active period of
these diseases. Diagnosis of chronic active hepatitis,
alcoholic cirrhosis, primary biliary cirrhosis and
cholangiocarcinoma were almost invariably proven by
biopsy. Carcinoma of the head of the pancreas was
demonstrated at laparotomy. Metastatic liver disease was
usually diagnosed by a combination of liver scanning and
biopsy. Problems arose with the group designated 'gall¬
stone obstruction/cholecystitis1 (Table 5.1.) . In every
case, the presence of gallstones was shown either at
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operation or radiologically prior to operation, but it
was not always possible to be certain whether the raised
ALP was due to obstruction by the gallstones, to oedema
of the biliary tree or to ascending infection affecting
the liver. This uncertainty meant that the diagnostic
category of gallstone obstruction/cholecystitis was
likely to be heterogeneous. Because the categories of
serum and infectious hepatitis were small, seemed to
exhibit similar behaviour with regard to the chemical
measurements and were clinically alike, they were amal¬
gamated into a single diagnostic category of acute viral
hepatitis for subsequent statistical analysis. For
similar reasons, osteomalacia and metastatic bone disease
were combined into a single diagnostic category of bone
disease. Carcinoma of the head of the pancreas and
cholangiocarcinoma were combined into a single category
of extrahepatic carcinoma causing biliary obstruction for
the purposes of discriminant function analysis only.
In general, only one plasma sample was analysed
from each subject, with the exception of patients with
serum or infectious hepatitis who had serial samples taken
at intervals of several days following admission. The
serial sampling was continued until the patient was dis¬
charged from hospital. Only the first of these samples
-208-




Table 5.2. shows the substances analysed in the serum
of each patient together with the method used, the co¬
efficient of variation and the reference range. With the
exception of total ALP activity which is raised in the
presence of both liver and bone pathology, all the other
variables were chosen to assess some aspect of liver
function. ALP isoenzymes were analysed qualitatively by
electrophoresis in each serum to check for possible sources
of interference in the ion-exchange method for high mol wt
ALP. No unusual isoenzymes were found in the study.
Bile acids were not measured owing to limitations in time
and facilities available.
5.3.2. Statistical analysis
Standard parametric statistical tests have been used
throughout. In order to equalise variances and normalise
the data (both requirements being necessary for parametric
tests), all measurements, except for plasma albumin, were
subjected to logarithmic transformation before statistical
analysis. In nearly all cases this rendered the variances
within each category homogeneous (Snedecor and Cochran, 1967).
TABLE5.2.
Methodsusedforbiochemicalm asu ementsundert keni tudy
Chemicalmeasurement (Abbreviationused intables) Highmolecularw ight alkalinephosphatase (HMW) Alkalinephosphatase (ALP) ^-glutamyltransferase (5CGT) Leucineaminopeptidase (LAP) Alanineami otra sf rase (ALT) Bilirubin (Bili) Lipoprotein-X (LPX) Albumin (Alb)
MethodCoefficientfRefer ce Referencevariation(%)Range Ion-exchange^l-loiu/1 Section2.93.5~~l-5% Bowersand McComb(1966) Henrytal (1960) Jendrassikand Grof(1938) Doumasetal (1971)2.540-100iu/1 RosalkiandM les:10-55iu/1 Tarlow(1974)" Females:5-35iu/1 Szasz(1967)0.0~30-80iu/1 2.010-40iu/1 3 .52-17mol/1 Seideltal (1970)"Negative 2.436-47g/1
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Different approaches have been advocated for
computer assisted diagnosis of liver disease. Bayesian
probability techniques suffer the twin disadvantages of
being based on presence/absence criteria which do not make
full use of continuous laboratory data, and of requiring
knowledge of incidence rates of disease^ not only in the
general population but also in the patients likely to
present to a particular clinic. Cluster analysis is
largely useful for identifying previously unsuspected
groups in unclassified data and is therefore more of a
research tool than a diagnostic process. For the purpose
of diagnosis based on biochemical data, discriminant
function analysis is the most suitable approach (Goldberg
and Ellis, 1978) . Various authors have combined batteries
of liver function tests into discriminant functions for
the diagnosis of liver disease (Fellingham and Mekel, 1966;
Winkel et al, 1975; Sherr, 1977; Goldberg and Ellis, 1978).
This formalises the intuitive approach of clinicians in
weighing up the probabilities of the different diagnostic
alternatives.
Discriminant analysis is a multivariate technique
for studying the extent to which different populations
overlap one another or diverge from one another (Snedecor
and Cochran, 1967). In the present context it was used
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to discover which measurements were most effective in
distinguishing between the different diagnostic categories,
how these measurements could best be combined to form a
discriminant function and how successful this discriminant
function was in making the distinction.
For discriminant function analysis, a standard
computer program was used (program BMDP7M from the Health
Sciences Computing Facility, University of California,
Los Angeles). This analysis finds linear combinations of
the biochemical variables which most clearly distinguish
groups (of diseases) from one another. For each variable,
a weighting factor is calculated such that, when the
weighted biochemical measurements for each patient are
added together, the resulting sums for each patient in a
particular group or disease category are similar to one
another and differ as much as possible from those for
patients in other groups. Depending on the number of
groups to be distinguished, a number of discriminant
functions may be required before optimal separation in one
or more dimensions can be achieved. Variables which do
not contribute independently and significantly to the
separation of groups are omitted from the discriminant
function.
A number of factors affect the tests incorporated
-212-
into discriminant functions. Firstly, in small samples
as in this pilot study, chance may play a considerable
role in the selection of discriminants. This can only be
eliminated by a much larger study. Secondly, obviously
the choice of liver diseases selected for comparison will
affect the discriminants. Thirdly, the overall choice of
liver function tests, all of which are interrelated and
are more or less correlated with one another, will affect
which of the tests are taken as the discriminants. This
means that an apparently poorly discriminating test
considered singly may be the second discriminant to be
entered in a function, simply because all the other
apparently more discriminating tests are correlated with
the first discriminant to be entered.
Since in this study the discriminant functions
obtained could not be evaluated prospectively, a cross-
validation procedure was carried out. This involves
assignment of each case to the disease category to which
it has the highest probability of belonging on the basis
of the discriminant functions, having first removed the
contribution of that particular case to the derivation of
the discriminant functions. Such prognostic classification
of patients into the different diagnostic categories may
or may not take into account the incidence of each disease
-213-
in the general population. I have avoided incorporation
of such a priori diagnostic probabilities into the cross-
validation procedure because (a) this would weight the
classification too heavily in favour of normal controls,
only a small proportion of whom are likely to present to
the clinician and (b) the relative proportions of the
different diagnostic groups at presentation will vary
from hospital to hospital and from clinic to clinic and
would not therefore have general applicability. It was
therefore assumed during cross-validation that the a^ priori
probabilities for the occurrence of each disease in the
sampled population were equal and that the observed
differences in sample size between the various categories
were due solely to sampling differences. The derived
classification was then compared with the true classifi¬
cation in order to test the accuracy of the discriminant
functions in distinguishing diagnostic categories.
5.4. HIGH MOLECULAR WEIGHT ALKALINE PHOSPHATASE
AS A SINGLE TEST
The results of all the biochemical measurements are
presented in Fig 5.1. and Table 5.3. but attention will be
primarily focussed on ALP and high mol wt ALP. ALP
activities in all the patients studied were, by selection,
abnormal. A high degree of overlap occurred between the
-214-
Figure 5.1. Results of biochemical measurements in different
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Geometricmeans,rang sa dfrequenciesofabnormalresultsfbioch micaltestsu edinh diagnosisofliverdisease Parameter Geometricmean* Range Frequencyof abnormalresultsBili ol/l) 11 7-15 0/8ALT (iu/1) 13 10-21 0/8LAP (iu/1) 50 36-64 0/8tfGT (iu/1)Alb
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results from patients with a wide variety of liver diseases
and patients with bone disease (Fig 5.1.(a), Table 5.3.).
High mol wt ALP activity was expressed both in iu/1
and as a percentage of total ALP activity. In order of
ascending high mol wt ALP activity, the following groups
had means which were significantly different from one
another (p <0.05) using the Q method for differences
between means (Snedecor and Cochran, 1967)(Fig 5.1.(b),
Table 5.3.) :
1. Normal controls
2 . Bone disease
3. Acute hepatitis, chronic active hepatitis,
alcoholic cirrhosis
4. Primary biliary cirrhosis, gallstones/cholecystitis
5. Carcinoma of the head of the pancreas, cholangio-
carcinoma and metastatic liver disease.
High mol wt ALP activities were therefore higher (1) in
liver disease than in bone disease and normal controls
(2) in obstructive lesions than in non-obstructive lesions
and (3) in patients with obstruction due to carcinoma in
the liver or its vicinity than in non-neoplastic forms of
obstruction.
When the results were expressed as a percentage of
total ALP activity the overall pattern was similar
-227-
(Fig 5.1.(c) , Table 5.3.). However, the difference between
the normal controls and patients with bone disease was no
longer apparent. On the other hand, the discrimination
between metastatic liver disease and other forms of liver
disease was better than when the results were reported in
units of activity: t-test analysis showed that, of all the
chemical measurements, the percentage activity of high mol
wt ALP distinguished metastatic from all other forms of
liver disease most effectively (p < 0.005, all other
chemical measurements non-significant) . Nevertheless the
overlap between groups was so great that only when a very
high percentage high mol wt ALP is found (arbitrarily
defined as over 25%) could such a result be considered a
strong pointer to a diagnosis of liver metastases, in the
absence of any other indicator. However, if a patient were
already known to have a primary carcinoma suspicion of
liver metastases might be aroused by a considerably lower
level of high mol wt ALP.
Comparison with previous findings. Many of the methods
used to demonstrate the presence of high mol wt ALP in
liver disease have been qualitative electrophoretic
techniques which can only be made semi-quantitative by means
of densitometry or elution. On a purely qualitative basis,
Burlina and Galzigna (197 6) found that the o-^globulin ALP
-228-
(equivalent to high mol wt ALP) on cellulose acetate
electrophoresis appeared in all cases of obstructive
jaundice, in some cases of cirrhosis but in virtually no
cases of viral hepatitis or bone disease and in no normal
controls . Semi-quantitation of the a-^globulin band by
densitometry (Rhone et al, 1973) gave the highest levels
in liver metastases with intermediate levels in cirrhosis
and relatively low levels in gallstone obstruction/
cholecystitis and acute hepatitis. Semi-quantitation of
the origin bands in starch gel (Kowlessar, Haeffner and
Riley, 1961) and polyacrylamide gel (Price and Sammons,
1976) by elution showed similar high levels in obstructive
jaundice and metastatic liver disease but lower levels in
acute hepatitis and undetectable amounts in normal controls
and patients with bone disease. All these results are in
conformity with the present findings.
Two quantitative studies on small numbers of
patients, based on Sephadex G200 gel filtration (Fennelly
et al, 1969; Jennings et al, 1970) have produced an
essentially similar distribution of results, the highest
percentage of high mol wt ALP being seen in metastatic
liver disease. The actual levels tended to be slightly
higher than I have observed, possibly because the void
volume peak on Sephadex G200 chromatography may contain
-229-
non-specific plipoprotein-associated ALP (see section 2.10
and 4.8) and therefore overestimates high mol wt ALP. In
none of these clinical studies was measurement of any
biochemical variable other than total and high mol wt ALP
undertaken.
The observation in the present study that high mol
wt ALP has a higher activity in bone disease than in normal
controls, but forms a similar percentage of the total ALP
in each category is in agreement with the findings of
Fennelly et al (1969). This could have been due to carry¬
over in the method although investigations could find no
evidence for this (section 2.9.2.) and high mol wt ALP,
measured by the ion-exchange method, showed no significant
correlation with total ALP in bone disease as might have
been expected if carry-over had occurred. Alternatively,
some of the patients with bone disease (e.g. bone metastases,
osteomalacia) may have had a slight degree of co-existing
liver disease which had been undetected clinically or
biochemically.
5.5. LIPOPROTEIN X
LPX was negative in normals and in patients with
bone disease but was at least transiently positive in some
cases of acute hepatitis, possibly reflecting a degree of
biliary stasis in these patients. It was most often
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positive in primary biliary cirrhosis, but in general the
test appeared to lack sensitivity. This may have been
related to the use of an antiserum of fairly low titre
since LEXhas previously been found to be positive in over
90% of patients with histological evidence of cholestasis
and, conversely, negative in a similar percentage of
patients with no histological evidence of cholestasis
(Fellin et al, 1978). Its correlation with high mol wt
ALP is presented in section 4.8.3.
5.6. ROLE OF HIGH MOLECULAR WEIGHT ALKALINE PHOSPHATASE
IN THE COMPUTER DIAGNOSIS OF LIVER DISEASE
5.6.1. Non-necrotic liver diseases combined
Inspection of Fig 5.1. and Table 5.3. shows that
individual tests exhibit overlap between most disease
categories, particularly within those categories of patients
with liver disease. The tests were therefore combined into
discriminant functions which were initially designed to
answer three questions:
1. Does the patient have liver disease or is he healthy?
2. Where there is a raised serum ALP activity, is this
due to liver or bone disease?
3. If the patient has liver disease, is it of a necrotic
type (acute hepatitis) or a non-necrotic type?






d) all other forms of liver disease excluding acute
hepatitis.
Table 5.4. shows the tests which contribute to the
discriminant for each possible pair of diagnostic categories,
together with their weighting factors (see section 5.3.2.)
and the percentage of correct classifications achieved by
the cross-validation procedure. The discrimination is also
shown diagrammatically in Fig 5.2. High mol wt ALP is
present in 4 of the 6 pairs as one of the discriminants.
It was only excluded from a fifth function because its F
value was marginally lower than the F value for LAP. Once
the latter had been entered into the discriminant the F
value of high mol wt ALP fell to insignificant levels
because it was correlated with LAP (see Table 5.4.) .
It is clear from Table 5.4 and Fig 5.2. that the
first two of the questions posed above can almost invariably
be correctly answered by means of discriminant function
analysis. The third could be answered with 91% accuracy.
Although high mol wt ALP was one of the discriminators in
deciding whether a raised ALP was of liver or bone origin,
TABLE5.4.
Thediscriminants(orderfe t yntodiscriminantfunctio ),w ightingfa rs andccuracyofcross-validationf eachp irfdiagnostictego es Diagnosticcategories compared Normalsvs Bonedisease Normalsvs Acutehepatitis Normalsvs Non-necrotic liverdisease Bonediseasev Acutehepatitis Bonediseasev Non-necrotic liverdisease Acutehepatitisvs Non-necrotic liverdiseaseDiscriminants (weightingfactor) ALP;HMW(0.98) HMW;Bili(0.72) HMW;ALT(0.68); yGT(0.72); Alb(-0.053) Bili;ALT(0.50) tfGT;ALP(-1.90); HMW(1.23); Bili(0.50) ALT;LApb(-1.20)Numbercorr ctly classified 7/7 14/14 7/7 8/8 7/7 58/59 14/14 8/8 14/14 57/59





aAlldiscriminantsarenlog.f mwiththexc ptionofalbumi .Thew ighting factorofthebestsinglediscriminatoreachc seb enttu ity, bFvaluesofHMWndLAPwerevirtuallyide icalb ton eLAPhadbe nt r din o thediscriminant,FvalueofHMWfelltinsignificantl vel.Forcorr l tion ofHMWwithLAPseeTable5.8.
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bilirubin and alanine aminotransferase (for acute
hepatitis), yGT (for non-necrotic liver disease) or iso¬
enzyme separation techniques are simpler tests which are
more effective. However, high mol wt ALP appeared to be
the best single discriminator in deciding whether or not
a patient had liver disease. In this respect, it
appeared to be superior even to tfGT•
In an attempt to distinguish all four categories
simultaneously, it was found that all the variables except
LAP and albumin contributed to a set of three discriminant
functions (Table 5.5.) . The first two of these plotted
against each other (Fig 5.3.) revealed four distinct
clusters. Cross-validation led to a correct classification
of 89% of the patients among the four groups. All except
one of the incorrect classifications occurred in the group
of non-necrotic liver diseases, some of whom were
incorrectly assigned to the acute hepatitis group.
5.6.2. All liver diseases considered separately
Having established that a patient has liver disease,
the next step is to identify the correct diagnosis. An
attempt to distinguish all 7 liver diseases simultaneously
led to a correct classification of only 39% of the patients
among the seven groups.
The liver diseases were therefore compared in pairs.
TABLE5.5.
Thediscriminants(iorderfent yintodiscri ifunct )anw ighti gfa tors usedtoachi vemaximumdiscriminationbetween)norm ls)ondi eac t hepatitisandd)non- eeroticlived sease DiscriminantWeightingfactorsofvar ableente ed* functionrGTALPHMWBil 12.00 8-.50 8 20.2-1.0.80 2-1.1 31.3-2 04.61 20 *Thevariablesarexpress dinlog rithmicf m.









































The variables (together with their weighting factors)
contributing to the single discriminant function for each
pair are shown in Table 5.6. Usually, optimal separation
of the pairs was achieved by the use of only two discrimi¬
nants since the addition of further discriminants did not
improve diagnostic accuracy. However, occasionally only
one discriminant contributed and sometimes 3 were needed.
In three of the pairs, no combination of the variables
could be found to discriminate. Cross-validation of the
discriminant functions led to accurate classification of
most patients (Table 5.7.) .
High mol wt ALP contributed to the discriminant
functions in 6 out of the possible 21 pairs i.e. it contri¬
buted as frequently as total ALP and LAP although less
frequently than alanine aminotransferase. In particular,
it appeared most frequently in the discriminants distin¬
guishing liver metastases from other liver diseases.
As far as tests other than high mol wt ALP are
concerned these conformed to established patterns of
behaviour in liver disease (Tables 5.3. and 5.6.). Alanine
aminotransferase was particularly useful in the discrimin¬
ation of acute hepatitis from other liver diseases.
Bilirubin, although high in acute hepatitis, was not helpful
in distinguishing between different types of liver diseases.
TABLE5.6.
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JfGT was a sensitive indicator of liver disease (c.f.
Szczeklik et al, 1961; Wieme and Demeulenaere, 1970),
reaching its highest levels under the influence of
induction in alcoholic cirrhosis, but was a poor discrim¬
inator between different types of liver disease (c.f.
Rutenburg et al, 1963). LAP was a fairly insensitive
test and a poor discriminant taken singly but formed the
second discriminant in several functions. The high levels
in biliary obstruction and relatively low levels in meta¬
static liver disease are in agreement with the observations
of Wieme and Demeulenaere (1970) . Albumin was low in
alcoholic cirrhosis but was otherwise unhelpful.
5.6.3. Comparison with previous computer assisted
diagnostic studies
When liver diseases were compared in pairs, the
percentages of patients who were correctly classified by
the cross-validation procedure were similar to those found
by earlier computer diagnostic studies using different
combinations of discriminants (Solberg et al, 1975) . The
low percentage of correct classification when all the liver
diseases were considered simultaneously was also similar to
those found by earlier studies (Fellingham and Mekel, 1966;
Solberg et al, 1975; Sherr, 1977). Classification accuracy
tends to decrease as the number of liver disease categories
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under consideration increases. Some previous studies,
perhaps for this reason, have tended to group liver
diseases in ways that seem clinically incompatible (e.g.
liver metastases, liver abscess, typhoid, sarcoidosis,
bilharzia, extrahepatic obstruction etc in one group
(Fellingham and Mekel, 1966). As illustrated in this
example, such a group may include liver diseases which are
relatively uncommon in Britain. Despite the drawbacks it
was felt in the present study that discriminant function
analysis, to be realistic, must incorporate most of the
commoner liver diseases in separate categories, as far as
possible. Ideally, the discriminant functions obtained
would then be combined with probability data based on
clinical criteria to achieve optimal diagnostic accuracy.
5.7. CORRELATION BETWEEN HIGH MOLECULAR WEIGHT ALKALINE
PHOSPHATASE AND OTHER LIVER FUNCTION TESTS
The group of patients with secondary carcinoma in
the liver was chosen for calculating correlations between
the variables because a) this was the largest diagnostic
group in the study, b) the group was of particular interest
because of the high levels of high mol wt ALP observed and
c) it was considered to be invalid to combine all liver
diseases in deriving these correlations because the
variables might be influenced by different factors in
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different diseases e.g. bilirubin in acute hepatitis and
extrahepatic obstruction.
Significant correlations (Table 5.8.) were observed
between YGT, LAP and ALP, thereby confirming an earlier
report (Wieme and Demeulenaere, 1970). In general, high
mol wt ALP was less well correlated with the other liver
function tests than these were among themselves, with the
exception of total ALP. In particular, no relationship at
all was observed with alanine aminotransferase, an index
of cell necrosis, and the correlation with degree of
jaundice was non-significant. There was only a low
correlation between high mol wt ALP and total XGT and
LAP, indicating that the pathological factors which govern
the release of high mol wt ALP into the circulation in
metastatic liver disease operate in a different way on
the release of total 2fGT and LAP, both of which may, like
ALP, occur largely in low mol wt forms (see Fig 4.6.).
For all three enzymes it seems likely that different
factors govern the release of the low and high mol wt
enzymes into the circulation.
It was not possible in this study to measure high
mol wt YGT and LAP in each serum since the ion-exchange
assay would have had to be repeated three times with
buffers of different ionic strength and this was imprac-
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TABLE 5.8(a) .
Correlation coefficients between liver function tests
measured in 21 patients with metastatic liver disease
(data were log-trans formed)
Bili ALT LAP ^GT ALP HMW
Bili .70 .36 .53 .71 .32
ALT .28 .41 .43 .08




TABLE 5 .8 (b) .
Two-tailed probabilities associated with correlation
coefficients between liver function tests measured in








LAP *GT ALP HMW
N.S . <.05 <.001 N S .





ticable both from the point of view of time available and
volume of serum required. Correlations between the high
mol wt enzymes alone were therefore not investigated.
5.8. SERIAL MEASUREMENTS IN INDIVIDUAL PATIENTS
Because patients with serum and infectious hepatitis
tend to have a well-defined acute illness, these diseases
were chosen to investigate the relationship of high mol wt
ALP with other variables in individual patients. The
following patients were studied (Fig 5.4.) .
a) 3 patients with serum hepatitis alone (patients A,B,C)
b) 1 patient with serum hepatitis and chronic cardiac
failure (patient D)
c) 2 patients with infectious hepatitis (patients E,F)
On admission all patients were jaundiced to a greater
or lesser extent and had raised alanine aminotransferase
activities in their serum, although in some cases the
activity peak had not yet been reached (Fig 5.4.). The
degree of cholestasis at this stage, as indicated by ALP,
JfGT and LAP activities, was variable but present to some
degree. The serum from 2 patients (patients C and F) were
even transiently positive for LPX.
The pattern of the biochemical measurements was
variable over the course of the disease but some trends
could be discerned. Usually, serum bilirubin and certain
-246-
Figure 5.4. Serial measurements following admission in 8
patients. Patients A, B, C, serum hepatitis;
D, serum hepatitis and chronic cardiac failure
(not included in general statistical analyses);
E, F, infectious hepatitis; G, carcinoma of the
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enzyme activities, namely alanine aminotransferase, 2fGT
and ALP varied in parallel and fell during the resolving
phase of the illness. However, the magnitudes were very
different: alanine aminotransferase reached 20 to 50 times,
bilirubin 3 to 20 times, and 2fGT and ALP only 2 to 4 times
the upper limit of their reference ranges. LAP often remained
out of step with the other enzymes but it never rose above
twice the upper limit of its reference range. The lack of
correlation with the other enzymes may therefore have been
largely due to chance fluctuations in serum, which owed
more to physiological than to pathological mechanisms.
Patient D (Fig 5.4.), who also had chronic cardiac
failure, had a secondary episode of cholestasis in which
2fGT, LAP and ALP activities in serum again rose in parallel
but without an accompanying increase in bilirubin and
alanine aminotransferase.
As far as high mol wt ALP was concerned, it generally
rose to 4 to 6 times the levels seen in normal controls.
It more closely paralleled the time course of the indices
of cholestasis, namely total ALP, JfGT and LAP, than the
indices of cell necrosis, namely bilirubin and alanine amino¬
transferase, but did on occasion vary independently.
General support for these observations came from sequential
measurements in two patients with much higher levels of
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high mol wt ALP in liver disease of an obstructive type,
namely carcinoma of the head of the pancreas (patient G)
and cholangiocarcinoma (patient H)(Fig 5.4.).
5.9. CONCLUSIONS
1) High mol wt ALP proved to be a sensitive and specific
test for liver disease. It was higher a) in liver
disease than in bone disease and normal controls,
b) in obstructive lesions than in non-obstructive
lesions and c) in patients with obstruction due to
carcinoma in the liver or its vicinity than in non¬
neoplastic forms of obstruction. It was the best
single test for diagnosing liver metastases and may
therefore prove to be useful in the early detection
of liver secondaries from a known primary carcinoma.
2) In the computer-assisted diagnosis of liver disease,
high mol wt ALP appeared in many of the discriminant
functions with a frequency second only to alanine
aminotransferase. In particular, it appeared in most
of the discriminant functions which distinguished
metastatic liver disease from other liver diseases.
3) High mol wt ALP was released into the circulation in
those pathological conditions characterised by intra-
or extrahepatic cholestasis. Both single measurements
in a number of patients and serial measurements in
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individual patients showed that it correlated more
closely with those variables generally regarded as
indicating cholestasis than with those principally
associated with cell necrosis. However, the
correlation was not close and it seems likely that
the pathophysiological factors governing the release
of high mol wt ALP into the circulation are not
identical to those governing the release of total
ALP, JTGT and LAP which are either partly or princip¬
ally composed of low mol wt forms.
-256-
CHAPTER 6.
AN ELECTROPHORETICALLY SLOW-MOVING VARIANT OF
ALKALINE PHOSPHATASE
6.1. INTRODUCTION
In addition to the high mol wt ALP which forms the
principal object of study in this thesis, a second high
mol wt form of ALP (designated slow band ALP to avoid
confusion) was observed in the sera of 22 out of approx¬
imately 4500 patients whose serum ALP patterns were
studied over a period of 52 months. Slow band ALP is
therefore much rarer than high mol wt ALP. It migrated
with about one third of the mobility of the liver isoenzyme
during electrophoresis in 1% polyacrylamide gel, and had
a mol wt intermediate between that of the liver isoenzyme
and that of high mol wt ALP (see section 6.3.). The large
size of slow band ALP might arise from aggregation of ALP
molecules or association of ALP with a) protein b) lipid
c) carbohydrate or d) a combination of these moieties. Its
nature was therefore investigated with a view to deter¬
mining whether it resembled the other high mol wt ALP, in
any way. The role of slow band ALP in diagnosis was also
assessed.
Using starch gel electrophoresis, an atypical slowly
migrating zone of ALP activity (slow band) was first
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reported by Streifler et al (1972) in a patient with
ulcerative colitis. This was followed by a paper by
Q^irbi and Moss (1975) which described the occurrence of
a similar slow band on polyacrylamide gel electrophoresis
in a further 3 out of a total of 54 patients with
ulcerative colitis or Crohn's disease. In each case the
slow band formed between 50% and 100% of the total ALP
activity. Isolated reports of similar slow bands have also
appeared (Nagamine and Ohkuma, 1975; Lee, 1975). Dingjan
et al (1975) found a slow band in 7 out of 2500 sera
submitted for routine ALP isoenzyme analysis.
The present study investigates a strongly-staining
slow band of ALP activity which moves with approximately
one-third the mobility of the liver isoenzyme during
electrophoresis in 7% polyacrylamide gel and forms 50% to
100% of the total ALP activity. Besides the 22 patients *
with this prominent slow band in their serum, many other
sera had faint irregular bands with comparable mobility
(e.g. patient M.G. in Fig 6.1.) but these looked quali¬
tatively different from the prominent slow band under
consideration. To avoid confusion, these commoner,
irregular, faint slow bands will be termed 'irregular
bands'. They were frequently multiple in number and
usually occurred in sera containing the intestinal
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Figure 6.1. ALP electrophoresis patterns on polyacrylamide
gel. Sera from 6 of the patients studied are
shown. The serum belonging to patient M.G.,
containing the irregular band, is included for
comparison. Bands: 0, origin; S-^, an anomalous
slow band seen only in the serum of patient 13;
S^/ the slow band under investigation; I,




isoenzyme. The two types of slowly-migrating ALP were
compared in all the investigations carried out. One serum
only (patient 13, Fig 6.1.) contained a second prominent
slow-moving band near the origin. This, because of its
rarity, was not intensively investigated.
Previous investigations have not demonstrated
whether the slow band is a single entity possessing
identical properties in the diverse disorders in which it
appears. In this study, sera from 8 patients with the
slow band were studied in depth to determine its likely
nature and origin.
6.2. CLINICAL SIGNIFICANCE
The age, sex and principal diagnosis of each of the
patients in whom the slow band occurred are given in
Table 6.1. The table also shows the total ALP activity
of the sera. No particular association with age or sex is
apparent although the band does tend to occur in the older
age group. In no case did the total ALP activity rise
above 4 times the upper limit of the reference range and
usually it was below 250 iu/1. It is not known whether
any patients with total ALP activity below 100 iu/1 have
the slow band since electrophoresis was not performed on
such sera. The slow band occurred most frequently in





















































10 58 M 151
11* 57 F 231
12 50 M 185
13* 60 M 350
14* 33 F 149
15 65 M 122
16 45 M 112
17 M 169
18* 55 M 156
19 63 F 114
20 52 F 191
21 75 F 160
22* 83 F 299





















* patients studied in depth.
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geneity of these makes it difficult to postulate a single
underlying mechanism or to attach any clinical significance
to its presence in serum. No association with any drug or
group of drugs (e.g. steroids) was found. Serum protein
and immunoglobulin concentrations were usually normal and
protein electrophoresis showed no characteristic abnormalities.
Because similar slow bands have been previously
reported in some cases of ulcerative colitis (Streifler et
al, 1972; Qirbi and Moss, 1975) and because 2 patients in
this series had ulcerative colitis, a further 9 sera from
patients with established ulcerative colitis in various
stages of activity were examined: none possessed the slow
band. Three patients who were followed up one month later
still had the slow band unchanged in their serum but no
long-term follow-up studies were carried out.
6.3 . MOLECULAR WEIGHT
A serum containing the slow band complex (patient 11)
was applied to a Sepharose 6B column which had been cali¬
brated with proteins of known mol wt. Fig 6.2. shows the
position at which the slow band complex eluted relative to
the liver isoenzyme. The mol wt was estimated to be
550 000. Polyacrylamide gel gradient electrophoresis
(Fig 6.3.) yielded an estimate of 540 000 for the mol wt
of the slow band complex (patient 1), a result in close






















agreement with that from gel chromatography. The irregular
band from patient M.G., also investigated for comparative
purposes, was estimated by gradient gel electrophoresis to
have a mol wt of 300 000.
6.4. CHARGE AND EFFECT OF INCUBATION WITH NEURAMINIDASE
Cellulose acetate, unlike polyacrylamide gel, exerts
little or no retarding effect due to molecular size and
thus afforded a better electrophoretic medium for assessing
the charge of the slow band complex relative to the liver
isoenzyme. In this medium, the slow band complex migrated
very closely behind the liver isoenzyme. The charges of
the two types of ALP must therefore have been similar.
Incubation with neuraminidase according to the
method outlined in section 4.3 resulted in retardation of
both liver and slow band ALP to approximately the same
extent during electrophoresis in cellulose acetate
(Table 6.2.) Very little retardation of the slow band
occurred in 7% polyacrylamide gel since its mobility was
already low in this medium owing to the molecular sieving
effect. The effect of neuraminidase on the slow band was
therefore masked. The intestinal isoenzyme, included for
control purposes, was not retarded by incubation with
neuraminidase. The mobility of the irregular band (patient
M.G.) was little altered by treatment with neuraminidase.
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TABLE 6.2.
Retardation of ALP bands by neuraminidase on two
electrophoretic support media
% Retardation of neuraminidase-treated isoenzyme













If anything, it migrated slightly faster in the neuramin-
idase-treated serum.
The content of sialic acid residues therefore seems
to be similar in the slow band complex and in the liver
isoenzyme.
6.5. CHEMICAL INHIBITION
9 sera in which the slow band predominated, one
serum containing the irregular band and 2 control sera in
which the liver and intestinal isoenzymes respectively
predominated were studied. ALP activities were measured
in the presence and absence of 5 mmol/1 L-homoarginine,
L-phenylalanine and L-leucine. The sera were also
subjected to electrophoresis in 1% polyacrylamide gel and
stained for ALP activity in the presence of 5 mmol/1
inhibitor. The resulting bands were compared with those
of a control gel stained in the absence of inhibitor.
The qualitative effects of the inhibitors on the
predominant electrophoresis band (Fig 6.4., Table 6.3.)
showed that all the slow bands resembled the liver/bone
rather than the intestinal isoenzyme. They were strongly
inhibited by L-homoarginine, partially by L-leucine but
only slightly by L-phenylalanine. This was in contrast to
the intestinal isoenzyme and the irregular band (patient
M.G.) which were both inhibited by L-phenylalanine but
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Figure 6.4. ALP electrophoresis patterns in polyacrylamide
gel stained in the presence of various inhib¬
itors. Sera from 6 of the patients studied
are shown. Serum from patient M.G., containing
the irregular band, is included for comparison.
Band notation as in Fig 6.1.
(a) Control gel: no inhibitor
18 14 22 11 13 M.G. 1 +
(b) 5 mmol/1 L-homoarginine
I




(c) 5 mmol/1 L-phenylalanine
18 14 22 11 13 M.G. 1 +
PATIENTS
(d) 5 mmol/1 L-leucine




Qualitative effects of inhibitors on slow band and irregular
Predominant Qualitative effect on predominant electro-
isoenzyme phores is band
in serum
L-Homoarq. L-Phe. L-Leu.
Intestinal Resistant Sensitive Partially sensitive
Irregular band)
(patient M .G .) )
Resistant Sensitive Partially sensitive
Liver Sensitive Resistant partially sensitive
Slow band
patients 1 Sensitive Resistant Partially sensitive
2 Sensitive Res istant partially sensitive
3 Sensitive Resistant partially sensitive
4 Sensitive Resistant Partially sensitive
11 Sensitive Resistant Partially sensitive
13 Sensitive Resistant partially sensitive
14 Sensitive Resistant partially sensitive
18 Sensitive Resistant Partially sensitive
22 Sensitive Resistant partially sensitive
"Slower" band)
patient 13 )
Sensitive Res istant Resistant
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TABLE 6.4.
Inhibition of slow band and irregular band ALP compared




% inhibition of total activity
L-Homoarg L-Phe L-Leu Urea
Intestinal 65 24 35 -
Irregular band)
(patient M.G.) )
64 20 32 56
Liver 73 15 31 47
Bone - - - 64
Slow band
patient 1 71 20 41 48
2 - - - 51
3 - - - 50
11 70 10 29 59
13 71 14 8 -
14 70 14 30 46
18 71 17 33 46
22 72 14 30 66
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were largely resistant to inhibition by L-homoarginine.
The quantitative studies (Table 6.4.) showed a similar
pattern in most cases but the results were probably partly
obscured by the presence of other isoenzymes in the sera.
The extra slow band near the origin in patient 13 (s^ in
Fig 6.4.) also behaved like the liver isoenzyme except
that it was resistant to inhibition by L-leucine. The
effect of this additional slow band probably explains the
reduced quantitative sensitivity to L-leucine shown by
serum 13 .
In summary, all the slow bands resembled the liver/
bone isoenzyme whereas the irregular band (patient M.G.)
resembled the intestinal isoenzyme in their responses to
these inhibitors.
The effect of 2 mol/1 urea on the ALP activities of
7 sera containing the slow band is also shown in Table 6.4.
5 of the slow band sera were inhibited by urea to about the
same extent as the liver isoenzyme whereas the other two
sera (patients 11 and 22) behaved more like the bone iso¬
enzyme. Both had bone isoenzyme activity in their serum
(Fig 6.4.(a)) in addition to the slow band and this may
have accounted for the greater inhibition by urea shown
by these sera. In other words, the evidence is insufficient
to conclude whether or not the slow band may have been
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derived from the bone rather than the liver isoenzyme in
these two sera. Serum from patient M.G. showed an inter¬
mediate degree of inhibition, probably accounted for by
the presence of appreciable amounts of liver, bone and
intestinal isoenzymes as well as the irregular band. The
results of urea inhibition of both the slow and the
irregular band must therefore be regarded as equivocal.
6.6. INACTIVATION BY HEAT
Heat inactivation curves were determined on whole
sera by the method of Whitby and Moss (1975). To determine
the qualitative effect of heat on the individual isoenzymes,
the sera were heated at 56°C (+ 0.2°C) for 10 minutes
(Johnson et al., 1972) and then cooled rapidly. The ALP
isoenzymes in the heated sera and in the unheated controls
were separated on 1% polyacrylamide gel. A similar experi¬
ment was carried out to determine the effect of heating at
o
65 C for 5 minutes.
The serum from patient 18 was selected for study
because its ALP was virtually entirely in the slow band
form (Fig 6.1.). On heating at 56°C, a biphasic exponen¬
tial decay curve was obtained (Fig 6.5. Table 6.5.). The
first component of this curve comprised one-third of the
total activity and was slightly more heat labile than the
bone isoenzyme; the second component formed two-thirds of
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Figure 6.5. The effect of heating at 56°C on ALP activity
in whole serum.
Time of heating at 56°C (min)
TABLE6.5.





the total activity and was more heat-labile than the liver
isoenzyme. It is possible, therefore, that the slow band
complex in this serum contained both liver and bone iso¬
enzymes which were both rendered slightly more heat-labile
by their attachment to the complex. Serum from patient
M.G. (not shown) had an overall ALP half-life of 5.6
minutes but the half-life of the irregular band could not
be separately estimated owing to the mixture of isoenzymes
in this serum. Qualitative electrophoretic studies on the
effect of heating at 56°C for 10 minutes (Fig 6.6.) con¬
firmed the heat lability of the slow band complex. The
'slower' band in patient 13 (S^ in Fig 6.6.) seemed to be
even more heat-labile than the slow band and disappeared
o
completely after heating at 56 C for 10 minutes. Heating
at 65°C for 5 minutes destroyed all the slow band activity
as well as the irregular band and the liver, bone and
intestinal isoenzymes.
6.7 . ASSOCIATION WITH IgG
Immunoelectrophoresis against antisera to human IgG,
IgA, IgM and K and A light chains (Scheidegger, 1955) was
performed in duplicate on 9 sera containing the slow band,
on serum from patient M.G. and on sera containing the liver,
bone and intestinal isoenzymes. After washing the plates
in saline for 2 days, they were stained for a) protein and
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o
Figure 6.6. The effect of heating at 56 C for 10 minutes
on ALP electrophoresis patterns in polyacryl-
amide gel. A, patient 18 control serum;
B, patient 18 serum after heating; C, patient
13 control serum; D, patient 13 serum after
heating,- E, patient M.G. control serum;
F, patient M.G. serum after heating. Band
notation as in Fig 6.1.
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b) ALP.
ALP activity was associated with the IgG precipitin
arc in all sera containing the slow band (Fig 6.7., Table
6.6.). No ALP activity was present in the IgA or IgM
precipitin arcs of these sera, nor was there any enzyme
activity in any of the precipitin arcs formed by the
control sera or serum from patient M.G. with the irregular
band. In most of the sera containing the slow band, it
was possible to demonstrate ALP activity in the arcs formed
against either the K or the X light chain antisera - but
never both. The equivocal results sometimes obtained were
possibly due to poorly reacting antisera.
In order to confirm an association between the slow
band and IgG, an attempt was made to demonstrate directly
the presence of IgG in the slow band. After polyacryla-
mide gel electrophoresis of a serum containing the slow
band, protein was eluted electrophoretically from the
section of gel surrounding the slow band. Other sections
of gel corresponding to the region of the liver isoenzyme
and the intermediate region were also eluted as controls.
An attempt was made to demonstrate the presence of IgG in
the eluates but IgG was undetectable by nephelometry and
by Laurell rocket electroimmunoassay (Laurell, 1966).
Assuming a specific activity for ALP of 1450 iu/mg
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Figure 6.7. Immunoelectrophoresis pattern stained for ALP
activity, using serum from patient 13 (W.B.)


















Imirunoelectrophoresis of sera containing slow bands
compared with control sera
Predominant Precipitin arcs with ALP activity
isoenzyme








Patient 1 IgG X
2 IgG k
3 IgG X
11 IgG ? x
13 IgG k





(Latner and Hodson, 1976) and that one molecule of ALP
combines with a maximum of two molecules of IgG, the
expected concentration of the ALP-specific IgG can be
calculated as follows. A serum with a slow band activity
of 150 iu/1 contains 0.1 mg/1, or about 0.5 nmol/1 ALP
protein which will combine with 1 nmol/1 or about 0.15 mg/1
IgG. This is 1:10^ of the normal serum concentration and
thus below the limits of detection of the methods of
measuring IgG which were used.
An indirect experiment involving precipitation by
antiserum was therefore carried out. The following
combinations of ALP-containing human sera and anti¬
immunoglobulin antisera were incubated at 4°C for 24 hours
in the ratio 1 volume serum:5 volumes antiserum:
a) Liver isoenzyme serum (control) + IgA antiserum
b) Liver isoenzyme serum (control) + IgG antiserum
c) Slow band serum (patient 3) + IgA antiserum
d) Slow band serum (patient 3) + IgG antiserum
The mixtures were then centrifuged to remove any precipi¬
tated antigen-antibody complexes. Immunoelectrophoresis
of the supernatants against IgG antiserum followed by
staining for both ALP activity and protein showed, for each
of the above incubation mixtures (Fig 6.8.):
a) IgG present; no ALP arc
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Figure 6.8. Immunoelectrophoresis using IgG antiserum.
The upper plate is stained for ALP activity
and the lower plate is stained for protein.
A, supernatant from incubation (a); B, super¬
natant from incubation (b); C, supernatant
from incubation (c); D, supernatant from




A B C D
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b) No IgG present; no ALP arc
c) IgG present associated with ALP activity
d) No IgG present; no ALP arc.
The anti-IgG antiserum had therefore been successful in
precipitating all detectable IgG in the sera.
Electrophoresis of the supernatants in 1% poly-
acrylamide gel showed that the slow band had disappeared
from the serum incubated with anti-IgG (d) but not from
the serum incubated with anti-IgA (c). The liver isoenzyme
was unaffected by either anti-IgG (b) or anti-IgA (a)
(Fig 6.9.). These experiments demonstrate conclusively
that the slow band consists of a complex between ALP and
IgG.
The following experiment was performed to determine
whether the sera containing the slow band were capable of
binding ALP isoenzymes added from other sources, in other
words, whether there was spare binding capacity. One
volume of a slow band serum (patient 2) was incubated for
24 hours at 4°C with one volume of each of the following
sera respectively;
a) liver ALP serum
b) bone ALP serum
c) intestinal and liver ALP serum.
As controls, each serum was incubated separately with the
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Figure 6.9. ALP electrophoresis patterns in polyacrylamide
gel showing the effect of removal of IgG from
a serum containing the slow band. A, IgA
antiserum control; B, IgG antiserum control;
C, supernatant from incubation (a);
D, supernatant from incubation (b);
E, supernatant from incubation (c);
F, supernatant from incubation (d);
Bands: S, slow band; X, IgG antiserum ALP;
L, liver isoenzyme; Y, IgA antiserum ALP.
See text for details.
0
A B C D E F
+
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appropriate volume of saline alone. Subsequent electro¬
phoresis on polyacrylamide gel (Fig 6.10.) showed that in
incubations (a), (b) and (c) the slow band had been
augmented and the liver and bone isoenzyme bands respec¬
tively had been diminished compared with the controls.
However, in incubation (c), only the liver isoenzyme band
was diminished compared with the control: no change was
observed in the intestinal isoenzyme band. This suggests
that there was indeed spare capacity of IgG in the slow
band sera which appeared to bind liver or bone but not
intestinal ALP to form the slow band complex.
Attempts to generate the slow band complex by
incubation of sera containing various ALP isoenzymes, and
also partially purified preparations of the isoenzymes with
purified polyclonal human V-globulin [Sigma Cohn Fraction
II] were unsuccessful.
6.8. EFFECT OF DISSOCIATING AGENTS
Sera containing the slow band complex were treated
with various dissociating agents as shown in Table 6.7.
Electrophoresis was then performed in polyacrylamide gel
containing either dissociating agent or no dissociating
agent as shown in the table. Staining for ALP activity was
invariably done in the absence of dissociating agent (and
required prior soaking of the gel after electrophoresis
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Figure 6.10. ALP electrophoresis patterns in polyacrylamide
gel showing binding of other isoenzymes in the
slow band serum to form the slow band.
A, slow band serum (patient 2) + liver
isoenzyme serum; B, slow band serum + bone
isoenzyme serum; C, slow band serum + intest¬
inal and liver isoenzymes serum; D, slow band
serum control; E, liver isoenzyme serum
control; F, bone isoenzyme serum control;
G, liver and intestinal isoenzymes serum
control. Band notation as in Fig 6.1. See
text for details.

























in several changes of buffer in the urea and guanidine
hydrochloride experiments).
The detergents, sodium dodecyl sulphate (SDS) and
Triton X-100, both of which interfere with hydrophobic
interactions, had no effect on the integrity of the slow
band complex. However, SDS did abolish the second 'slower'
band in the serum of patient 13 (Fig 6.11. c.f. Fig 6.1.),
possibly converting it to a faster moving form. Similarly,
the irregular band in the serum from patient M.G.
disappeared and a new band appeared migrating closely
behind the intestinal isoenzyme.
The organic solvent butan-l-ol (combined with di-
isopropyl ether to mitigate its denaturing effects, as
described by Cham and Knowles, 1976) which extracts lipo¬
philic substances had no effect on any of the ALP bands of
activity. Urea and guanidine hydrochloride, which
disrupt hydrogen bonding, both irreversibly inactivated
ALP in this experiment. This was because ALP is irrever¬
sibly inactivated at 8 mol/1 urea, whereas at 2 mol/1
(used in section 6.5.) the inhibition is reversible and
of a non-competitive type (Birkett et al, 1967) . Irre¬
versible inactivation also occurred with acidification
which has been used to disrupt protein-immunoglobulin
linkages (Singer and Campbell, 1955). Since its enzymic
Figure6.11.ALPelectrophoresispa terninpolyacrylamideg lcont ining0.1%SDS. Serafrom6patientsossessingthslowband,erumpati nt M.G.weretreatedith1%SDSb foelectrophoresis.B nnotation asinFig6.1.Thepatterns(poorqualitywingtheffectf detergent)shouldbcomparedwithth sinF g6.1. PATIENTS
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activity was the only means of detecting and locating the
slow band complex, it was not possible to tell whether
these last three dissociating agents were successful or
not in splitting up the slow band complex.
6.9. DISCUSSION AND CONCLUSIONS
To avoid confusion with the high mol wt ALP
considered elsewhere in this thesis, the individual
findings relating to the slow band complex will be con¬
sidered here. The two forms of high mol wt enzyme will
then be briefly compared and contrasted in Chapter 7.
All the properties tested in a number of sera con¬
taining the slow band complex were similar. It seems that
the slow band complex is therefore a single entity with
definable properties in all patients in whose sera it
occurs. As a comparison, serum from patient M.G., which
contained the irregular band,was included in the study as
being representative of the many sera in which faint,
irregular, sometimes multiple, slowly-migrating bands are
seen on routine electrophoresis. These sera generally also
contain the intestinal isoenzyme.
6.9.1. Inhibition
Inhibition studies using L-homoarginine, L-phenyl-
alanine and L-leucine demonstrated that the slow band
complex resembled liver or bone ALP rather than the
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intestinal isoenzyme. Similarly, Dingjan et al (1975)
and Nagamine and Ohkuma (1975) found that the slow band
complex was resistant to inhibition by L-phenylalanine.
By contrast, the irregular band resembled the intestinal
isoenzyme in its inhibition properties.
6.9.2. Charge and neuraminidase treatment
In cellulose acetate which exerts little or no
retarding effect due to molecular size, the slow band
complex runs in the bone isoenzyme position, very closely
behind the liver isoenzyme, suggesting that the charges of
all three forms of ALP are similar. It is the higher mol
wt of the slow band complex which retards it in polyacryl-
amide gel. Using polyacrylamide gel electrophoresis,
Qirbi and Moss (1975) and Dingjan et al (1975) found
almost no change in mobility of the slow band following
treatment with neuraminidase. By contrast, using agar
gel electrophoresis Nagamine and Ohkuma (1975) demonstrated
a reduction in mobility. The present study confirms both
findings. It seems likely that the molecular sieving
action of polyacrylamide gel masks a true alteration in
charge which is apparent in cellulose acetate. The slow
band complex therefore resembles the liver and bone iso¬
enzymes in the number and accessibility of its sialic acid
residues. The irregular band, on the other hand, altered
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its mobility very little when treated with neuraminidase
and resembles the intestinal isoenzyme in this respect.
6.9.3. Inactivation by heat and urea
In the properties so far discussed the liver and
bone isoenzymes behave identically. Urea inactivation
studies were undertaken in an attempt to discover whether
the slow band resembled the liver or the bone isoenzyme,
but the results were equivocal. However, heat inactivation
studies suggested that the slow band complex might contain
both liver and bone isoenzymes, both of which might be
rendered slightly more heat labile by their presence in
the complex.
6.9.4. Association with IgG
ALP activity was associated with the precipitin arc
against IgG antiserum in all 9 sera possessing the slow
band in which immunoelectrophoresis was performed, thereby
confirming and extending the observation of Nagamine and
Ohkuma (1975). The light chain type varied from serum to
serum, but in any one serum only one type of light chain
was associated with ALP activity, suggesting that the IgG
might be monoclonal. No IgG-associated ALP activity was
detectable in control sera nor in serum from patient M.G.
containing the irregular band.
Too little ALP-associated IgG was present in the
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slow band sera for it to be measured directly. Instead,
removal of IgG from a patient's serum by immuno-precipit-
ation was accompanied by a concomitant removal of the
slow band. Failure to generate the slow band by
incubation of the liver, bone and intestinal isoenzymes
with human polyclonal IgG implied that the ALP-associated
IgG may be a monoclonal immunoglobulin not widely present
in the population. That it may be present in excess in the
slow band sera is suggested by the experiment in which
incubation of a slow band serum with various control sera
resulted in an enhancement of the slow band and a diminution
of the liver and bone isoenzyme bands, but not of the
intestinal isoenzyme band. Since the liver and bone iso¬
enzymes are similar in their antigenic properties and
differ from the intestinal isoenzyme in this respect
(Boyer, 1963), it is possible that this binding occurs as
an antigen-antibody-type reaction in vivo. Alternatively,
the binding could be a non-specific attachment to the Fc
fragment of IgG via the carbohydrate moiety, such as
occurs between complement and IgG (Latner, 1975) . In
either case, it appears that IgG will bind any liver and
bone isoenzymes present in the serum of the patient.
Nagamine and Ohkuma (1975) found that the slow band
in their patient eluted from a Sephadex G200 gel in a
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position intermediate between that of the liver isoenzyme
and high mol wt ALP, but they did not measure the mol wt.
The present study found a mol wt of 540 000 for the slow
band complex. This suggests that the complex may consist
either of two IgG molecules (mol wt 160 000) associated
with one liver or bone ALP molecule (mol wt 220 000) , or
of two ALP molecules associated with one IgG molecule, the
mol wt of 600 000 for the latter complex probably being
within the analytical error for the mol wt estimates. The
latter possibility is more consistent with the divalent
nature of immunoglobulins.
6.9.5. Effect of dissociating agents
Attempts to dissociate the slow band complex using
various agents were uniformly unsuccessful, suggesting
that strong bonds other than disulphide bonds were
involved. Only the 'slower1 band in patient 13 and the
irregular band in patient M.G. may have been dissociated
by SDS. This detergent, unlike Triton X-100, frequently
disrupts hydrophobic linkages between adjacent polypeptide
chains. Both these complexes may therefore have been
aggregates of lower mol wt isoenzymes. In the case of
patient M.G., the evidence suggests that the irregular
band was probably an aggregate of the intestinal isoenzyme.
Other similar bands in sera may also be intestinal
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isoenzyme aggregates and the multiple bands frequently
observed in the same sera may represent aggregates of
increasing numbers of monomers.
6.9.6. Clinical implications
Streifler et al (1972) found a strongly-staining
slow band in a patient with ulcerative colitis. This
initial report was followed up by Qirbi and Moss (1975)
who reported the presence of the band in 2 out of 22 cases
of ulcerative colitis and 1 out of 32 cases of Crohn's
disease but in none of 33 patients with other diseases of
the intestinal tract. Of the 7 patients with the strong
slow band described by Dingjan et al (1975), only one had
ulcerative colitis and another had a duodenal ulcer. 2
further patients had chronic bronchitis, one with carcinoma
of the bronchus in addition. The remaining 3 patients had
a variety of conditions . The patients investigated by
Nagamine and Ohkuma (1975) and Lee (1976) had skeletal
abnormalities and congestive cardiac failure respectively
with no evidence presented of intestinal or lung pathology.
In the present study, 8 of the 22 patients had intestinal
disorders and 9 had lung disorders. The remaining 5
patients had a variety of diseases with no apparent common
feature. This is in agreement with previous reports.
Only 2 patients had ulcerative colitis and in a further 9
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cases of ulcerative colitis examined no strong slow bands
could be detected. Since steroid administration affects
the immune response and is a therapy frequently used in
such conditions as ulcerative colitis and chronic asthma,
the drugs taken by the patients in this series were
checked. No correlation was found between the presence of
the slow band and administration of steroids or any other
drug.
6.9.7. Other enzyme-immunoglobulin complexes
ALP is not unique in forming a complex with an
immunoglobulin. Lactate dehydrogenase has been shown in
a series of papers to form complexes in vivo with IgA
(Biewenga and Feltkamp, 1975) of variable light chain type
(Biewenga and Van Loghem, 1978). Amylase may form
complexes in vivo with either IgG or IgA to form macro-
amylase (Levitt and Cooperband, 1968? Hansen et al, 1972;
Harada et al, 1975; Kanno and Sudo, 1977; Kobayashi et al,
1978). The light chain type of these complexes is also
variable. Kaczmarek and Rosenmund (1977) succeeded in
generating a macroamylase complex in vitro by incubating
purified amylase with polyclonal human X globulin. There
have also been isolated reports of an aspartate amino-
transferase-IgG complex (Konttinen et al, 1978) and a
creatine kinase BB isoenzyme-IgG complex (Urdal and
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Landaas, 1979). None of the patients with these enzyme-
immunoglobulin complexes had any underlying pathology in
common. Indeed, two individuals with the lactate dehydro-
genase-IgA complex and one with the aspartate amino-
transferase-IgG complex were apparently healthy. The
ALP-IgG complex described here must therefore be seen as
only one of a number of such enzyme-immunoglobulin
complexes which arise, apparently spontaneously, in the




7.1. COMPARISON BETWEEN THE DIFFERENT HIGH MOLECULAR
WEIGHT FORMS OF ALKALINE PHOSPHATASE
This thesis is largely concerned with the very high
mol wt ALP released into serum in liver disease, but in
Chapter 6 another ALP of intermediate mol wt, designated
'slow band ALP', was described in the sera of patients with
a variety of diseases. There are some similarities between
the two high mol wt forms:
1) Both probably consist of ALP attached in some way
to another biochemical substance, as demonstrated
by similar immunochemical techniques .
2) Both are inhibited by L-homoarginine but largely
unaffected by L-phenylalanine, demonstrating that
they belong to the liver/bone class of ALP iso¬
enzymes rather than the intestinal or placental
class.
3) Both are slightly more heat-labile overall than the
liver isoenzyme.
4) The electrophoretic mobility of both is retarded
by neuraminidase treatment, suggesting that they
contain sialic acid residues.
However, the differences are more striking than the
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similarities :
1) There may be as much as an order of magnitude
difference in the mol wts.
2) The substances to which ALP is attached are quite
different, namely IgG in the case of slow band
ALP and probably membrane fragments in the case
of high mol wt ALP (see sections 7.3 - 7.9).
3) The nature of the attachment is different since it
is unaffected by detergents in the case of slow band
ALP but is ruptured by detergents in the case of
high mol wt ALP, suggesting that hydrophobic inter¬
action is involved.
4) The presence of slow band ALP in serum is a rare
event which is not specific for any particular
ooVien it does occur
disease, although^it occurs more often than not in
intestinal or lung disorders; whereas a raised
level of high mol wt ALP in serum is specific for
liver disease.
5) Slow band ALP arises from an interaction in vivo
between liver or bone ALP and IgG to give soluble
complexes, whereas high mol wt ALP probably derives
from shedding of membrane fragments from the bile
canaliculi into bile in vivo and regurgitation into
the circulation (see section 7.9.).
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Slow band ALP, in view of its rarity and apparent lack of
usefulness in clinical diagnosis, was less intensively
investigated than the high mol wt ALP released into the
circulation in liver disease. Its nature and possible
origins have already been discussed in Chapter 6. The
remainder of this chapter will therefore be devoted to a
discussion of the nature and possible origins of the high
mol wt ALP which appears in the serum of patients with
liver disease.
7.2. ELECTROPHORETIC AND CHROMATOGRAPHIC BEHAVIOUR
OF HIGH MOLECULAR WEIGHT ALKALINE PHOSPHATASE
In order to eliminate any confusion arising from the
large number of different analytical methods used in the
literature, experiments were carried out to establish the
electrophoretic and chromatographic behaviour of high mol
wt ALP in various media. These showed that the high mol
wt ALP excluded from Sepharose 6B gel is identical to:
1) the ALP which eluted at an ionic strength of
135 mmol/1 during salt gradient DEAE-cellulose
chromatography
2) the enzyme activity present in Fraction II in the
two-step ion exchange assay (section 2.9.)
3) the activity remaining at the origin after
electrophoresis in 1% polyacrylamide gel (c.f.
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Walker and Pollard, 1971)
4) the enzyme band which migrated a little way into
the gel during electrophoresis in 2.5% polyacryl-
amide gel
5) the enzyme band which migrated immediately behind
the liver isoenzyme during electrophoresis in 1%
agarose gel (c.f. Demetriou and Beattie, 1971),
and between the intestinal isoenzyme and the origin
in 2.2% agarose gel (c.f. Ewen, 1974).
6) the isoenzyme which migrated ahead of the liver
isoenzyme in the a^globulin position during
electrophoresis in cellulose acetate (c.f. Fritsche
and Adams-park, 1972)
Starch gel was not studied as an electrophoretic
medium because of the slow and tedious nature of the
technique and because it has largely been abandoned as the
medium of choice in favour of the simpler faster techniques
now available. However, it seems likely that high mol wt
ALP remains at the origin in starch gel. The ALP band
migrating in the ^lipoprotein position in starch gel, which
may appear both in health and disease, appears to be
distinct from the high mol wt ALP which appears in serum
only in liver disease. In this connection, Van Husen and
Gerlach (1974) found that if the liver isoenzyme and the
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/3lipoprotein-associated ALP in serum increased in liver
disease without an increase in activity at the origin, no
concomitant increase was seen in LAP, 5'NT and lipids in
serum. On the other hand, if the activity at the origin
also increased, these markers of cholestasis also rose.
This is further evidence for the fundamental difference
between jSlipoprotein-associated ALP and high mol wt ALP.
This 0lipoprotein-associated ALP may constitute the non¬
specific enzyme staining observed in the ^lipoprotein
precipitin arcs (section 4.8.), and may represent non¬
specific sequestering of a wide variety of enzymes by
^lipoprotein in serum as suggested by Lawrence and Melnick
(1961). This thesis is not concerned with this non-specific
/3lipoprotein-associated ALP.
By studying the behaviour of high mol wt ALP in
these various media, continuity with the literature was
made possible. Discussion of the results in detail and
comparison with any similar experiments carried out by other
authors have already been presented in the relevant chapters.
In this chapter, the findings will be combined more gene¬
rally with other research in various fields to form a
unified theory of the nature and behaviour in disease of
high mol wt ALP.
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7.3. RELATIONSHIP OF HIGH MOLECULAR WEIGHT ALKALINE
PHOSPHATASE WITH OTHER MEMBRANE MARKER ENZYMES
ALP exists in the liver as a membrane-bound enzyme
(Birns et al, 1962) and high mol wt ALP has been shown to
share one or more antigenic determinants with liver plasma
membrane (Shinkai and Akedo, 1972). Of the various hypo¬
theses which might account for the large size of high mol
wt ALP (e.g. association of ALP with either protein, lipid
or carbohydrate, or aggregation of ALP itself), the
possibility that it might represent circulating fragments
of liver cell membrane was therefore taken as the working
hypothesis to be tested.
7.3.1. Serum
tfGT, LAP, and 5'NT are also membrane-bound enzymes
which are released into serum in liver disease. Investiga¬
tion showed that they too had high mol wt components
(section 4.6.), and this has been confirmed by Shinkai and
Akedo (1972), de Broe et al (1975) and Huseby (1978).
Moreover, the activities of the high mol wt components of
all four membrane marker enzymes appeared to vary roughly
in parallel in serum. No high mol wt component was found
for the cytoplasmic enzyme, lactate dehydrogenase, in a
serum which contained high mol wt ALP, ^GT, LAP and 5'NT.
It seems likely therefore that only enzymes which are of
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membrane origin give rise to high mol wt components in
serum. All four high mol wt enzymes migrated with
identical mobilities during electrophoresis and eluted in
the same void volume peak during gel filtration chromato¬
graphy. Supporting circumstantial evidence from previous
authors, each studying one enzyme only, suggests that }£GT,
LAP and 5'NT all have bands which remain at the origin on
starch gel or polyacrylamide gel electrophoresis in serum
from patients with liver disease but not from healthy
individuals (Orlewski and Szczeklik, 1967; Azzopardi and
Jayle, 1973; Kowlessar and Haeffner, 1961). In addition,
de Broe et al (1975) showed that the high mol wt ALP band
on agar gel electrophoresis also stained for ¥GT activity.
At first sight, the different elution positions of
high mol wt ALP, "JfGT and LAP on ion-exchange chromatography
would seem to contradict this hypothesis. However, all
the peaks overlapped to some extent and it must be
remembered that membrane fragments are not necessarily
homogeneous. If one therefore postulates a family of
membrane fragments of large molecular size, to each of
which are attached the enzymes in different proportions
vis a vis each other, then this would give the observed
pattern of sequential but overlapping peaks. This is in
agreement with recent theories of membrane structure which
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no longer regard the membrane as a uniform entity consisting
of a phospholipid bilayer interspersed with an even distrib¬
ution of protein, but as a mosaic of functionally and
morphologically distinct regions of different protein
composition. Such mosaicism of enzyme localisation has
been demonstrated for a number of membranes including
plasma membrane, endoplasmic reticulum, chloroplasts and
bacterial cell membranes (Siekevitz, 1972) . Moreover, the
enzymes in these membranes may be induced or repressed
independently of each other. Therefore, although high mol
wt ALP, *GT, LAP and 5'NT appeared to be roughly correlated,
such correlation is not a necessary corollary of the
membrane fragment hypothesis.
7.3.2. Bile
In normal human hepatic bile, only plasma membrane
enzymes are found in relative abundance: there is a
relative lack of intracellular enzymes (Holdsworth and
Coleman, 1975) . The investigations presented in this thesis
demonstrate that, like serum in patients with liver disease,
normal bile contains high mol wt ALP, GT and LAP (section
4.6.) in addition to low concentrations of the low mol wt
isoenzymes. In electrophoretic and chromatographic
properties these high mol wt biliary enzymes closely
resemble the high mol wt serum enzymes.
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7.4. EFFECT OF DISSOCIATING AGENTS
7.4.1. Butanol
Butan-l-ol has frequently been employed to
solubilise membrane-bound proteins by removal of the lipid
phase (Morton, 1954) . Conflicting reports of its effects
on high mol wt ALP have been reported in the literature
(see section 4.7.1.) . These discrepancies probably arise
from the varying severity of the effect of this powerful
organic solvent on enzyme structure under different
extraction conditions. In the present study, high mol wt
ALP, yGT and LAP from both serum and bile were all
apparently destroyed by butanol without conversion to a
lower mol wt form, under conditions which did not denature
the low mol wt isoenzymes. This suggests that these high
mol wt enzymes are associated with a lipid moiety and is
consistent with the membrane fragment hypothesis. It is
probable that the high mol wt enzymes were extracted into
the butanol layer, together with the membrane fragments to
which they were attached, and there denatured.
7.4.2. Detergents
Detergents have been employed as rather gentler
agents in the solubilisation of membrane proteins. These
are amphiphilic substances which solubilise membrane-bound
proteins by the combined interaction of their nonpolar
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1 tails' with the nonpolar portion of the protein (which is
hydrophobically linked to the lipid-rich membrane), and
their polar 'heads' with the water molecules. By similar
mechanisms, detergents disrupt the structure of the
membrane lipid bilayer itself. This interaction makes
solubilisation energetically favourable, resulting in an
increase in entropy (Helenius and Simons, 1975) . Since
ALP is an integral protein in the hepatocyte membrane
i.e. tightly bound to the membrane, this is the only means
of achieving solubilisation.
When the more powerful anionic detergents such as
SDS are used, they may cause, in addition, dissociation of
polypeptide chains and conformational changes in tertiary
structure since protein-protein interaction is also
affected, leading to loss of enzyme activity. In the
present study, this explains the loss of YGT and LAP
activity in the presence of SDS. It is thought that the
sialic acid residues of ALP in some way protect it against
such denaturation (Trepanier et al, 1976).
Triton X-100 converted the high mol wt forms of
ALP, yGT and LAP from serum and bile to lower mol wt forms
(section 4.7.2.). However, SDS, the more powerful deter¬
gent, resulted in conversion to even lower mol wt forms
(section 4.7.3.) . Similarly, in the solubilisation of
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rat liver nucleotide pyrophosphatase, Bachorik and
Dietrich (1972) noted that SDS reduced the size of membrane
fragments obtained by Triton X-100.
Following solubilisation by detergents, membrane
proteins exist in the form of protein-detergent complexes
whose mol wts are dependent on the degree of hydration and
the number of detergent molecules associated with each
protein molecule. This may explain the mol wt of 410 000
for the SDS-solubilised high mol wt ALP compared with
220 000 for the liver isoenzyme. There may be a variety
of sizes of complexes in equilibrium, the relative
proportions of which depend on the conditions. This may
partly explain the range of mol wts observed for the
Triton X-100-solubilised high mol wt ALP, although partial
re-association of the membrane fragments, a frequent
occurrence following reduction in Triton X-100 concentration,
may also have been responsible.
It was not considered worth while to attempt
complete removal of the detergents following solubilisation
in order to measure the true mol wt of the solubilised
protein and compare it with the liver isoenzyme to check
whether the two might be identical. This was because
complete removal of detergents is very difficult since they
are largely present in micellar form and therefore dialyse
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very poorly. Even when it can be brought about it usually
leads to protein aggregation, often to the extent of form¬
ation of amorphous precipitates, probably as a result of
hydrophobic interaction (Helenius and Simons, 1975).
Nevertheless, the evidence is compatible with the hypo¬
thesis that the high mol wt enzymes consist of the normal
low mol wt liver isoenzymes attached to membrane fragments
which can be disrupted by detergents.
7.4.3. Papain
Relevant to the detergent studies presented here is
a study on the effects of the proteolytic enzyme, papain,
on the LAP activity associated with rat liver plasma
membrane (Emmelot et al, 1968). It was noted that papain
released LAP almost completely from most membranes and that
this coincided with the release of 6nm globular knobs seen
under the electron microscope on the surface of the
membrane lining the bile canaliculus. It was concluded
that LAP was located on these knobs which represented a
structurally and functionally specialised repeating unit
on the membrane.
Recently, Huseby (1978), using a detergent combin¬
ation of deoxycholate and Lubrol W, converted high mol wt
yGT from serum and bile to a lower mol wt form. Treatment
with papain had a similar effect. He explained these
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findings by postulating hydrophobic domains on the low mol
wt form of the enzyme which might complex with lipids or
proteins in serum in vivo following release into the
circulation in liver disease. However, his observations
could equally well be explained by the release into the
circulation of membrane fragments consisting of lipid and
structural protein to which VGT is attached, as suggested
by the membrane fragment hypothesis.
In the series of investigations presented here, the
effects of bile acids (which are detergents) and papain on
the high mol wt enzymes in serum and bile have not yet been
studied. This would be a worthwhile direction for further
research to take since the ability of papain to disrupt all
four high mol wt enzymes would suggest the presence not
only of lipids (as shown by the butanol and detergent
experiments) but also of structural protein in the
complexes. thereby providing additional evidence for the
membrane fragment theory.
7.5. HEAT INACTIVATION
There are a number of possible explanations for the
bi-exponential heat inactivation curves of serum and biliary
high mol wt ALP (section 4.5.) based on the hypothesis that
they consist of ALP attached to membrane fragments:
1) Two different forms of ALP with different heat
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stability may be attached to a single membrane
fragment.
2) A single form of ALP may be attached to two
different membrane fragments whose differing
compositions confer different degrees of heat
stability on the attached ALP.
3) The membrane fragments may be relatively homo¬
geneous but the ALP molecule may be attached to two
different sites on the membrane which confer
different degrees of heat stability.
No hard evidence is available to distinguish between these
possibilities although the otherwise homogeneous properties
of high mol wt ALP make (1) unlikely. They are all
consistent with the membrane fragment hypothesis.
7.6. KINETICS
The observed fact that high mol wt ALP from both
serum and bile obeys the same general kinetics as the liver
isoenzyme and the low mol wt biliary isoenzyme, with
regard to optimum conditions of assay, mechanism of
inhibition by L-homoarginine and activation by magnesium
(Chapter 3), supports the hypothesis that these isoenzymes
may all derive from similar sources and be genetically
coded at the same locus. The observation of differences
in K s, K.s and K s between serum high mol wt ALP and
m x A ^
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biliary high mol wt ALP, biliary low mol wt ALP and the
liver isoenzyme does not contradict this theory, since a
general characteristic of membrane enzymes is a difference
in such kinetic properties between the membrane-bound and
solubilised forms. This phenomenon is known as "allotopy"
and arises from conformational changes between the two
states (Farias et al., 1975). In other words, the presence
of the membrane structure will affect the catalytic
parameters of the enzyme, although the same fundamental
mechanism of catalysis will be retained.
7.7. CHANGES IN LIVER CELL HISTOLOGY IN CHOLESTASIS
In order to develop the membrane fragment theory
further and provide an explanation for the release of high
mol wt enzymes in liver disease, it is necessary to take
into account the morphological and enzymic changes in
liver cell histology following either experimental bile
duct ligation in laboratory animals or biliary obstruction
in humans.
In normal rat and human livers ALP is principally
located on the sinusoidal membrane with only faint
activity associated with the bile canalicular membrane.
(Birns et al, 1962; Hagerstrand 1975) . LAP is also
associated with the liver plasma membrane, particularly
that lining the bile canaliculi (Emmelot et al, 1968).
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51 NT is localised both on the sinusoidal and the bile
canalicular membrane and also frequently along the
canalicular-sinusoidal connections (Birns et al, 1962).
Following bile duct ligation in rats, the bile
canaliculi are first distended and become tortuous owing
to the pressure of bile and then an increasing number of
canalicular-sinusoidal connections open up (Birns et al,
1962). This is accompanied by an increasing amount of
5'NT lining these connections and the canaliculi also begin
staining for ALP, this staining reaching its greatest
intensity 24 hours after bile duct ligation. The
sinusoidal membrane also stains for ALP and this staining
is always more intense than that of the bile canaliculi.
On the other hand, rats who have been exposed to carbon
tetrachloride, which causes liver cell necrosis rather than
extrahepatic obstruction, show only sinusoidal ALP staining
and no ALP staining of the bile canaliculi (Wachstein and
Meisel, 1958) .
In liver disease in humans, hepatitis and related
diseases causing liver cell necrosis result in increases
in the sinusoidal membrane ALP but no detectable activity
associated with the bile canaliculi (Hagerstrand, 1975).
However, in extrahepatic obstruction and metastatic liver
disease and, to a lesser extent, in cirrhosis and chronic
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active hepatitis, dilatation and ALP staining of the bile
canaliculi is observed in addition to the more intense
ALP staining of the sinusoidal membrane and, as in the
rat, increasing numbers of canalicular-sinusoidal
connections appear (Wachstein and Meisel, 1958; Hagerstrand,
1975). The appearance of ALP staining of the bile canali¬
culi therefore occurs under the same pathological conditions
in which high mol wt ALP appears in largest amounts in the
circulation (Chapter 5).
Looking now at the properties of ALP following bile
duct ligation in rats, Kaplan and Righetti (1969) claimed
that no new isoenzymes appeared in serum following
ligation. Nevertheless their photographs show a steady
increase in previously non-existent activity at the origin
(corresponding to high mol wt ALP) on polyacrylamide gel
electrophoresis over the 24 hour period following ligation
i.e. at the same time as the bile canaliculi stain most
intensely for ALP (Birns et al, 1962). Moss et al (1974)
in similar experiments showed an increase in the heat
stability of whole liver ALP within 24 hours following
bile duct ligation and this was even more marked after
10 days.
Taking the evidence from humans and rats together,
one may therefore postulate that high mol wt ALP derives
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principally or wholly from the membranes lining the bile
canaliculi and that the liver isoenzyme derives principally
or wholly from the sinusoidal membrane of the hepatocyte.
The observed increase in heat stability following bile
duct ligation could then be explained by the greater
increase in sinusoidal ALP (liver isoenzyme) than in
canalicular ALP (high mol wt ALP) which is less heat
stable (section 4.5.) .
7.8. RELATIONSHIP BETWEEN HIGH MOLECULAR WEIGHT
ENZYMES AND LIPOPROTEIN X
LPX is an abnormal lipoprotein which appears in the
serum of patients with obstructive jaundice (Seidel et al,
1969) and, much more rarely, in patients with a deficiency
of lecithin-cholesterol acyl transferase (LCAT) which
governs the esterification of cholesterol from phospho¬
lipid. In cholestasis, the appearance of LPX in serum
tends to be inversely correlated with LCAT activity i.e.
when LCAT activity is low (as often happens in biliary
obstruction) LPX can be detected, but when, as sometimes
happens, LCAT activity is normal or high LPX is not
detected (Mclntyre, 1978). This close relationship ties
in with the composition of LPX which is rich in phospho¬
lipid and unesterified cholesterol,, with esterified
cholesterol and triglyceride virtually absent (Seidel et
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al, 1969). About 2% of the molecule is protein, mainly
apo-C and albumin. LPX has been shown to exist in
heterogeneous forms of varying molecular size, one or more
of which are, like the high mol wt enzymes, excluded by
Sepharose 4B (Brocklehurst et al., 1976; Hauser et al,
1977) . Electron microscopy of purified LPX revealed
various sizes of hollow vesicles surrounded by a membran-
-ous bilayer, with a distinctive tendency to be grouped
in stacks (Hauser et al, 1977) . Following bile duct
ligation in rats, LPX appeared in the serum after a few
hours, reached a peak at 40 hours and thereafter showed a
progressive fall to become undetectable after approxi¬
mately one week (Seidel et al, 1976). This time course
parallels that of total ALP following bile duct ligation.
There is some evidence that high mol wt ALP may
have a chemical composition similar to that of LPX. Price
et al (1972) found that butanol extracts of high mol wt
ALP from bile contained principally phospholipid (which is
the principal component of membranes also) . In chloroform:
methanol extracts of high mol wt ALP from serum, Shinkai
and Akedo (1972) found a mixture of phospholipid,
cholesterol, triglyceride and free fatty acid, although
the relative proportions were not measured. Electron
microscopy of concentrated pellets of high mol wt ALP
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from serum showed vesicles similar to those of LPX which
stained to varying extents for ALP (Brocklehurst et al,
1976) and 5' NT (de Broe et al, 1975) . Since such
vesicles may occur in any particle with approximately
the right lipid composition, this is further evidence that
the chemical composition of LPX and the high mol wt
enzymes may be similar.
The experiments described in section 4.8. indicate
that the high mol wt enzymes share antigenic determinants
with LPX and also migrate cathodally with LPX during
electrophoresis in agar gel. The evidence for the immuno¬
chemical and electrophoretic identity of high mol wt ALP,
YGT, LAP and 5'NT with LPX is, however, counterbalanced by
the lack of detectable LPX in bile which nevertheless
contains these high mol wt enzymes. It is also counter¬
balanced by the evidence presented in section 4.8.3. that
although sera containing detectable LPX invariably had
raised levels of high mol wt ALP, many sera possessing
high activities of high mol wt ALP did not contain detec¬
table LPX. This was also found by de Broe et al (1975) .
Such observations need not necessarily conflict with the
theory that the high mol wt enzymes and LPX consist of mem¬
brane fragments of similar or identical composition. There
are two possibilities consistent with this hypothesis.
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Firstly, the membrane fragments to which the enzymes
are attached may always have an identical composition which
can be immunologically and electrophoretically identified
as that of LPX. However, the number of enzyme molecules
associated with a given LPX particle might vary (again the
concept of membrane mosaicism) so that large amounts of
high mol wt enzyme activity might be associated with low
amounts of LPX, undetectable by the methods used. This
does not satisfactorily explain why, when LPX can be
detected, the enzyme activities associated with it appear
to vary in parallel with each other and with LPX.
The second possible explanation is that the high
mol wt enzymes, although always associated with membrane
fragments of some kind (as may LPX), may not necessarily
be invariably associated with membrane fragments which
behave immunochemically and electrophoretically as LPX.
Slight differences in membrane composition might alter the
characteristic electrophoretic mobility of LPX in agar gel
or make the membrane undetectable by LPX antiserum, even
at high concentration. When the membrane is detectable as
LPX, though, the enzyme activities associated with it
would be correlated with it, as was observed.
Such a difference in membrane composition may be
brought about by contact with high circulating concentrations
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of bile salts which are known to alter the characteristic
electrophoretic migration of LPX from cathodal to anodal
(Manzato et al, 19*7 6) . This would explain why LPX is
never detected in bile even when large amounts of high
mol wt enzymes are present. There is some evidence to
show that lipoprotein lipase may have a similar effect
(Sauar et al, 1978) .
Relationship between LPX and biliary lipoprotein
Detailed studies of the lipoprotein composition of
hepatic bile have shown that its lipid composition is
almost identical to that of LPX but that its apoprotein is
albumin rather than apo-C and the protein:lipid ratio is
different (Manzato et al, 1976). It migrated towards the
anode rather than the cathode during electrophoresis in
agar gel. Under the electron microscope it formed
lamellar structures rather than the stacked vesicles
characteristic of LPX. However, it could be converted in
vitro , by the addition of serum to the native bile, to a
lipoprotein which was identical to LPX in its electro¬
phoretic, immunological and morphological properties. At
least part of this transformation involved the association
of Apo-C from serum with the biliary lipoprotein. This
conversion was critically dependent on the bile salt:
albumin concentration ratio and did not take place if
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this ratio increased or decreased beyond certain limits.
Conversely, LEX cculd be converted to a lipoprotein resemb¬
ling the biliary lipoprotein in every way by the addition
of bile salts to a LPX-positive serum in vitro. In dogs,when
the common bile duct was experimentally connected to
the vena cava in vivo, LPX appeared in the plasma after 3
hours but after 8 hours rapidly declined, presumably owing
to altered serum factors e.g. bile acid concentration.
This evidence strongly suggests that the biliary lipo¬
protein is a precursor of LPX which refluxes into the plasma
pool during cholestasis. Whether or not LPX is formed
depends critically on the serum bile salt:albumin ratio
and possibly other factors also.
Two slightly different forms of the high mol wt
enzymes must therefore be postulated, one immunochemically
and electrophoretically identical to the biliary lipo¬
protein and the other to LPX. Bile would contain only the
biliary lipoprotein-enzyme complex, whereas serum would
contain either the biliary lipoprotein-enzyme complex or
the LPX-enzyme complex or even both in equilibrium depen¬
ding on various serum factors. This would be consistent
with the biphasic heat inactivation curve for high mol wt
ALP since this was purified from more than one serum
(section 4.5.), and also with the observation that two kinds
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of high mol wt ALP, LAP and 5 ' NT were found on sucrose
density gradient ultracentrifugation, one in the 6.3S
region and the other in the 17.5S region (Shinkai and
Akedo, 1972) . The attachment of ALP to two membrane frag¬
ments of slightly differing composition would not alter
the mechanism of catalysis, activation or inhibition but
might alter some of the parameters, and this was observed
for the K s in particular (section 3.2.4.) .
m
The observation that purified high mol wt ALP from
serum and from bile did not migrate on agar gel electro¬
phoresis, but precipitated around the sample well during
LPX Immunoelectrophoresis (section 4.8.2.) is consistent
with the observation by Manzato et al (1976) that purified
biliary lipoprotein also failed to migrate, requiring the
presence of bile salts to exhibit its characteristic
anodal migration. High mol wt enzymes from both serum
and bile were, however, both specifically precipitated by
incubation with LPX antiserum (section 4.8.2.) suggesting
that, although the biliary-enzyme complex did not have
detectable cathodally-migrating LPX, it did share antigenic
determinants with the LPX-enzyme complex. What these
determinants might be is uncertain since it seems that the
biliary lipoprotein does not contain Apo-C (Manzato et al,
1976). Studies similar to those carried out by Manzato et
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al (1976) on the effects on the high mol wt enzymes and
their association with LPX of a) adding albumin, Apo-C or
whole serum to bile and b) adding bile salts to serum
might help to elucidate this point and to confirm or
refute the theory outlined of two types of high mol wt ALP.
The concept of two main types of membrane fragment
in serum need not conflict with the previous postulate that
the various membrane-marker enzymes are associated with
membrane fragments in varying proportions depending on the
exact position in the bile canalicular membrane mosaic
from which they are derived. These would form sub-classes
of membrane fragments. It must be remembered that LPX
itself as an immunochemically distinct species is hetero¬
geneous (Hauser et al, 1977) and so may derive from a
number of localities in the membrane mosaic.
An alternative theory
One alternative theory to the membrane fragment
hypothesis, but incorporating many of its features, should
be mentioned. This is that LPX may not consist of frag¬
ments of membrane (containing membrane marker enzymes) to
which Apo-C has been added in the circulation, but simply
of a lipoprotein of altered composition arising in a way
similar to that of ^lipoprotein. The low mol wt enzymes
may then attach themselves to LPX following their release
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into the circulation, to form high mol wt enzymes. This
attachment would presumably be a hydrophobic one since it
could be disrupted by organic solvents and detergents. A
similar attachment might occur between the low mol wt
enzymes and biliary lipoprotein. It is difficult to
distinguish between this possibility and the membrane
fragment hypothesis on the evidence so far available.
However, the theory is rendered less likely by the experi¬
ments of Manzato et al (1976) which demonstrated that the
precursor of LPX almost certainly comes from bile and not
from altered synthesis of very low density lipoprotein
(the precursor of low density lipoprotein) in the hepato-
cyte followed by direct release into the circulation.
Furthermore, only membrane-marker enzymes seem to be
attached to LPX and, as shown by Shinkai and Akedo (1972) ,
high mol wt ALP shares antigenic determinants with liver
plasma membrane.
7.9. FORMATION OF HIGH MOLECULAR WEIGHT ENZYMES
IN CHOLESTASIS
In health, all membrane constituents are involved
in dynamic turnover in the steady state (Siekevitz, 1972) .
On a larger scale, many intact viable cells appear to shed
membrane fragments In vivo, the composition of the frag¬
ments resembling that of the intact membrane (de Broe et
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al, 1977). This may represent a normal physiological
turnover of the membranes, although the rate of shedding
may be increased if there is local degeneration of the
cells or a modified cellular environment. It is probable
that such shedding of the bile canalicular membrane into
bile occurs in the healthy individual to form the high mol
wt enzymes which are present in normal hepatic bile.
The pathological process resulting in the appearance
of high mol wt ALP and LPX in the circulation may be as
follows. During extrahepatic or intrahepatic cholestasis,
ALP synthesis is induced both on the sinusoidal and on the
bile canalicular membrane. In some way, the ALP on the
sinusoidal membrane is solubilised, possibly by the
detergent action of the increased local concentration of
unexcreted bile salts, resulting in an increase in the
normal liver isoenzyme in serum. At the same time there
may be increased shedding of fragments from the bile
canalicular membrane (and possibly also from the sinus¬
oidal membrane) owing to the modified environment and
possible cellular degeneration. Some of this increased
shedding may be due to altered membrane composition as a
result of reduced LCAT activity and some may be brought
about by a less complete action of bile salts. Some of
the fragments may pass into bile as high mol wt enzyme
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complexes; these would be equivalent to biliary lipoprotein.
They may then be regurgitated along with bile into serum
via the increased number of bile canalicular-sinusoidal
connections which open up in cholestasis. The biliary
lipoprotein membrane fragments may be converted to frag¬
ments immunochemically and electrophoretically identical
with LPX, depending on various serum factors including bile
salt and albumin concentration, and possibly lipoprotein
lipase and LCAT activities. It is possible that some
fragments are also shed directly into serum from the
sinusoidal membrane.
It has been observed that administration of litho-
cholate to normal rabbits resulted in the appearance of LPX
in their serum (James et al, 1974). If LPX is indeed
equivalent to membrane fragments, this observation is
consistent with the argument that increased shedding of bile
canalicular and sinusoidal membrane fragments may occur in
the presence of increased concentrations of bile salts in
cholestasis.
Metastatic liver disease
The explanation for the particularly high levels of
high mol wt ALP in serum in metastatic liver disease in the
absence of jaundice and usually in the absence of detectable
LPX (Chapter 5) may be as follows. Firstly, local deposits
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of tumour stimulate preferential induction of bile canal¬
icular ALP (Hagerstrand, 1975) and this may shed at an
increased rate into bile. Reflux of bile occurs into serum
owing to local intrahepatic obstruction by the tumour,
carrying with it biliary lipoprotein-associated high mol
wt ALP. Bilirubin will of course also be regurgitated but
can be re-excreted by another unaffected portion of the
liver, so that jaundice does not occur. High mol wt ALP,
on the other hand, cannot be excreted by the liver and
remains in the circulation. Biliary lipoprotein-associated
high mol wt ALP rarely seems to be converted to LPX-
associated high mol wt ALP under these circumstances,
possibly because of high circulating bile salt concentra¬
tions (which were not measured in the study) or other
altered serum factors such as high lipoprotein lipase or
LCAT activities, both of which also result in the disappear¬
ance of cathodally-migrating LPX (Sauar et al, 1978;
Mclntyre, 1978) .
Viral hepatitis
In viral hepatitis, where slight increases in high
mol wt ALP were shown to occur roughly in parallel with
total *GT and LAP (section 5.8.), these may result from an
increased rate of shedding of membrane fragments into the
sinusoid, since viral infection attacks liver cell
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membranes . In addition, cholestasis caused by intrahepatic
obstruction of the bile canaliculi by swollen parenchymal
cells may cause increases in high mol wt ALP by the
mechanisms outlined in the preceding paragraph.
In all these diseases, the actual amount of high
mol wt ALP in the circulation may depend on:
1) the degree of induction of the bile canalicular
membrane ALP
2) the rate of shedding of bile canalicular membrane
fragments into bile and serum which itself may depend
on local factors such as bile salt concentration and
cellular degeneration
3) the degree of biliary obstruction and therefore of
bile reflux
4) the number of canalicular-sinusoidal connections
5) the rate of removal of high mol wt ALP from the
circulation possibly partly by inactivation and
partly by uptake by the reticulo-endothelial system.
Whether or not the high mol wt ALP is associated with
cathodally-migrating LPX may depend on the circulating
albumin and bile salt concentration, lipoprotein lipase and
LCAT activity and possibly other, as yet unknown, serum
factors.
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7.10. CLINICAL EVALUATION OF HIGH MOLECULAR WEIGHT
ALKALINE PHOSPHATASE
Turning from general theoretical considerations to
the practical clinical evaluation of high mol wt ALP as
outlined in Chapter 5, this was necessarily limited by
the problems which affect all such studies. One such
problem is variation in the severity of disease from one
patient to the next within any given diagnostic category,
giving rise to a range of possible pathological processes
e.g. cholestasis, cell necrosis, loss of biosynthetic
capacity. Another problem was that only one sample was
taken for discriminant function analysis, and the timing
of the samples varied from patient to patient in relation
to the time course of their disease. Both these factors
tended to widen the range of biochemical results within a
given disease and to blur the distinction between diseases.
But these problems are also likely to be encountered in
routine practice; therefore, the conclusions derived from
this clinical evaluation are likely to be sufficiently
robust to apply to routine diagnostic practice.
The other limitation of the study relates to the
criterion that only patients with raised ALP levels were
included, thereby biassing the results. This was done
because at this stage only a pilot study was contemplated
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to assess whether high mol wt ALP offered more than total
ALP in the diagnosis of liver disease, and some form of
pre-selection seemed desirable to focus attention on those
patients who were definitely ill. More clinical studies
on a prospective basis on larger numbers of patients,
including those with normal total ALP activities, would be
required to assess fully the role of high mol wt ALP in
diagnosis. Further serial studies might also elucidate
its role in management, for example as a marker for liver
secondaries.
Nevertheless, the clinical evaluation provided a
useful guide to the value of high mol wt ALP in routine
diagnosis and highlights the areas which may repay further
research. On the one hand, the study has shown that,
although high mol wt ALP may contribute to the decision as
to whether a raised ALP activity is of liver or bone
origin, there are other simpler tests, which do this equally
effectively. Nor is high mol wt ALP more effective in the
diagnosis of viral hepatitis than the tests currently in
common use. On the other hand, high mol wt ALP was a
sensitive test for obstructive liver disease, particularly
local intrahepatic obstruction caused by liver metastases.
It seems possible, therefore, that high mol wt ALP may be
a sensitive test for detecting early liver metastases
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where there is a known primary carcinoma. This would be
a rewarding area for further research.
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APPENDIX 1
Abbreviations made in the text
In general, the trivial names of enzymes recommended
by the International Union of Pure and Applied Chemistry
and the International Union of Biochemistry (1972), have
been employed, with the exception of aminopeptidase which
has been termed leucine aminopeptidase in order to maintain
continuity with the literature. A list of the abbrevia¬
tions used in the text together with the systematic name









































In addition a few further abbreviations have been used in











High molecular weight alkaline phosphatase
In Chapter 5 the diagnostic categories were abbreviated in













Osteomalacia and metastatic bone disease
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